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DEFINITION OF TURNER SYNDROME
Turner syndrome (TS), also known as Ullrich-Turner Syndrome (UTS), is a chromosomal 
condition that affects phenotypic females who have one intact X-chromosome and complete 
or partial absence of the second sex chromosome, in association with one or more clinical 
manifestations.1 TS belongs to the group of rare diseases and affects 25-50 per 100.000 females. 
TS was first described by Ullrich in 1930,2 and by H. Turner in 1938.3 They reported females with 
typical features including ‘webbing of the neck, infantilism and cubitus valgus’. Nowadays, due 
to improved diagnostics, a broad and highly variable spectrum of clinical features is described. 
Short stature and premature ovarian insufficiency are present in almost all females. Furthermore, 
early hearing difficulties, congenital malformations of the heart, kidneys or bones, neurocognitive 
issues, dysmorphic features and conditions such as hypothyroidism, hypertension and celiac 
disease are described.1 
GENETICS
The human karyotype consists of 23 pairs of chromosomes, of which one pair of sex 
chromosomes (generally 46,XY in males and 46,XX in females, see Figure 1a). The number and 
type of chromosomes in a eukaryotic cell is defined as the karyotype. In women with TS, one sex 
chromosome is completely missing (monosomy 45,X) or abnormal (see Figure 1b). 
Figure 1. A: Karyotype of a healthy woman B: Karyotype of a patient with TS (monosomy 45,X)
A B
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The karyotype in females with TS has been described in many variations (see Figure 2):
Numeric abnormalities
• Monosomy 45,X: monosomy of the X-chromosome in all cells
• Mosaicism 45,X/46,XX: monosomy of the X-chromosome in part of the cells
• Multiple cell lines: mosaicism with two or more cell lines (e.g., 45,X/46,XX/47,XXX)
• Y-material: mosaicism with Y-material (e.g., 45,X/46,XY)
Structural abnormalities
• Deletion: deletion of the short arm (46,X,del(Xp)) or long arm (46,X,del(Xq)) of the 
X-chromosome
• Isochromosome: for instance, the short arm of the X-chromosome is deleted, while the long 
arm is duplicated (46,X,iso(Xq))
• Ring,X: an X-chromosome in ring form, while in most cases (large) parts of the short and long 
arm are absent
Structural abnormalities of the X-chromosome (e.g., an isochromosome) can also be found in 
combination with 45,X cells (mosaicism). Small deletions of the X-chromosome cause specific 
features and are not always included in the definition of TS. Furthermore, phenotypic males with 
45,X/46,XY (or other variants) are excluded from the diagnosis of TS.1 
A Normal female karyotype     46,XX
B Monosomy of the X-chromosome    45,X
C Deletion of part of the short arm of the X-chromosome  46,X,del(Xp)
D Deletion of part of the long arm of the X-chromosome  46,X,del(Xq)
E Isochromosome      46,X,i(Xq)
F Ring X-chromosome     46,X,r(X)
Figure 2. Overview of the most common abnormalities of the X-chromosome in females with Turner 
syndrome.
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TS can be diagnosed by using different methods:
• The gold standard is karyotyping, which shows the stained and photographed chromosomes 
in a visual profile (see Figure 1). In routine karyotyping, the chromosomal patterns of 30 
cultured lymphocytes are being counted. Although it is a time-consuming method and 
requires live lymphocytes, it can view the entire genome and visualize individual cells and 
individual structure of the chromosomes. However, it could miss low-level mosaicism or 
small deletions.4
• FISH analysis (fluorescence in situ hybridization) is a technique using fluorescent DNA-probes 
to locate a specific DNA sequence on a chromosome (see Figure 3a).5 It is a sensitive 
technique that can detect the number of chromosomes in a cell, but unlike karyotyping, the 
structure of the chromosome cannot be visualized. In TS, FISH is mostly used to investigate 
a second tissue (e.g., buccal cells) for hidden 46,XX or 46,XY cell lines, by using probes that 
detect the centromere of the X-chromosome or the Y-chromosome. In routine FISH analysis, 
100 cells (often non-dividing interphase cells) are being counted. 
• Array can be used to detect deletions and duplications of the X-chromosome at a higher 
resolution than karyotyping (see Figure 3b).6 This technique compares the patient’s 
genome against a reference genome, to identify differences (copy number variations 
(CNVs)). It has been proposed as a feasible alternative for karyotyping and can identify 
monosomy 45,X, mosaicism, Y-material and structural abnormalities.7 However, diagnosis 
can also be missed, e.g., in females with a 45,X/46,XX/47,XXX or very low-grade mosaicism 
karyotype, since no individual cells are analyzed but merely a DNA sample of many cells.7, 8 
• New techniques for diagnosis of TS include whole-exome sequencing (WES). This is a 
method to sequence only the RNA coding regions of a genome (the exome).9 One study 
showed that this technique can be an accurate method of diagnosing TS, including cases 
with mosaicism, isochromosome Xq, and Y-chromosome material.10 Still, the use of this 
technique for diagnosis of TS needs further investigation.
With the current techniques, individuals with very small percentages of mosaicism can be found 
of which the clinical implications are not yet clear. There is no official lower limit of percentage 
45,X cells for diagnosis of TS. In general, a mosaicism of >10% in combination with clinical 
symptoms is defined as TS.1 In girls or women with a percentage of 45,X cells between 5 and 
10% (low grade mosaicism), diagnosis should be considered only if clinical signs of TS are 
present. In individuals with <5% 45,X cells, TS is not diagnosed unless there is a strong clinical 
suspicion.1 In these cases, investigation of a second tissue (such as buccal cells) might be 
helpful.11 Mosaicism of the X-chromosome also occurs in healthy aging women.12 Therefore, TS 





Figure 3. A: FISH analysis of a woman with mosaic TS. The arrow shows a cell with only one X-chromosome 
(monosomy 45,X); the other cell contains two X-chromosomes. B: SNP array of a woman with TS and a deletion 
of the short arm of one X-chromosome. Negative LogR ratios represent copy losses (deletion; see arrow).
Adapted from: Prakash et al.7; Mackic-Durovic et al.13
Many 45,X conceptions spontaneously abort in the early stages of pregnancy, accounting 
for 7-10% of miscarriages in the general population.14, 15 In other words, fetuses with a 46,XX 
cell line have a higher chance of survival compared with 45,X fetuses.16 Therefore, it has been 
suggested that all females with TS have some degree of 46,XX cells somewhere in the body, 
also called ‘cryptic mosaicism’,15 although this second (normal) cell line is often not found in 
females with monosomy 45,X. The level of mosaicism may be too low to be detected with the 
current techniques, or may be present in tissues other than the ones studied.16 Currently, the 
investigation of a second tissue is not included in routine care.
Karyotype-phenotype associations in general
The phenotype in females with TS is highly variable and only partially based on the karyotype. 
In general, the following associations between karyotype and phenotype have been reported:
• Monosomy 45,X: the association between karyotype and phenotype has often been 
investigated, mostly comparing the monosomy 45,X group with ‘all other karyotypes’. 
In many studies, the females with monosomy 45,X showed a more severe phenotype 
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compared with other karyotypes.14, 17-19 A higher prevalence of dysmorphic features, cardiac 
abnormalities and premature ovarian failure has been described. Furthermore, studies have 
reported an earlier age at diagnosis in women with monosomy 45,X compared with other 
karyotypes.20 
• Mosaicism 45,X/46,XX: this karyotype is associated with a milder phenotype, such as less 
dysmorphic features, congenital malformations and less gonadal dysfunction.14, 18, 19, 21
• A karyotype with an Y-chromosome is associated with an increased risk of gonadoblastoma.22, 
23 The risk of malignancy is determined by the presence of Y-material, and the degree of 
masculinization.1 Therefore, a gonadectomy should be considered in girls or women with TS 
with Y-chromosome material identified on standard karyotyping, especially when virilization 
is present.
• A ring X-chromosome is reported to be associated with variable intellectual disability, 
depending on the size of the ring chromosome and presence or absence of the X-inactivation 
center.24, 25
• Isochromosome: an association between isochromosome and a higher incidence of auto-
immune diseases has been described.26-28
Karyotype-phenotype analyses are complicated because of the variability in definition of clinical 
features. Furthermore, within a single patient the karyotype can vary between different cell lines 
or tissues. Subgroups including females with comparable karyotypes are often small, which 
complicates the investigation of subgroups with an isochromosome or ring X-chromosome. 
Recent studies have proposed new hypotheses on the genetic and genomic mechanisms of the 
clinical presentation:29
• X-chromosome inactivation: in females, normally one of both X-chromosomes is inactivated.30 
However, some genes on this X-chromosome escape from X-inactivation and require two 
active copies to function properly; these genes are candidates for the etiology of TS. Some 
of these genes are situated in the pseudo-autosomal region (PAR) of the X-chromosome. 
PAR is a homologues region at the tips of the X- and Y-chromosome, that behaves like an 
autosome and recombines during meisosis.31 One example of a gene in this region is the 
SHOX (short stature homeo-box) gene, which is located within the pseudo-autosomal region 
1 (PAR1) of the distal short arm of the X-chromosome. Other candidate genes probably also 
play a role in TS, but the mechanism is not (yet) clear.32 
• Imprinting of genes on the X-chromosome: imprinting is a process by which some genes are 
preferentially activated depending on their parental origin (either paternally or maternally).33 
• Epigenetics and RNA expression: haploinsufficiency might affect other autosomal genes and 
may alter the regulation of gene expression across the genome.29




Individuals with TS are diagnosed at different ages and the mean age at diagnosis has decreased 
over the past decades.34 There is an increased number of girls diagnosed prenatally, due to 
advances in prenatal diagnostics and genetic testing. In the fi rst trimester, nuchal translucency is 
an ultrasound fi nding that can be seen in fetuses with TS. In addition, sometimes the diagnosis 
TS is suspected after birth, due to presence of dysmorphic features or after detecting renal or 
cardiac defects, such as coarctation of the aorta. Thereafter, TS is commonly diagnosed in 
childhood (generally during evaluation of a short stature). Some girls are not diagnosed until 
adolescence (due to delayed puberty), or even later in life.35, 36 This means that the diagnosis 
of TS is often delayed. One study calculated an average delay of 7.7 years for girls diagnosed 
in childhood or adolescence, based on presence of dysmorphic features and/or height <5th
percentile.37 An increased awareness of dysmorphic features and more routinely screening in 
girls with a short stature or delayed puberty could help to avoid delays in diagnosis.38 An early 
age at diagnosis has several potential advantages, such as an early start of growth hormone, 
early detection of associated conditions, psychosocial support, and appropriate induction of 
puberty. An appropriate age at puberty induction optimizes self-esteem, social adjustment and 
the initiation of sexual activity.39
PHENOTYPE
TS is associated with several dysmorphic features (see Figure 4), which are present in varying 
degrees. Data about the prevalence of dysmorphic features are inconsistent, probably because 
there is a large variability in the defi nition of dysmorphic features. Additionally, the dysmorphic 
features may change over time, although this has never been investigated in a large cohort. 
The phenotype of girls and women with TS can be roughly divided into two types: a skeletal 
phenotype and a lymphatic phenotype. 
Skeletal phenotype
The skeletal phenotype includes short stature, high arched palate, increased carrying angle of 
the elbow (cubitus valgus), scoliosis, micrognathia, madelung deformity and hearing impairment. 
This phenotype is known to be caused by SHOX haploinsuffi ciency.40 The SHOX gene is located 
on pseudo-autosomal region 1 (PAR1) of the X-chromosome, which contains genes escaping 
X-inactivation. SHOX is generally expressed on both sex chromosomes. 
Lymphatic phenotype
Many other phenotypic features are believed to be a consequence of oedema in utero: the 
lymphatic phenotype. This phenotype is thought to be caused by lymphatic hypoplasia or 
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aplasia of the lymphatic tracts, resulting in stasis of lymph fl uid and swelling.41 Consequently, this 
increased lymphatic pressure might lead to webbing of the neck and hypoplastic nails. It might 
also be associated with jugular lymphatic obstruction, resulting in redirection of intra-cardiac 
blood fl ow. This could explain the cardiac defects often seen in females with TS, although it has 
not been proven conclusively.42



















Figure 4. Dysmorphic features associated with Turner syndrome.
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CONGENITAL HEART DISEASE
TS is associated with a number of cardiac abnormalities, resulting in an increased morbidity and 
mortality.20, 28 Congenital heart disease occurs in approximately 50% of girls with TS, of which 
a bicuspid aortic valve, coarctation (narrowing) of the aorta, and partial anomalous pulmonary 
venous return are the most common, see Figure 5a. 
Bicuspid aortic valve
Normally, the aortic valve consists of 3 leaflets, but in some females with TS the functional aortic 
valve consists of only 2 leaflets (bicuspid aortic valve, BAV). A BAV is one of the most common 
congenital cardiovascular malformations, with an estimated incidence of 1%-2% in the general 
population.43 There are different types of BAV, varying from a nearly trileaflet aortic valve with cusp 
inequality to a unicuspid and dysplastic valve. Most young patients with BAV do not have clinical 
symptoms;44 in girls and women with TS, a BAV is often found during screening. As in non-
syndromic patients, also females with TS and BAV have a higher risk for infective endocarditis, 
development of clinically relevant aortic valve stenosis and aortic regurgitation later in life.43, 45 
In the case of severe aortic valve stenosis, valve surgery is often required. In childhood, balloon 
valvuloplasty is the treatment of choice in most cases. Aortic valve replacement is the most 
common intervention in adulthood.44 Mainly in adulthood, BAV is associated with progressive 
dilatation of the aortic root, aortic aneurysm and even rupture or dissection.46
Coarctation of the aorta
Coarctation of the aorta (COA) is a congenital condition in which a distal part of the aorta is narrower 
than usual. It can present at any age, but a ‘critical coarctation’ in neonates often presents with 
heart failure, acidosis and shock following closure of the ductus arteriosus.47 Without surgical 
intervention it may lead to a high morbidity and mortality. Systemic hypertension, weak femoral 
pulsations, or even a heart murmur may trigger diagnosis in patients with less severe coarctation 
later in childhood. Treatment options for COA are resection with end-to-end anastomosis, mainly 
early in life, or endovascular repair (balloon angioplasty or stenting).48 Presence of a COA is 
associated with a BAV (relative risk 4.6) in women with TS.49 Another abnormality of the aortic 
arch is elongation of the transverse arch.50 Elongation of the transverse aortic arch is defined 
as an increased distance between the origin of the left common carotid and the left subclavian 
arteries, with flattening of the arch and kinking along its lesser curvature.51 This is sometimes 
referred to as ‘pseudocoarctation’. The reported prevalence is 32-49% demonstrated using MRI, 
and it is associated with a BAV, COA and aortic sinus dilatation.51, 52 
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Other cardiovascular malformations
Besides abnormalities of the aortic arch, venous abnormalities have been described. Partial 
anomalous pulmonary venous return (PAPVR) is a congenital anomaly in which one of the 
pulmonary veins drains either into the systemic venous circulation or directly into the right 
atrium.53 This can cause a left-to-right shunt, which may lead to right chamber dilatation and 
eventually pulmonary hypertension. In adult women with TS, its prevalence was recently reported 
to be up to 25% using MRI or CT.54 Another reported anomaly is a persistent left superior vena 
cava (in 8-13%).51, 52 Finally, atrial septal defect (ASD), ventricular septal defect (VSD), a patent 
ductus arteriosus (PDA), pulmonary valve stenosis and hypoplastic left heart syndrome have 
been reported in a few cases.50, 55, 56
CARDIOVASCULAR DISEASE
In addition to the congenital heart defects, other cardiovascular diseases are also a serious 
concern in females with TS, see Figure 5b.
Figure 5. Congenital heart disease and acquired heart disease in Turner syndrome. 
Adapted from ‘Turner syndrome: mechanism and management’.32
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Hypertension
Hypertension is a common comorbidity in girls with TS (up to 40%), and even more in women 
with TS (up to 60%).57 Furthermore, blunted nocturnal dipping has been described in this 
population. Systemic hypertension, although most common idiopathic, can be secondary 
to renal abnormalities or coarctation of the aorta. It is known as an important risk factor for 
cardiovascular disease, such as aortic dissection and stroke, and therefore should be treated.57
Aortic dilatation and dissection
Females with TS are at risk for the development of aortic dilatation and dissection. This is due to 
the presence of risk factors, but TS alone has also been mentioned as an independent predictor 
of a larger proximal aorta.58 Aortic dissection can occur in relatively young women (mean age 
31, range 4-64 years), in contrast to the general population where the mean age in women is 68 
years.59 The reported incidence is 40 per 100.000 TS years, greatly exceeding the estimate in 
the general population.60 Pregnant women are especially at risk for aortic dissection, so careful 
counseling and monitoring of these women in a specialized hospital is required.61 Other known 
risk factors for aortic dissection are a BAV, aortic coarctation and systemic hypertension, but it 
was also described in women without any known risk factors.59 
The most important associated factor with aortic dissection, however, is dilatation of the aorta. 
Therefore, guidelines recommend strict follow-up of aortic dimensions using echocardiography 
and/or CMR.1, 45 For growing girls and women with TS and a relatively short stature, standardized 
scores (also called z-scores) are mostly used. In addition, the aortic size index (the ascending 
aortic diameter divided by body surface area; ASI) can be used in older individuals with TS (≥15 
years of age), which is proposed as a way to better predict the risk for aortic dissection in TS.45 
Different formulas for the calculation of z-scores in girls with TS can be used, based on data of a 
healthy population (e.g., according to Gautier et al.) or a TS population (e.g., according to Quezada 
et al.; TS-specific Z-scores).62, 63 The use of TS specific z-scores may be preferable to those 
derived from a healthy population, as the latter could lead to overtreatment or stigmatization.45 
Apart from this, z-scores depend on height and weight, and one should be careful when using 
these formulas in girls with a very high or very low BMI, as it may underestimate, respectively 
overestimate, the z-score in these girls. The appropriate z-score to be used for the assessment 
of aortic dilatation is an important knowledge gap. 
An increased aortic diameter is known as a risk factor for aortic dissection, but the latter can also 
occur in females with completely normal aortic diameters.64 Consequently, it is very challenging 
to determine the right timing for intervention. No clinical trials investigating this subject exist. 
Limited evidence suggests that aortic dissection usually occurs above 16 years of age and at 
an ascending ASI ≥2.5 cm/m2, or TS specific z-score of >4.1, 65 Therefore, elective operations 
for dilatation of the aortic root and/or ascending aorta should be considered in these females, 
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depending on the presence or absence of associated risk factors.1 Further research is needed 
to determine the prevalence and clinical consequences of aortic dilatation in females with TS.
CARDIAC SCREENING AND MANAGEMENT
Screening
It is important to screen for cardiovascular malformations at diagnosis and regularly thereafter, as 
patients with these malformations are often asymptomatic. These malformations, however, can lead 
to serious complications. Therefore, the TS guideline has proposed a cardiac monitoring protocol 
for girls and women with TS.1 The protocol for girls is shown in Figure 6. The most common 
imaging modalities are trans-thoracic echocardiography (TTE), cardiac magnetic resonance 
(CMR) and computed tomography (CT).45 TTE is used in the diagnosis of congenital heart defects, 
such as BAV, and for measuring the aortic dimensions.66 However, CMR is of additional value and 
has been proposed as a better way to diagnose abnormalities such as PAPVR or elongation of the 
aorta, and to measure aortic sizes beyond the aortic root, especially in adults.52, 67 
Infancy – 16 years
Cardiology exam, TTE, CMR, ECG
No COA, BAV, HT COA, BAV and/or HT
TSZ ≤3
Low risk
Repeat TTE or 





Repeat TTE or 





Repeat TTE or 





Repeat TTE or 
CMR every 6 m –
1 y by pediatric 
cardiologist
Figure 6. Suggested monitoring protocol for girls with TS from infancy to 16 years of age. 
Adapted from Gravholt et al.1 TTE = trans-thoracic echocardiography, CMR = cardiovascular magnetic resonance imaging, 
ECG = electrocardiogram, COA = coarctation of the aorta, BAV = bicuspid aortic valve, HT = hypertension, TSZ = Turner-




Besides the measurement of the aortic root, routine echocardiography enables the assessment 
of left ventricular dimensions and function in females with TS. For example, the ejection fraction 
(EF) can be evaluated, which is an important measure of systolic function. For the left ventricular 
dimensions, z-scores are used to correct for BSA in children. With the dimensions of the left 
ventricle, eventually the left ventricular mass (LVM) can be calculated, e.g., for the diagnosis of 
left ventricular hypertrophy (LVH). The latter could be expected in females with TS, due to 1) a 
high prevalence of hypertension, and 2) a high prevalence of coarctation of the aorta and aortic 
valve stenosis, which eventually could lead to LVH and left systolic dysfunction. Measurement 
of the LVM is not a standard procedure in clinical care but could provide more insight in the 
function of the left ventricle. The effect of the small stature of girls and women with TS should be 
considered when evaluating these results.
Studies investigating left ventricular dimensions and mass in females with TS have reported 
contradicting results. Most of them reported left ventricular hypertrophy and enlarged left 
chamber dimensions.68-70 Mortensen et al. found increased LV dimensions and LVM in 
women with TS compared with controls, which was associated with aortic valve disease, age, 
hypertension, physical stature and metabolic status.71 Oz et al. found an increased LVM in girls 
with TS compared with controls.70 In contrast, other studies found comparable dimensions and 
LVM with the general population.72, 73 Sas et al. described that girls with TS without clinically 
relevant cardiac abnormalities had comparable LV dimensions with healthy girls, and that growth 
hormone therapy did not change these dimensions abnormally.74 So, whether left ventricular 
hypertrophy is prevalent in females with TS, especially in girls, needs further investigation in 
unselected cohorts. 
New techniques 
Besides EF, there are also new techniques to detect (subtle) left ventricular systolic dysfunction, 
such as the assessment of myocardial deformation. Strain, a unit-les parameter, is defined as 
the percentage change in the length (deformation) of a myocardial segment over a given period 
of time, compared with the resting state.75 Two-dimensional speckle tracking echocardiography 
(2D-STE) is the most widely used method to assess myocardial deformation, a technique which 
makes use of the presence of unique acoustic markers (‘speckles’) within the myocardium 
to track their position throughout the cardiac cycle. This method offers distinct advantages in 
comparison with earlier doppler based techniques, and previous studies show that this technique 
can produce scores with high interobserver, intra-observer and intra-patient reliability.76 Strain 
can be assessed in three principle directions (longitudinal, circumferential and radial), of which 
the longitudinal strain is the most reproducible.77 Currently, global longitudinal strain (GLS) is 
recommended to describe LV systolic function.78
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GLS in females with TS was only evaluated in very small study populations (maximum of 48 
females), with contradicting results. Oz et al. assessed strain parameters in girls with TS (using 
tissue doppler strain) and found decreased strain values, but normal EF.70 Abdelmassih et al. also 
showed lower GLS values using 2D-STE in girls with TS compared with controls, but comparable 
left ventricular systolic function.72 Oberhoffer et al. showed higher global myocardial work index 
in females with TS, but no difference in global peak systolic strain between patients and controls, 
using 2D-STE.73 Besides, several studies report on (subclinical) diastolic dysfunction in females 
with TS.68, 69, 79 It is not clear whether strain imaging might contribute to earlier detection of left 
ventricular systolic dysfunction in females with TS. Furthermore, GLS varies with age, sex, LVM 
and is vendor dependent. Cut off values for abnormal strain in females with TS are not yet 
determined.
Electrocardiography
Electrocardiogram (ECG) abnormalities have been described in small study groups of females 
with TS, of which prolongation of the corrected QT (QTc) interval was the most common reported 
abnormality (see Figure 7).80-85 This is a relevant finding, as QTc prolongation in the general 
population is associated with an increased risk for arrhythmias and even sudden cardiac death. 
Identification of QTc prolongation may have consequences in the form of further diagnostic tests 
as well as recommendations of lifestyle, such as avoiding QT-prolonging medication and high-
potassium foods, and obviously may be of concern to the patient.86 Because of the reported 
prevalence of QTc prolongation, the clinical TS guidelines advises for a resting ECG in every 
individual with TS at the time of diagnosis.1 However, there are many uncertainties regarding 
the definition of QTc prolongation and the right formula to correct for heart rate.45 Additionally, 
there is no published evidence to date for sudden cardiac death related to QTc prolongation 
in patients with TS except for one case report.87 Further investigations are needed to evaluate 
whether QTc prolongation is an intrinsic factor of females with TS, using the advised methods 
and investigating a large study population. 
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Figure 7. QT interval on an ECG.
Derived from: https://commons.wikimedia.org/wiki/File:QT_interval.jpg
ECG abnormalities other than QTc prolongation have only been described by Bondy et al. 
in 2006.80, 81 Besides QTc prolongation, they have reported a high prevalence of abnormal 
ECG readings, including RSR’ complexes, right axis deviation, right ventricular hypertrophy, 
accelerated atrioventricular conduction, and T-wave abnormalities in girls with TS, compared 
with age-matched healthy girls. Comparable results were found in women with TS. Furthermore, 
studies have reported a high intrinsic heart rate and heart rate variability in women with TS, which 
might be attributed to an underlying autonomic effect.85 Shortening of the PR interval (resulting 
from accelerated atrioventricular conduction), may be a consequence of excessive sympathetic 
drive.45 The clinical consequences of the other ECG abnormalities remain unclear, and should 
be further investigated. 
OTHER COMORBIDITIES
Besides cardiovascular abnormalities, other comorbidities can occur in females with TS. As 
these are not the main focus of this thesis, but important to understand the extensive spectrum 
of characteristics within TS, these comorbidities are briefly discussed below.  
Growth
Almost all females with TS are characterized by short stature. The average height of females 
with TS is almost 20 cm shorter than the target height. This is the height that one could expect 
based on the height of the parents. Most girls with TS are treated with growth hormone therapy, 
which results in an average height gain of 5-10 cm.88-90 Other studies investigating the effect of 
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high dose growth hormone therapy, found an increased final height of up to 17 cm.91, 92 Although 
women with TS may benefit from the height gain, for example when driving a car, buying clothes 
or cooking, studies investigating the association between use of growth hormone and an 
improved health-related quality of life have reported conflicting results.93 
Gonadal dysfunction
More than 90% of the women with TS develop premature ovarian failure. Although approximately 
30-50% of the girls with TS show some pubertal changes such as breast development, most of 
these girls eventually need puberty induction for complete pubertal development.94-97 In general, 
girls with a mosaicism karyotype show more spontaneous pubertal changes than girls with a 
monosomy 45,X karyotype. Few is known on the gonadal function in other karyotype groups. 
Clinical guidelines recommend that puberty induction in TS should be started at the age of 
11-12 years, to provide an optimal physical and psychosocial development.1 After reaching 
adult replacement doses, hormone replacement therapy (HRT) should be continued to maintain 
secondary sex characteristics, and to facilitate uterine growth and peak bone mass. Furthermore, 
a recent study showed a beneficial effect on preventing diabetes mellitus, osteoporotic fractures 
and stroke from HRT treatment.98 It is advised to continue HRT until the average age of 
menopause, so around 50 years. 
Spontaneous pregnancies are described in only 2 – 7,6% women with TS.99-102 Most spontaneous 
pregnancies occur in women with a low-grade mosaicism 45,X/46,XX karyotype. Women with 
TS have an increased risk to develop aortic dissection, especially during pregnancy. Therefore, 
pregnant women should be monitored carefully in a specialized hospital.61 
Comorbidities
•   Diabetes mellitus and obesity: diabetes mellitus type 1 and 2 are more common in females 
with TS compared with the general population, although the reported prevalence differs 
between studies.17, 103-105 This is hypothesized to be linked to insulin resistance or impaired 
β-cell function in females with TS.106, 107 The higher prevalence of diabetes, obesity, insulin 
resistance, dyslipidemia and hypertension results in a higher risk for the development of 
metabolic syndrome.17 Therefore, the promotion of a healthy lifestyle and prevention of obesity 
is very important. 
•   Bones: TS is associated with musculoskeletal abnormalities such as congenital hip dysplasia, 
scoliosis and kyphosis. Scoliosis is more common with increasing height, and may develop 
during GH therapy.108, 109 Furthermore, the risk for fractures in TS is increased (estimated relative 
risk 2-3),17 even as the risk for osteopenia, resulting from inadequate estrogen exposure. 
•   Auto-immune disorders: auto-immune disorders are common in females with TS. The most 
prevalent disorders are auto-immune hypothyroidism (Hashimoto thyroiditis) and celiac 
CHAPTER 128
disease, but studies have also described a higher prevalence of chronic inflammatory bowel 
disease.17, 26, 110 It is suggested that patients with an isochromosome karyotype are more at 
risk for auto-immune disorders,26-28 but the genetic basis for this predisposition is unknown.
•   Ontology, ophthalmology and dermatology: ontological disease (e.g., chronic ear infections) 
and hearing loss are frequent problems in females with TS.111 Besides, the prevalence of 
refractive errors in girls and women with TS (~40%) is high, but also amblyopia (almost 30%) 
and strabismus (33%) are common.112 Hearing loss and poor vision may cause problems in 
the social environment and at school or work, eventually leading to an impaired socioeconomic 
status, so early detection is important.113 Last, numerous cutaneous findings are observed in 
TS, such as benign melanocytic nevi.114 A recent study found an increased risk for skin cancer, 
but not for malignant melanomas.115 
•   Renal and liver disease: structural abnormalities of the kidneys (e.g., horseshoe kidney) are 
found in 23-40% of the women with TS, although the kidney function is mostly not impaired. 
Additionally, many females have an increased serum concentration of liver enzymes, which is 
often asymptomatic. The exact etiology is unknown.116 
NEUROCOGNITIVE PROFILE, SOCIOECONOMIC STATUS AND QUALITY OF 
LIFE
TS is associated with a specific neurocognitive profile, including intact intellectual function and 
verbal abilities, but relative weaknesses in visual-spatial, executive and/or social tasks.117 These 
features may lead to an impaired socioeconomic status and quality of life in some domains, as 
explained below.
Neurocognitive profile and motor function
The specific neurocognitive profile in females with TS can be divided into different parts: 
•   First, the profile is characterized by average to low-average intelligence.117 Full-scale IQ is 
mostly normal, but subtests generally show low performance IQ and normal or even above-
average verbal IQ. Visuo-spatial and executive deficits are the most common impairments 
among individuals with TS, although there is wide variability in cognitive function. These 
deficits could be due to one or a combination of multiple environmental, genetic, or 
endocrine factors.118 Common examples in girls and women with TS are difficulties with 
mathematics, spatial perception, working memory, processing speed, organization or 
planning117, 119, 120 
•   Second, socio-cognitive tasks may be impaired. Studies have shown that females with TS 
may demonstrate poor facial and emotion recognition.121 Furthermore, low self-esteem and 
impaired social competence when compared with peers have been described.122
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•   Third, many females with TS have difficulties with motor skills, which are associated with 
the above-mentioned visuo-spatial deficits. These problems can already occur at a young 
age. Common manifestations are clumsiness, delayed motor milestones (such as walking, 
feeding and dressing self) and difficulties with writing. Furthermore, complex tasks, such 
as cycling, swimming and driving a car are often more difficult to learn for these females 
compared with others. Early recognition of impaired motor function is important, so that 
adequate intervention can be provided, for example trough physical therapy.1 
•   Fourth, TS is reported to be associated with attention-deficit/hyperactivity disorder (ADHD) 
and autism spectrum disorder, although the latter association remains controversial.123-126
The combination of these features, such as difficulties with complex tasks, planning, mathematics, 
and social cognitive defects, often lead to problems in school or in working life. As a result, 
socioeconomic status and quality of life may be impaired.
Socioeconomic status
Socioeconomic status (SES) is the descriptive term for the position of persons within society, 
based on three main components: (1) level of education, (2) occupation and (3) income, see 
Figure 8.127 It is well known that SES can influence the health of individuals, and vice versa.128 
Because of the medical problems and specific neurocognitive profile in TS, SES and quality of 
life could be impaired.
Figure 8. Components of the socioeconomic status (SES).
SES in women with TS has been less described than other (medical) factors in the field, although it 
is important information. A number of studies have investigated the SES, and mostly reported that 
in general the SES was not impaired in females with TS.129-133 Still, there are also inconsistencies 
between studies. Educational attainment was found to be similar or increased compared with 
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the general population.129, 131, 133 Gould et al. investigated SES in 261 American women with TS, 
and described that 70% of the women had a baccalaureate degree or higher.129 The employment 
status was also found to be equal or higher compared with controls.129-131 Despite this, an early 
age of retirement and lower income in women under 30 (compared with controls) are reported 
by a large birth cohort registry study from Denmark.132 Naess et al., however, found a high 
degree of satisfaction with their financial and leisure situation among women with TS.131 Looking 
at social factors, females with TS are less likely married or living together, and report more 
social difficulties, including increased shyness, social anxiety, depression, and decreased self-
esteem.131, 134 In addition, they mostly have a later sexual debut and fewer sex partners compared 
with controls.131 The inconsistencies in SES between studies might be partly explained by the 
selected cohorts of females from one country in these studies. Further studies should evaluate 
SES in larger, multicenter cohorts, and should investigate influencing factors such as karyotype, 
which are hardly described. 
Quality of life
Quality of life (QoL) encompasses how an individual measures the ‘goodness’ of multiple aspects 
of their life, also often referred to as ‘well-being’.135 QoL in TS is a subject often described, but 
with contradicting results. Reis et al. described in a meta-analysis that the QoL of women with TS 
appears to be compromised, but that factors that are related to their QoL are controversial in the 
literature.136 A more recent study described an impaired health related QoL, correlated to higher 
stress and more fatigue compared with controls.137 Krantz et al. found a similar health-related 
QoL (HRQoL) in women with TS compared with a reference population.93 They also reported that 
HRQoL is negatively affected by higher age, higher age at diagnosis and hearing impairment. 
The relationships between QoL and GH treatment or height remain controversial. Because these 
results are conflicting, most studies suggest that there is a need for the development of a TS 
specific QoL questionnaire to evaluate QoL specifically in these females.
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AIM OF THE THESIS
“How can personalized healthcare for females with Turner syndrome be optimized?” 
Healthcare professionals providing care for females with Turner syndrome (TS) are dealing 
with this question. As girls and women with TS show a large variety of clinical features and 
comorbidities, individualized care is of utmost importance. Although much has been published 
on the clinical characteristics of females with TS, significant knowledge gaps still exist. This 
thesis focuses on three main knowledge gaps:
•   First, there is a lack of knowledge about a clear karyotype-phenotype association. In this 
thesis, we study the possibilities and pitfalls of karyotype-phenotype associations. 
•   Second, we concentrate on cardiac abnormalities in girls with TS, including 
electrocardiography and myocardial strain imaging. We zoom in on the most reported ECG 
abnormality, QTc prolongation, and investigate whether these abnormalities have clinical 
consequences.
•   Third, we investigate the socioeconomic status of women with TS. Comorbidity and neuro-
cognitive problems may lead to an impaired SES, but this has been investigated by only 
a few studies. It is an important topic that provides information on the happiness and 
perspective of women with TS. 
With increasing knowledge in these three domains, we aim to be of value to the healthcare for 
girls and women with TS. The ultimate goal is to provide these females with appropriate care and 
to give them tools to thrive in the medical and socioeconomic fields.
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OUTLINE OF THE THESIS
This thesis answers the three major research topics in eight chapters:
Chapter 1 provides the reader an overview of the clinical features of TS and the knowledge gaps 
existing in the field. 
Chapter 2 zooms in on karyotype-phenotype associations regarding phenotypic features, 
cardiovascular malformations and phenotypic patterns in a prospective way.
Chapter 3 describes the karyotype-phenotype associations in a European cohort of patients 
with TS. 
Chapter 4 discusses the most reported and potentially dangerous ECG abnormality: QTc 
prolongation. We describe our findings in a large cohort of girls and women with TS and discuss 
the clinical consequences of our results.
Chapter 5 presents an overview of the cardiac abnormalities in girls with TS, including ECG 
abnormalities, aortic dimensions, routine- and myocardial strain parameters, and karyotype-
cardiac phenotype associations.
Chapter 6 describes the socioeconomic status of European women with TS, compared with 
the general population. Additionally, we discuss the possible associated factors with the socio-
economic status in women with TS, including karyotype.




1.  Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley 
CA, Rubin K, Sandberg DE, Sas TCJ, Silberbach M, Soderstrom-Anttila V, Stochholm K, van Alfen-van 
derVelden JA, Woelfle J, Backeljauw PF, Grp ITSC. Clinical practice guidelines for the care of girls 
and women with turner syndrome: Proceedings from the 2016 cincinnati international turner syndrome 
meeting. European Journal of Endocrinology. 2017;177:G1-G70
2.  Ullrich O. Über typische kombinationsbilder multipler abartungen. Zeitschrift für Kinderheilkunde. 
1930;49:271-276
3.  Turner HH. A syndrome of infantilism, congenital webbed neck, and cubitus valgus (reprinted from 
endocrinology, vol 23, pg 566-574, 1938). Endocrinologist. 1995;5:330-338
4.  Freriks K, Timmers HJ, Netea-Maier RT, Beerendonk CC, Otten BJ, van Alfen-van der Velden JA, Traas 
MA, Mieloo H, van de Zande GW, Hoefsloot LH, Hermus AR, Smeets DF. Buccal cell fish and blood 
pcr-y detect high rates of x chromosomal mosaicism and y chromosomal derivatives in patients with 
turner syndrome. European journal of medical genetics. 2013;56:497-501
5.  Eastmond DA, Schuler M, Rupa DS. Advantages and limitations of using fluorescence in situ 
hybridization for the detection of aneuploidy in interphase human cells. Mutat Res Lett. 1995;348:153-
162
6.  Silva M, de Leeuw N, Mann K, Schuring-Blom H, Morgan S, Giardino D, Rack K, Hastings R. European 
guidelines for constitutional cytogenomic analysis. European Journal of Human Genetics. 2019;27:1-16
7.  Prakash S, Guo DC, Maslen CL, Silberbach M, Milewicz D, Bondy CA, Investigators G. Single-
nucleotide polymorphism array genotyping is equivalent to metaphase cytogenetics for diagnosis of 
turner syndrome. Genetics in Medicine. 2014;16:53-59
8.  Bondy C. Recent developments in diagnosis and care for girls in turner syndrome. Advances in 
Endocrinology. 2014;2014:231089
9.  van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C. Ten years of next-generation sequencing technology. 
Trends Genet. 2014;30:418-426
10.  Murdock DR, Donovan FX, Chandrasekharappa SC, Banks N, Bondy C, Muenke M, Kruszka P. Whole-
exome sequencing for diagnosis of turner syndrome: Toward next-generation sequencing and newborn 
screening. The Journal of clinical endocrinology and metabolism. 2017;102:1529-1537
11.  Graff A, Donadille B, Morel H, Villy MC, Bourcigaux N, Vatier C, Borgel A, Khodawardi A, Siffroi JP, 
Christin-Maitre S. Added value of buccal cell fish analysis in the diagnosis and management of turner 
syndrome. Human reproduction. 2020;35:2391-2398
12.  Russell LM, Strike P, Browne CE, Jacobs PA. X chromosome loss and ageing. Cytogenet Genome Res. 
2007;116:181-185
13.  Mackic-Durovic M, Stomornjak-Vukadin M, Ibrulj S. Turner syndrome: A unique mosaic case with 
45,x/47,xx,+21/46,xx cell lines. Iran J Med Sci. 2018;43:436-439
14.  Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner’s syndrome in adulthood. Endocrine reviews. 
2002;23:120-140
CHAPTER 134
15.  Hook EB, Warburton D. Turner syndrome revisited: Review of new data supports the hypothesis that all 
viable 45,x cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss. Human 
genetics. 2014;133:417-424
16.  Hassold T, Pettay D, Robinson A, Uchida I. Molecular studies of parental origin and mosaicism in 
45,x-conceptuses. Human genetics. 1992;89:647-652
17.  Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in turner syndrome. Journal of clinical epidemiology. 
1998;51:147-158
18.  El-Mansoury M, Barrenas ML, Bryman I, Hanson C, Larsson C, Wilhelmsen L, Landin-Wilhelmsen 
K. Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in turner syndrome. 
Clinical endocrinology. 2007;66:744-751
19.  Cameron-Pimblett A, La Rosa C, King TFJ, Davies MC, Conway GS. The turner syndrome life course 
project: Karyotype-phenotype analyses across the lifespan. Clinical endocrinology. 2017;87:532-538
20.  Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and 
mortality in turner syndrome. The Journal of clinical endocrinology and metabolism. 2006;91:3897-3902
21.  Klaskova E, Tudos Z, Sobek A, Zapletalova J, Dostal J, Zborilova B, Sobek A, Adamova K, Lattova V, 
Dostalova Z, Prochazka M. Low-level 45,x/46,xx mosaicism is not associated with congenital heart 
disease and thoracic aorta dilatation:Prospective magnetic resonance imaging and ultrasound study. 
Ultrasound Obst Gyn. 2015;45:722-727
22.  Gravholt CH, Fedder J, Naeraa RW, Muller J. Occurrence of gonadoblastoma in females with turner 
syndrome and y chromosome material: A population study. J Clin Endocr Metab. 2000;85:3199-3202
23.  azzanti L, Cicognani A, Baldazzi L, Bergamaschi R, Scarano E, Strocchi S, Nicoletti A, Mencarelli F, 
Pittalis M, Forabosco A, Cacciari E. Gonadoblastoma in turner syndrome and y-chromosome-derived 
material. Am J Med Genet A. 2005;135:150-154
24.  Kuntsi J, Skuse D, Elgar K, Morris E, Turner C. Ring-x chromosomes: Their cognitive and behavioural 
phenotype. Ann Hum Genet. 2000;64:295-305
25.  El Abd S, Patton MA, Turk J, Hoey H, Howlin P. Social, communicational, and behavioral deficits 
associated with ring x turner syndrome. American journal of medical genetics. 1999;88:510-516
26.  Hayward PAR, Satsangi J, Jewell DP. Inflammatory bowel disease and the x chromosome. Qjm-Mon J 
Assoc Phys. 1996;89:713-718
27.  Elsheikh M, Wass JAH, Conway GS. Autoimmune thyroid syndrome in women with turner’s syndrome - 
the association with karyotype. Clinical endocrinology. 2001;55:223-226
28.  Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA, United Kingdom Clinical Cytogenetics 
G. Mortality in women with turner syndrome in great britain: A national cohort study. The Journal of 
clinical endocrinology and metabolism. 2008;93:4735-4742
29.  Viuff M, Skakkebaek A, Nielsen MM, Chang S, Gravholt CH. Epigenetics and genomics in turner 
syndrome. Am J Med Genet C. 2019;181:68-75
30. Lyon MF. Gene action in the x-chromosome of the mouse (mus musculus l.). Nature. 1961;190:372-373
31.  Helena Mangs A, Morris BJ. The human pseudoautosomal region (par): Origin, function and future. Curr 
Genomics. 2007;8:129-136
GENERAL INTRODUCTION 35
32.  Gravholt CH, Viuff MH, Brun S, Stochholm K, Andersen NH. Turner syndrome: Mechanisms and 
management. Nat Rev Endocrinol. 2019;15:601-614
33.  Lepage JF, Hong DS, Hallmayer J, Reiss AL. Genomic imprinting effects on cognitive and social 
abilities in prepubertal girls with turner syndrome. The Journal of clinical endocrinology and metabolism. 
2012;97:E460-464
34.  Massa G, Verlinde F, De Schepper J, Thomas M, Bourguignon JP, Craen M, de Zegher F, Francois I, Du 
Caju M, Maes M, Heinrichs C, Belgian Study Group for Paediatric E. Trends in age at diagnosis of turner 
syndrome. Archives of disease in childhood. 2005;90:267-268
35.  Apperley L, Das U, Ramakrishnan R, Dharmaraj P, Blair J, Didi M, Senniappan S. Mode of clinical 
presentation and delayed diagnosis of turner syndrome: A single centre uk study. Int J Pediatr 
Endocrinol. 2018;2018:4
36.  Lee MC, Conway GS. Turner’s syndrome: Challenges of late diagnosis. Lancet Diabetes Endocrinol. 
2014;2:333-338
37.  Savendahl L, Davenport ML. Delayed diagnoses of turner’s syndrome: Proposed guidelines for change. 
The Journal of pediatrics. 2000;137:455-459
38.  Grote FK, Oostdijk W, Keizer-Schrama SMPFM, Dekker FW, van Dommelen P, van Buuren S, Kooij 
AMLVD, Verkerk PH, Wit JM. Referral patterns of children with poor growth in primary health care. Bmc 
Public Health. 2007;7
39.  Carel JC, Elie C, Ecosse E, Tauber M, Leger J, Cabrol S, Nicolino M, Brauner R, Chaussain JL, Coste 
J. Self-esteem and social adjustment in young women with turner syndrome--influence of pubertal 
management and sexuality: Population-based cohort study. The Journal of clinical endocrinology and 
metabolism. 2006;91:2972-2979
40.  Binder G. Short stature due to shox deficiency: Genotype, phenotype, and therapy. Horm Res Paediat. 
2011;75:81-89
41.  von Kaisenberg CS, Nicolaides KH, Brand-Saberi B. Lymphatic vessel hypoplasia in fetuses with turner 
syndrome. Hum Reprod. 1999;14:823-826
42.  Lacro RV, Jones KL, Benirschke K. Coarctation of the aorta in turner syndrome - a pathologic-study of 
fetuses with nuchal cystic hygromas, hydrops fetalis, and female genitalia. Pediatrics. 1988;81:445-451
43.  Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, 
Graham TP, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb 
GD. Acc/aha 2008 guidelines for the management of adults with congenital heart disease: A report 
of the american college of cardiology/american heart association task force on practice guidelines 
(writing committee to develop guidelines on the management of adults with congenital heart disease): 
Developed in collaboration with the american society of echocardiography, heart rhythm society, 
international society for adult congenital heart disease, society for cardiovascular angiography and 
interventions, and society of thoracic surgeons. Circulation. 2008;118:E714-E833
44.  Siu SC, Silversides CK. Bicuspid aortic valve disease. Journal of the American College of Cardiology. 
2010;55:2789-2800
CHAPTER 136
45.  Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, De Backer J, 
Eagle KA, Hiratzka LF, Johnson WH, Kadian-Dodov D, Lopez L, Mortensen KH, Prakash SK, Ratchford 
EV, Saidi A, van Hagen I, Young LT, Cardiov AHAC, Med CGP, Dis CPV. Cardiovascular health in turner 
syndrome a scientific statement from the american heart association. Circ-Genom Precis Me. 2018;11
46.  Beroukhim RS, Kruzick TL, Taylor AL, Gao DX, Yetman AT. Progression of aortic dilation in children with 
a functionally normal bicuspid aortic valve. American Journal of Cardiology. 2006;98:828-830
47.  Torok RD, Campbell MJ, Fleming GA, Hill KD. Coarctation of the aorta: Management from infancy to 
adulthood. World J Cardiol. 2015;7:765-775
48.  Suradi H, Hijazi ZM. Current management of coarctation of the aorta. Glob Cardiol Sci Pract. 
2015;2015:44
49.  Mortensen KH, Hjerrild BE, Andersen NH, Sorensen KE, Horlyck A, Pedersen EM, Lundorf E, 
Christiansen JS, Gravholt CH. Abnormalities of the major intrathoracic arteries in turner syndrome as 
revealed by magnetic resonance imaging. Cardiology in the young. 2010;20:191-200
50.  Mortensen KH, Andersen NH, Gravholt CH. Cardiovascular phenotype in turner syndrome--integrating 
cardiology, genetics, and endocrinology. Endocrine reviews. 2012;33:677-714
51.  Ho VB, Bakalov VK, Cooley M, Van PL, Hood MN, Burklow TR, Bondy CA. Major vascular anomalies 
in turner syndrome - prevalence and magnetic resonance angiographic features. Circulation. 
2004;110:1694-1700
52.  Kim HK, Gottliebson W, Hor K, Backeljauw P, Gutmark-Little I, Salisbury SR, Racadio JM, Helton-Skally 
K, Fleck R. Cardiovascular anomalies in turner syndrome: Spectrum, prevalence, and cardiac mri 
findings in a pediatric and young adult population. AJR Am J Roentgenol. 2011;196:454-460
53.  El-Kersh K, Homsy E, Daniels CJ, Smith JS. Partial anomalous pulmonary venous return: A case series 
with management approach. Respir Med Case Rep. 2019;27
54.  van den Hoven AT, Chelu RG, Duijnhouwer AL, Demulier L, Devos D, Nieman K, Witsenburg M, van den 
Bosch AE, Loeys BL, van Hagen IM, Roos-Hesselink JW. Partial anomalous pulmonary venous return in 
turner syndrome. Eur J Radiol. 2017;95:141-146
55.  Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO. Prevalence of cardiovascular 
malformations and association with karyotypes in turner’s syndrome. Archives of disease in childhood. 
1994;71:433-436
56.  Liedmeier A, Jendryczko D, van der Grinten HC, Rapp M, Thyen U, Pienkowski C, Hinz A, Reisch N. 
Psychosocial well-being and quality of life in women with turner syndrome. Psychoneuroendocrinology. 
2019;113:104548
57.  De Groote K, Demulier L, De Backer J, De Wolf D, De Schepper J, T’Sjoen G, De Backer T. Arterial 
hypertension in turner syndrome: A review of the literature and a practical approach for diagnosis and 
treatment. J Hypertens. 2015;33:1342-1351
58.  Lopez L, Arheart KL, Colan SD, Stein NS, Lopez-Mitnik G, Lin AE, Reller MD, Ventura R, Silberbach 
M. Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics. 
2008;121:E1622-E1627
GENERAL INTRODUCTION 37
59.  Carlson M, Silberbach M. Dissection of the aorta in turner syndrome: Two cases and review of 85 cases 
in the literature. Journal of medical genetics. 2007;44:745-749
60.  Gravholt CH, Landin-Wilhelmsen K, Stochholm K, Hjerrild BE, Ledet T, Djurhuus CB, Sylven L, Baandrup 
U, Kristensen BO, Christiansen JS. Clinical and epidemiological description of aortic dissection in 
turner’s syndrome. Cardiology in the young. 2006;16:430-436
61.  Hynes JS, Kuller JA, Goldstein SA, Ward CC, Muasher SJ. Increased risk of aortic dissection associated 
with pregnancy in women with turner syndrome: A systematic review. Obstet Gynecol Surv. 2020;75:566-
575
62.  Gautier M, Detaint D, Fermanian C, Aegerter P, Delorme G, Arnoult F, Milleron O, Raoux F, Stheneur 
C, Boileau C, Vahanian A, Jondeau G. Nomograms for aortic root diameters in children using two-
dimensional echocardiography. American Journal of Cardiology. 2010;105:888-894
63.  Quezada E, Lapidus J, Shaughnessy R, Chen Z, Silberbach M. Aortic dimensions in turner syndrome. 
Am J Med Genet A. 2015;167A:2527-2532
64.  Wong SC, Cheung M, Zacharin M. Aortic dilatation and dissection in turner syndrome: What we know, 
what we are unclear about and what we should do in clinical practice? International journal of adolescent 
medicine and health. 2014;26:469-488
65.  Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dilatation and dissection in turner syndrome. Circulation. 
2007;116:1663-1670
66.  Lanzarini L, Larizza D, Prete G, Calcaterra V, Meloni G, Sammarchi L, Klersy C. Aortic dimensions 
in turner’s syndrome: Two-dimensional echocardiography versus magnetic resonance imaging. J 
Cardiovasc Med. 2007;8:428-437
67.  Ostberg JE, Brookes JAS, McCarthy C, Halcox J, Conway GS. A comparison of echocardiography and 
magnetic resonance imaging in cardiovascular screening of adults with turner syndrome. J Clin Endocr 
Metab. 2004;89:5966-5971
68.  Sozen AB, Cefle K, Kudat H, Ozturk S, Oflaz H, Akkaya V, Palanduz S, Demirel S, Ozcan M, Goren T, Guven 
O. Left ventricular thickness is increased in nonhypertensive turner’s syndrome. Echocardiography. 
2009;26:943-949
69.  Tancredi G, Versacci P, Pasquino AM, Vittucci AC, Pucarelli I, Cappa M, Di Mambro C, Marino B. 
Cardiopulmonary response to exercise and cardiac assessment in patients with turner syndrome. 
American Journal of Cardiology. 2011;107:1076-1082
70.  Oz F, Cizgici AY, Ucar A, Karaayvaz EB, Kocaaga M, Bugra Z, Mercanoglu F, Oncul A, Nisli K, Oflaz 
H. Doppler-derived strain imaging detects left ventricular systolic dysfunction in children with turner 
syndrome. Echocardiography. 2014;31:1017-1022
71.  Mortensen KH, Gravholt CH, Hjerrild BE, Stochholm K, Andersen NH. Left ventricular hypertrophy in 
turner syndrome: A prospective echocardiographic study. Echocardiogr-J Card. 2012;29:1022-1030
72.  AbdelMassih AF, Attia M, Ismail MM, Samir M. Insulin resistance linked to subtle myocardial dysfunction 
in normotensive turner syndrome young patients without structural heart diseases. J Pediatr Endocr 
Met. 2018;31:1355-1361
CHAPTER 138
73.  Oberhoffer FS, Abdul-Khaliq H, Jung AM, Zemlin M, Rohrer TR, Abd El Rahman M. Assessment of left 
ventricular myocardial work in turner syndrome patients: Insights from the novel non-invasive pressure-
strain loop analysis method. Quant Imag Med Surg. 2020;10:15-25
74.  Sas TC, Cromme-Dijkhuis AH, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Drop SL. 
The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood 
pressure in girls with turner’s syndrome. Dutch working group on growth hormone. The Journal of 
pediatrics. 1999;135:470-476
75.  Collier P, Phelan D, Klein A. A test in context: Myocardial strain measured by speckle-tracking 
echocardiography. Journal of the American College of Cardiology. 2017;69:1043-1056
76.  Mavinkurve-Groothuis AM, Weijers G, Groot-Loonen J, Pourier M, Feuth T, de Korte CL, Hoogerbrugge 
PM, Kapusta L. Interobserver, intraobserver and intrapatient reliability scores of myocardial strain 
imaging with 2-d echocardiography in patients treated with anthracyclines. Ultrasound Med Biol. 
2009;35:697-704
77.  Velagapudi VM, Pidikiti R, Tighe DA. Is left ventricular global longitudinal strain by two-dimensional 
speckle tracking echocardiography in sepsis cardiomyopathy ready for prime time use in the icu? 
Healthcare-Basel. 2019;7
78.  Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein 
SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, 
Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: An 
update from the american society of echocardiography and the european association of cardiovascular 
imaging. Journal of the American Society of Echocardiography : official publication of the American 
Society of Echocardiography. 2015;28:1-39 e14
79.  Andersen NH, Hjerrild BE, Sorensen K, Pedersen EM, Stochholm K, Gormsen LC, Horlyck A, Christiansen 
JS, Gravholt CH. Subclinical left ventricular dysfunction in normotensive women with turner’s syndrome. 
Heart. 2006;92:1516-1517
80.  Bondy CA, Ceniceros I, Van PL, Bakalov VK, Rosing DR. Prolonged rate-corrected qt interval and other 
electrocardiogram abnormalities in girls with turner syndrome. Pediatrics. 2006;118:e1220-1225
81.  Bondy CA, Van PL, Bakalov VK, Sachdev V, Malone CA, Ho VB, Rosing DR. Prolongation of the cardiac 
qtc interval in turner syndrome. Medicine. 2006;85:75-81
82.  Dalla Pozza R, Bechtold S, Kaab S, Buckl M, Urschel S, Netz H, Schwarz HP. Qtc interval prolongation 
in children with ulrich-turner syndrome. European journal of pediatrics. 2006;165:831-837
83.  Trolle C, Mortensen KH, Pedersen LN, Berglund A, Jensen HK, Andersen NH, Gravholt CH. Long qt 
interval in turner syndrome--a high prevalence of lqts gene mutations. PloS one. 2013;8:e69614
84.  Atici A, Panc C, Karaayvaz EB, Demirkiran A, Kutlu O, Kasali K, Kekec E, Sari L, Akyol Sari ZN, Bilge AK. 
Evaluation of the tp-te interval, tp-te/qtc ratio, and qt dispersion in patients with turner syndrome. Anatol 
J Cardiol. 2018;20:93-99
85.  Sozen AB, Cefle K, Kudat H, Ozturk S, Oflaz H, Pamukcu B, Akkaya V, Isguven P, Palanduz S, Ozcan 
M, Goren T, Guven O. Atrial and ventricular arryhthmogenic potential in turner syndrome. Pacing and 
clinical electrophysiology : PACE. 2008;31:1140-1145
GENERAL INTRODUCTION 39
86.  Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, 
Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C. Hrs/ehra/
aphrs expert consensus statement on the diagnosis and management of patients with inherited primary 
arrhythmia syndromes: Document endorsed by hrs, ehra, and aphrs in may 2013 and by accf, aha, 
paces, and aepc in june 2013. Heart Rhythm. 2013;10:1932-1963
87.  Nielsen DG, Nielsen JC, Trolle C, Gravholt CH, Andersen NH. Prolonged qt interval and cardiac arrest 
after a single dose of amiodarone in a woman with turner’s syndrome. Clin Case Rep. 2017;5:154-158
88.  Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze 
J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ. Growth hormone therapy of turner’s 
syndrome: Beneficial effect on adult height. The Journal of pediatrics. 1998;132:319-324
89.  Ross JL, Quigley CA, Cao D, Feuillan P, Kowal K, Chipman JJ, Cutler GB, Jr. Growth hormone 
plus childhood low-dose estrogen in turner’s syndrome. The New England journal of medicine. 
2011;364:1230-1242
90.  Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen 
M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van 
Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM. 
Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome. The Journal of 
clinical endocrinology and metabolism. 2010;95:1151-1160
91.  Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma 
T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL. 
Normalization of height in girls with turner syndrome after long-term growth hormone treatment: 
Results of a randomized dose-response trial. The Journal of clinical endocrinology and metabolism. 
1999;84:4607-4612
92.  van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman 
JJ, Vulsma T, Stokvis-Brantsma WH, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken 
C, Drop SL. Final height in girls with turner syndrome after long-term growth hormone treatment in three 
dosages and low dose estrogens. The Journal of clinical endocrinology and metabolism. 2003;88:1119-
1125
93.  Krantz E, Landin-Wilhelmsen K, Trimpou P, Bryman I, Wide U. Health-related quality of life in turner 
syndrome and the influence of growth hormone therapy: A 20-year follow-up. The Journal of clinical 
endocrinology and metabolism. 2019;104:5073-5083
94.  Carpini S, Carvalho AB, Guerra-Junior G, Baptista MT, Lemos-Marini SH, Maciel-Guerra AT. Spontaneous 
puberty in girls with early diagnosis of turner syndrome. Arq Bras Endocrinol Metabol. 2012;56:653-657
95.  Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in 
turner’s syndrome. Italian study group for turner’s syndrome. The Journal of clinical endocrinology and 
metabolism. 1997;82:1810-1813
96.  Hankus M, Soltysik K, Szeliga K, Antosz A, Drosdzol-Cop A, Wilk K, Zachurzok A, Malecka-Tendera 
E, Gawlik AM. Prediction of spontaneous puberty in turner syndrome based on mid-childhood 
CHAPTER 140
gonadotropin concentrations, karyotype, and ovary visualization: A longitudinal study. Horm Res 
Paediatr. 2018;89:90-97
97.  Negreiros LP, Bolina ER, Guimaraes MM. Pubertal development profile in patients with turner syndrome. 
Journal of pediatric endocrinology & metabolism : JPEM. 2014;27:845-849
98.  Viuff MH, Berglund A, Juul S, Andersen NH, Stochholm K, Gravholt CH. Sex hormone replacement 
therapy in turner syndrome: Impact on morbidity and mortality. J Clin Endocr Metab. 2020;105:468-478
99.  Birkebaek NH, Cruger D, Hansen J, Nielsen J, Bruun-Petersen G. Fertility and pregnancy outcome in 
danish women with turner syndrome. Clinical genetics. 2002;61:35-39
100.  Bryman I, Sylven L, Berntorp K, Innala E, Bergstrom I, Hanson C, Oxholm M, Landin-Wilhelmsen K. 
Pregnancy rate and outcome in swedish women with turner syndrome. Fertility and sterility. 2011;95:2507-
2510
101.  Bernard V, Donadille B, Zenaty D, Courtillot C, Salenave S, Brac de la Perriere A, Albarel F, Fevre A, 
Kerlan V, Brue T, Delemer B, Borson-Chazot F, Carel JC, Chanson P, Leger J, Touraine P, Christin-Maitre 
S, Disease CCfR. Spontaneous fertility and pregnancy outcomes amongst 480 women with turner 
syndrome. Human reproduction. 2016;31:782-788
102.  Hadnott TN, Gould HN, Gharib AM, Bondy CA. Outcomes of spontaneous and assisted pregnancies 
in turner syndrome: The u.S. National institutes of health experience. Fertility and sterility. 2011;95:2251-
2256
103.  Bakalov VK, Cheng C, Zhou J, Bondy CA. X-chromosome gene dosage and the risk of diabetes in 
turner syndrome. J Clin Endocr Metab. 2009;94:3289-3296
104.  Landin-Wilhelmsen K, Bryman I, Wilhelmsen L. Cardiac malformations and hypertension, but not 
metabolic risk factors, are common in turner syndrome. J Clin Endocr Metab. 2001;86:4166-4170
105.  Freriks K, Timmermans J, Beerendonk CC, Verhaak CM, Netea-Maier RT, Otten BJ, Braat DD, Smeets 
DF, Kunst DH, Hermus AR, Timmers HJ. Standardized multidisciplinary evaluation yields significant 
previously undiagnosed morbidity in adult women with turner syndrome. The Journal of clinical 
endocrinology and metabolism. 2011;96:E1517-1526
106.  Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA. Impaired 
insulin secretion in the turner metabolic syndrome. J Clin Endocr Metab. 2004;89:3516-3520
107.  Hjerrild BE, Holst JJ, Juhl CB, Christiansen JS, Schmitz O, Gravholt CH. Delayed beta-cell response and 
glucose intolerance in young women with turner syndrome. BMC Endocr Disord. 2011;11:6
108.  Kim JY, Rosenfeld SR, Keyak JH. Increased prevalence of scoliosis in turner syndrome. J Pediatr 
Orthoped. 2001;21:765-766
109.  Ricotti S, Petrucci L, Carenzio G, Klersy C, Calcaterra V, Larizza D, Dalla Toffola E. Prevalence and 
incidence of scoliosis in turner syndrome: A study in 49 girls followed-up for 4 years. Eur J Phys Rehab 
Med. 2011;47:447-453
110. Bonamico M, Pasquino AM, Mariani P, Danesi HM, Culasso F, Mazzanti L, Petri A, Bona G, 
Gastroenterolog ISP. Prevalence and clinical picture of celiac disease in turner syndrome. J Clin Endocr 
Metab. 2002;87:5495-5498
GENERAL INTRODUCTION 41
111.  Alves C, Oliveira CS. Hearing loss among patients with turner’s syndrome: Literature review. Braz J 
Otorhinolar. 2014;80:257-263
112.  Denniston AKO, Butler L. Ophthalmic features of turner’s syndrome. Eye. 2004;18:680-684
113.  Wikiera B, Mulak M, Koltowska-Haggstrom M, Noczynska A. The presence of eye defects in patients 
with turner syndrome is irrespective of their karyotype. Clinical endocrinology. 2015;83:842-848
114.  Lowenstein EJ, Kim KH, Glick SA. Turner’s syndrome in dermatology. J Am Acad Dermatol. 2004;50:767-
776
115.  Viuff MH, Stochholm K, Lin A, Berglund A, Juul S, Gravholt CH. Cancer occurrence in turner syndrome 
and the effect of sex hormone substitution therapy. Eur J Endocrinol. 2020
116.  Larizza D, Locatelli M, Vitali L, Vigano C, Calcaterra V, Tinelli C, Sommaruga MG, Bozzini A, Campani R, 
Severi F. Serum liver enzymes in turner syndrome. European journal of pediatrics. 2000;159:143-148
117.  Hong D, Scaletta Kent J, Kesler S. Cognitive profile of turner syndrome. Dev Disabil Res Rev. 
2009;15:270-278
118.  Ross J, Roeltgen D, Zinn A. Cognition and the sex chromosomes: Studies in turner syndrome. Horm 
Res. 2006;65:47-56
119.  Mullaney R, Murphy D. Turner syndrome: Neuroimaging findings: Structural and functional. Dev Disabil 
Res Rev. 2009;15:279-283
120.  Lepage JF, Dunkin B, Hong DS, Reiss AL. Contribution of executive functions to visuospatial difficulties 
in prepubertal girls with turner syndrome. Dev Neuropsychol. 2011;36:988-1002
121.  Lawrence K, Kuntsi J, Coleman M, Campbell R, Skuse D. Face and emotion recognition deficits in turner 
syndrome: A possible role for x-linked genes in amygdala development. Neuropsychology. 2003;17:39-
49
122.  Lagrou K, Froidecoeur C, Verlinde F, Craen M, De Schepper J, Francois I, Massa G. Psychosocial 
functioning, self-perception and body image and their auxologic correlates in growth hormone and 
oestrogen treated young adult women with turner syndrome. Hormone Research. 2006;66:277-284
123.  Russell HF, Wallis D, Mazzocco MMM, Moshang T, Zackai E, Zinn AR, Ross JL, Muenke M. Increased 
prevalence of adhd in turner syndrome with no evidence of imprinting effects. J Pediatr Psychol. 
2006;31:945-955
124.  Creswell CS, Skuse DH. Autism in association with turner syndrome: Genetic implications for male 
vulnerability to pervasive developmental disorders. Neurocase. 1999;5:511-518
125.  Kesler SR. Turner syndrome. Child Adol Psych Cl. 2007;16:709-+
126.  Lepage JF, Lortie M, Deal CL, Theoret H. Empathy, autistic traits, and motor resonance in adults with 
turner syndrome. Soc Neurosci-Uk. 2014;9:601-609
127.  Last JM. Dictionary of public health. Eur J Public Health. 2002;12:308-308
128.  Adler NE, Ostrove JM. Socioeconomic status and health: What we know and what we don’t. Ann Ny 
Acad Sci. 1999;896:3-15
129.  Gould HN, Bakalov VK, Tankersley C, Bondy CA. High levels of education and employment among 
women with turner syndrome. J Womens Health. 2013;22:230-235
CHAPTER 142
130.  Boman UW, Bryman I, Halling K, Moller A. Women with turner syndrome: Psychological well-being, self-
rated health and social life. J Psychosom Obst Gyn. 2001;22:113-122
131.  Naess EE, Bahr D, Gravholt CH. Health status in women with turner syndrome: A questionnaire study on 
health status, education, work participation and aspects of sexual functioning. Clinical endocrinology. 
2010;72:678-684
132.  Stochholm K, Hjerrild B, Mortensen KH, Juul S, Frydenberg M, Gravholt CH. Socioeconomic parameters 
and mortality in turner syndrome. Eur J Endocrinol. 2012;166:1013-1019
133.  Verlinde F, Massa G, Lagrou K, Froidecoeur C, Bourguignon JP, Craen M, De Schepper J, Du Caju 
M, Heinrichs C, Francois I, Maes M, Belgian Study Group of Paediatric E. Health and psychosocial 
status of patients with turner syndrome after transition to adulthood: The belgian experience. Horm Res. 
2004;62:161-167
134.  Schmidt PJ, Cardoso GMP, Ross JL, Haq N, Bondy CA. Shyness, social anxiety, and impaired self-
esteem in turner syndrome and premature ovarian failure. Jama-J Am Med Assoc. 2006;295:1374-1376
135.  Theofilou P. Quality of life: Definition and measurement (retraction of vol 9, 2013). Eur J Psychol. 
2013;9:150-150
136.  Reis CT, de Assumpcao MS, Guerra G, de Lemos-Marini SHV. Systematic review of quality of life in 
turner syndrome. Qual Life Res. 2018;27:1985-2006
137.  van den Hoven AT, Bons LR, Dykgraaf RHM, Dessens AB, Pastoor H, de Graaff LCG, Metselaar MR, 
Kneppers-Swets A, Kardys I, Mijnarends H, Zweerus F, Hazelzet JA, Utens EMWJ, van den Bosch AE, 
Roos-Hesselink JW. A value-based healthcare approach: Health-related quality of life and psychosocial 




Phenotype in girls and women with Turner 
syndrome: association between dysmorphic 
features, karyotype and cardio-aortic 
malformations
Iris D. Noordman1, Anthonie L. Duijnhouwer2, Livia Kapusta1,3, Marlies Kempers4, Nel Roeleveld5, 
Michiel Schokking1, Dominique Smeets4, Kim Freriks6, Henri J.L.M. Timmers7, Janiëlle A.E.M. 
van der Velden1
1.  Department of Pediatrics, Amalia Children’s Hospital, Radboud university medical center, Nijmegen, The Netherlands
2.  Department of Cardiology, Radboud university medical center, Nijmegen, The Netherlands
3.  Pediatric Cardiology Unit, Tel-Aviv Sourasky Medical Center, Sackler school of Medicine, Tel Aviv University, Tel Aviv, 
Israel
4.  Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands
5.  Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands
6.  Department of Internal Medicine, Tjongerschans hospital, Heerenveen, The Netherlands
7.  Department of Internal Medicine, section of Endocrinology, Radboud university medical center, Nijmegen, The 
Netherlands




Turner syndrome (TS) is a genetic disorder characterized by the (partial) absence or a structural 
aberration of the second sex chromosome and is associated with a variety of phenotypes with 
specific physical features and cardio-aortic malformations. The objective of this study was to gain 
a better insight into the differences in dysmorphic features between girls and women with TS and 
to explore the association between these features, karyotype and cardio-aortic malformations.
Methods
This prospective study investigated 14 dysmorphic features of TS girls and women using a 
checklist. Three major phenotypic patterns were recognized (severe phenotype, lymphatic 
phenotype and skeletal phenotype). Patient data including karyotype and cardio-aortic 
malformations (bicuspid aortic valve (BAV) and aortic coarctation (COA)) were collected. 
Associations between the prevalence of dysmorphic features, karyotype and cardio-aortic 
malformations were analyzed using chi2-tests and odds ratios. 
Results
A total of 202 patients (84 girls and 118 women) were analyzed prospectively. Differences in 
prevalence of dysmorphic features were found between girls and women. A strong association 
was found between monosomy 45,X and the phenotypic patterns. Furthermore, an association 
was detected between COA and lymphatic phenotype, but no association was found between 
karyotype and cardio-aortic malformations.
Conclusion
This study uncovered a difference in dysmorphic features between girls and women. Monosomy 
45,X is associated with a more severe phenotype, lymphatic phenotype and skeletal phenotype. 
All patients with TS should be screened for cardio-aortic malformations, because in contrast to 
previous reports, karyotype and cardio-aortic malformations showed no significant association.
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INTRODUCTION
Turner Syndrome (TS) is caused by a chromosomal defect, characterized by the absence of 
one sex chromosome (45,X), absence of this sex chromosome in some cells (mosaicism) or 
by structural abnormality of the second sex chromosome. Other karyotypes associated with TS 
involve phenotypic females with a normal or an abnormal Y-chromosome.1 These defects can 
lead to abnormalities in almost all organs.2 Specific dysmorphic features are common, such as 
webbing of the neck, cubitus valgus and lymphedema. Previous studies showed inconsistent 
results regarding the prevalence of dysmorphic signs in children and adults.2-6 There are no clear 
data on how these features change from childhood into adolescence.
The wide variability in dysmorphic features in TS patient is still not fully understood. Some argued 
that patients with a 45,X karyotype have a more severe phenotype compared to TS patients 
with a mosaicism.7 But contradicting results on karyotype-phenotype associations have been 
reported as well.3, 7-9
TS is associated with cardio-aortic malformations. The most common malformations are: bicuspid 
aortic valve (BAV, reported prevalence 12-30%), aortic coarctation (COA, reported prevalence 
7-18%) and arterial and venous vessel malformations.10-12 Compared to a tricuspid aortic valve, 
BAV is more prone to degenerate which can lead to valvular stenosis and regurgitation. In 
association with BAV, ascending aortic dilatation is also seen in TS patients which can lead to 
aortic dissection.13, 14 These complications are a major cause of mortality in TS. 
BAV and COA have been associated with webbing of the neck, lymphedema and a more severe 
phenotype.15-17 No other associations between cardio-aortic malformations and dysmorphic 
features have been described in TS. Earlier studies suggest that monosomy 45,X is associated 
with a higher incidence of cardio-aortic malformations, although prevalence of monosomy 45,X 
was high in these cohorts and selection bias might have occurred.1, 16, 18
The objective of this study was to investigate the differences in dysmorphic features between 





TS patients visiting the outpatient clinic of our tertiary center from May 2005 until June 2009 
(women) and December 2015 until November 2016 (girls) were included. Patients ≤ 18 years 
old were considered girls. Information about karyotype and cardio-aortic malformations in the 
adults with TS is also partly reported in previous published data.19 This study was approved by 
the local ethical committee.
Karyotype
Diagnosis of TS was based on cytogenetic analysis of at least 30 cells from peripheral blood 
cultures. If monosomy 45,X was found, the karyotype was reevaluated analyzing at least 100 
buccal cells to search for undetected cell lines (FISH). Results of buccal smear were decisive.20 
Patients with a 45,X/46,XY karyotype were included if the phenotype was female. To describe 
the karyotype of the population, we created eight groups: karyotype with monosomy 45,X, 
mosaicism 45,X/46,XX, isochromosome (e.g.,  46,X,iso(X)), deletion (e.g., 46,X,del(X)), ring X 
(e.g., 45,X/46,X,r(X)), multiple cell lines (e.g., 45,X/46,XX/47,XXX), Y-material (e.g., 45,X/46,XY) 
and other (not to classify). We compared patients with monosomy 45,X to patients with other 
karyotypes. 
Cardio-aortic malformations
Presence of a BAV and COA was reassessed using transthoracic 2-dimensional echocardiography. 
Many TS patients have a slight indentation of the aortic arch near the origin of the left subclavian 
artery, which we did not consider as a COA. COA was defined as the patient having a history of 
surgical repair or balloon angioplasty of the aorta. 
Classification of dysmorphic features
Each TS patient was checked at the outpatient clinic for distinct dysmorphic features using 
a checklist. After an extensive literature search, this checklist was designed to include the 14 
most often reported dysmorphic signs (see Table 2). Dysmorphic features were used to classify 
two groups of TS patients: mild phenotype (patients with 0-5 features) and severe phenotype 
(patients with 6-12 features). 
Two phenotypic patterns were recognized. A patient was considered to have a ‘skeletal 
phenotype’, if at least three skeletal features were present (small lower jaw, cubitus valgus, high 
palate, short metacarpal/metatarsal (MC/MT) IV bone, Madelung deformity or scoliosis). The 
term ‘lymphatic phenotype’ refers to a situation in which a patient has at least three lymphatic 
features (lymphedema, webbed neck, low hairline or hypoplastic/hyperconvex nails). The three 
major phenotypic patterns (severe phenotype, lymphatic phenotype and skeletal phenotype) 
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were not mutually exclusive and a patient with severe phenotype could also have either a skeletal 
phenotype, a lymphatic phenotype, or both.
Statistical analysis
Statistical analysis was carried out using SPSS 22 (SPSS Inc, Chicago, IL). The dysmorphic 
features were scored dichotomous and each separate feature had the same weight in the 
analysis. Chi2-tests and odds ratios were used to evaluate associations between dysmorphic 
features, karyotype and cardio-aortic malformations. P values <0.05 and odds ratios (OR) with 
a confidence interval that excluded 1 were considered statistically significant. 
RESULTS
In total 230 patients were eligible for the study, of whom 202 were included (84 girls and 118 
women). For karyotype and patient characteristics, see Table 1. Patients were excluded if 
information about dysmorphic features was incomplete (n=28). Analysis of buccal mucosa was 
performed in 45,X monosomy patients (n=90), which showed that 74% had the same karyotype 
in buccal cells (45,X), 13% turned out to have a 45,X/46,XX mosaicism and 13% turned out to 
have other mosaic karyotypes (e.g., 45,X/46,XX/47,XXX or 45,X/46,XY).
The prevalence and statistical evaluation of dysmorphic features and cardio-aortic malformations 
in girls and women with TS is shown in Table 2. All karyotypes were included in this table. Most 
common dysmorphic features in the total population were low posterior hairline (53%), high 
arched palate (52%) and multiple pigmented nevi (51%). Scoliosis (11%), strabismus (8%) and 
madelung deformity (5%) were less common in our population. We observed differences in the 
clinical phenotype between TS girls and women: a short neck and pigmented nevi were more 
present in women than in girls. In addition, a high arched palate, cubitus valgus, short MC/MT IV 
bones and hypoplastic/hyperconvex nails were more prevalent in the pediatric cohort. 
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Table 1. Karyotype and baseline characteristics of girls and women with Turner syndrome.
Karyotype
Girls Women Total
N (%) Mean age ± 
SD (years)
N (%) Mean age ± 
SD (years)




-  Mosaicism 45,X/46,XX
-  Isochromosome
-  Deletion
-  Ring X



















































Total 84 11.6 ± 4.2 118 31.6 ± 10.2 202 23.2 ± 12.8
Table 2. Prevalence and statistical evaluation of dysmorphic features and cardio-aortic malformations in 
girls and women with Turner syndrome (all karyotypes).
Dysmorphic features Girls (%)  Women (%) Total (%) P-value 
N = 84 N = 119 N = 202
Strabismus 10 8 8 ns 
Ptosis 12 21 17 ns 
Small lower jaw 29 23 25 ns 
Short neck 29 53 43 0.001 
Webbed neck 23 21 22 ns 
Low hairline 47 57 53 ns 
High arched palate 66 43 52 0.002
Scoliosis 9 13 11 ns 
Pigmented nevi 40 59 51 0.008
Cubitus valgus 56 22 36 <0.0001 
Short MC/MT IV bones 27 15 20 0.031
Madelung deformity 6 4 5 ns 
Lymphedema hands/feet 25 15 19 ns 

















A few data about dysmorphic features were missing, percentages were calculated on available data. 
Abbreviations: ns = not significant, MC/MT = metacarpal/metatarsal.
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Confidence intervals were calculated using the Clopper-Pearson Exact Method. Patients are divided into age groups 
of 5 years (e.g., 0-5 years old, 5-10 years old etc.). Patients >50 years old are also shown as one group, due to small 
numbers. Abbreviations: MC/MT = metacarpal/metatarsal.
Figure 1. Overview of dysmorphic features in each age category based on clinical evaluation of patients with 
Turner syndrome (all karyotypes).
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Figure 1 shows an overview of the dysmorphic features in different age categories in TS patients 
with all karyotypes. The frequency of dysmorphic features was based on a cross-sectional, 
clinical evaluation of TS patients at different ages. The prevalence of short neck and multiple 
pigmented nevi seemed to increase as patients grow older. The prevalence of high arched 
palate and hypoplastic/hyperconvex nails seemed to slightly decrease with age. The prevalence 
of cubitus valgus and short MC/MT IV bones showed no clear changes in time. 
The number of dysmorphic features was higher in the monosomy 45,X group than in the group 
with other karyotypes, in both girls and women. Monosomy 45,X and webbing of the neck showed 
the strongest association (OR 4.9, 95%CI 2.4-10; see Table 3). Furthermore, a strong association 
was present between monosomy 45,X and ptosis, small lower jaw, short neck, webbed neck, 
low hairline, lymphedema and hypoplastic nails. No significant association was found between 
monosomy 45,X and cardio-aortic malformations (see Table 3). 
Table 4 presents the association between dysmorphic features and cardio-aortic malformations 
in girls and women with Turner syndrome (all karyotypes). COA showed a significant association 
with webbing of the neck, which is the only significant association found. In the total population, 
ptosis and scoliosis showed a statistically significant association with BAV.
An overview of the three major phenotypic patterns in TS patients with monosomy 45,X versus 
patients with TS based on other karyotypes is shown in Table 5. A strong association between 
monosomy 45,X and a severe phenotype (OR 7.1 95%Cl 3.3-15.1) was found. In addition, 
both the lymphatic and the skeletal phenotype were more common in individuals with a 45,X 
monosomy. However, the association with skeletal phenotype was not statistically significant 
in women possibly due to small numbers in the skeletal phenotype group. Table 6 presents an 
analysis of cardio-aortic malformations in TS girls and women with all karyotypes, with regard 
to the three major phenotypic patterns. Aside from COA, which was significant associated with 
a lymphatic phenotype, no association between cardio-aortic malformations and phenotypic 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































This is the first study that describes a difference in dysmorphic features between TS girls 
and women, suggesting a change in dysmorphic features with age. This study uncovered a 
strong association between monosomy 45,X and a lymphatic, skeletal and severe phenotype. 
Furthermore, an association was found between COA and lymphatic phenotype.
In the literature, the described prevalence of dysmorphic features in girls and women with TS 
showed a wide variety.2-6 In our study, the prevalence of cubitus valgus and short MC/MT IV 
bones (36% and 20%) was relatively low compared to the prevalence described in literature 
(respectively 50-76% and 25-74%). The prevalence of other features was comparable to the 
indicated range of earlier studies. However, former studies described relatively small patient 
groups, while dysmorphic features of children and adults were never compared in one single 
study. Our study included a large patient population and showed that dysmorphic features 
between children and adults differ. 
Dysmorphic nails were more common in children than in adults. Hypoplastic or hyperconvex 
nails are known to be caused by peripheral lymphedema which mostly presents within the first 
year of life. It can persist throughout life, but in most cases the swelling resolves before the age 
of four.16, 21, 22 Therefore, we hypothesize that the deformities of the nails diminish over the years.
Regarding the prevalence of a high arched palate, recent research suggests that the palatal 
height is not affected compared to control subjects.23 It is argued that a low tongue position and 
presence of prominent lateral palatine ridges create an illusion of a high-arched palate.23-25 Still, 
this illusion of a high arched palate seemed to decrease with age in our study. The observation 
of a high arched palate is high at birth, possibly due to a lack of space in the mouth during 
embryonic development, mostly because of a small lower jaw. After birth, other forces (for 
example of the masticatory system) seem to play a role in the further development of the palate 
and skull. This might be an explanation of the less reported high arched palate in TS women.
Pigmented nevi mostly become obvious in childhood or puberty in the normal population.7 Our 
study shows the same development of multiple pigmented nevi over time in TS. The differences 
in the reported prevalence of short neck in TS girls and women could be explained by the fact 
that head-body proportions are different in children. A short neck will therefore become more 
obvious during adolescence and adulthood. Furthermore, we did not objectively measure the 
length of the neck, so the prevalence we found might be less accurate and the difference we 
found between girls and women might be overestimated. 
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Reports about the relationship between karyotype and dysmorphic features have shown 
conflicting results. The most recent study collected information about 25 dysmorphic signs 
of 80 girls and divided these girls in four groups of different karyotypes using cytogenetic 
evaluation (45,X, mosaicism, marker chromosome and isochromosome), instead of two groups 
in our study.3 This study showed no association between monosomy 45,X and phenotype. 
Other studies described a clear association between karyotype and dysmorphic features.6-9 In 
particular, an association between monosomy 45,X and webbing of the neck was found, even 
as an association with lymphedema.9, 16 Our results confirm a strong association between 45,X 
monosomy and severe phenotype, lymphatic phenotype and skeletal phenotype. This suggests 
that patients with other karyotypes (e.g., mosaicism 46,XX) mostly have a milder phenotype, 
which could make (early) diagnosis of TS more difficult. 
The percentage of monosomy 45,X in our study is relatively low (35%) compared to others. This 
may be due to our search for undetected cell lines in buccal smears of 45,X monosomy patients, 
which revealed a mosaic pattern in 26% of the cases. This means we have a pure group of girls 
and women with karyotype 45,X, a strength of our study. Besides this, in the Netherlands all girls 
with short stature are being screened for TS, which might lead to more frequent diagnosis of (low 
grade) mosaicism in our study population.
Although an association between karyotype and cardio-aortic malformations has been described 
by some studies,1, 6, 16, 26 we did not find a link between these two. This might be due to the 
low prevalence of COA (3%, n=6) in our population compared to the prevalence described in 
literature (7-18%),11, 12 possibly because we only defined the clinically relevant (i.e. patients who 
underwent an intervention) COA in our study. 
Webbing of the neck has been associated with BAV and COA.15, 16 We found the same significant 
association between webbed neck and COA. The association between webbed neck and cardio-
aortic malformations suggests a possible relationship between these two. Increased lymphatic 
pressure might be associated with jugular lymphatic obstruction, resulting in redirection of intra-
cardiac blood flow. This could lead to COA and other left-sided cardiac defects.16, 22 Furthermore, 
we found an association between BAV and ptosis or scoliosis. Although this association was 
statistically significant, we question the clinical relevance. There were no reports in literature 
about a possible association.
A key strength of this study is the large study population with prospective examination of 
dysmorphic features. This is the first study which prospectively evaluates the differences 
in dysmorphic features between children and adults and describes the association between 
cardio-aortic malformations and dysmorphic features other than lymphedema and webbing of 
the neck. We included all TS patients visiting our outpatient clinic, which means there was no 
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selection bias in contrast to most other studies. The current findings provide a framework for 
further exploration of these associations. 
The most important limitation in our study was the objective assessment of dysmorphic features 
in children and adults. Physical examination in children and adults was performed by different 
physicians. However, we used the same checklist to decrease the possibility of inter-observer 
variability.  
CONCLUSION
Our study describes a difference in dysmorphic features between girls and women with TS, 
indicating a change in dysmorphic features with increasing age. Furthermore, our study shows 
that monosomy 45,X is associated with a severe phenotype, lymphatic phenotype and skeletal 
phenotype. Dysmorphic features of patients with a mosaic karyotype can be very mild, which 
suggests that identification of TS might be difficult. Health care professionals should be alert 
when webbing of the neck is seen in a patient with TS, because of the significant association 
between neck webbing and COA. Since the incidence of BAV and COA was not associated 
with karyotype, we stress to screen all patients for cardio-aortic malformations, irrespective of 
karyotype or grade of mosaicism.
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ABSTRACT 
Variation in karyotype may be associated with the phenotype of patients with Turner syndrome 
(TS). Our objective was to identify these associations between karyotype and phenotype in 
patients with TS. This study was part of the European multicenter dsd-LIFE study. We evaluated 
the associations between different karyotypes of TS patients and age at diagnosis, Turner 
stigmata, cardiac/renal involvement and gonadal function. Information was available for 328 
patients with TS. Participants had a monosomy 45,X (46%), mosaicism 45,X/46,XX (10%), 
karyotype with isochromosome (18%), or other karyotype (26%). The clinical signs of TS were 
the most severe in patients with monosomy 45,X and the least severe in patients with mosaicism 
45,X/46,XX. Patients with isochromosome and Y-material showed an intermediate phenotype. 
Despite the more severe features in patients with monosomy 45,X, the median age at diagnosis 
was only slightly lower compared to patients with other karyotypes, which suggests opportunities 
for improvement of knowledge and diagnostics.
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INTRODUCTION
Turner syndrome (TS) is caused by sex chromosomal aberrations, characterized by monosomy 
of the X-chromosome (45,X), absence of a sex chromosome in some cells (mosaicism), or a 
structural abnormality of the X-chromosome. The phenotype caused by these defects is highly 
variable.1 Common features of TS are growth retardation and gonadal dysfunction. Other features 
include dysmorphic signs (Turner stigmata), cardiac defects, such as bicuspid aortic valve and 
coarctation of the aorta, and renal defects, such as horseshoe kidney.2 
Age at diagnosis of patients with TS varies from prenatal diagnosis up to diagnosis at 60 years 
of age, with a mean or median age ranging from 4.2 to 15.1 years according to the literature.3-7 
Diagnosis of TS is often delayed. One study calculated an average delay of 7.7 years for girls 
diagnosed in childhood or adolescence, based on presence of dysmorphic features and/or 
height <5th percentile.3 Early diagnosis has several potential advantages, such as an early start 
of growth hormone treatment, appropriate induction of puberty, and early detection of associated 
conditions.3, 5 Prior studies suggest that the age at diagnosis is lower in patients with monosomy 
45,X compared to other karyotypes, probably because of more typical Turner stigmata in the 
monosomy 45,X group.4-8
Ovarian dysfunction is one of the most severe complications in TS, leading to absence of 
spontaneous puberty in most cases, with estrogen deficiency and infertility in almost all patients. 
Previous studies showed that approximately 30% of girls with TS show spontaneous pubertal 
changes, although most girls do not fully progress into puberty.9 It is suggested that patients 
with the mosaicism 45,X/46,XX karyotype are more likely to develop spontaneous puberty 
than monosomy 45,X patients.9-12 Furthermore, spontaneous pregnancy occurs in 4.8-7.6% of 
patients with TS, mostly in women with a mosaicism 45,X/46,XX karyotype and spontaneous 
menarche.13-15
We hypothesize that the variation in karyotype may be associated with the clinical presentation 
of TS including gonadal function. Early insight into the clinical phenotype is important for the 
personalized follow-up of patients. The objective of this study was to identify associations 
between variations in karyotype and phenotype (age at diagnosis, clinical presentation and 
gonadal dysfunction) in patients with TS in a European population. 
CHAPTER 366
METHODS
Subjects and data collection
This study was part of the dsd-LIFE study, a cross-sectional clinical outcome study investigating 
medical, surgical, psychosocial, and ethical issues to improve treatment and care of patients 
included in the umbrella term disorder/differences of sex development (DSD). For the theoretical 
and methodological framework of the dsd-LIFE study we refer to the paper by Roehle et al.16 From 
February 2014 until September 2015, participants with different forms of DSD were recruited in 
fourteen study centers in six European countries: France, Germany, The Netherlands, Poland, 
Sweden, and the United Kingdom. Standard operating procedures were developed by and for 
professionals to perform the study in a standardized manner in all study centers. Furthermore, 
patient support groups contributed to the development of the study protocol. Patients were 
investigated in their local treatment center. The data were obtained through a medical interview 
on current signs and symptoms, an evaluation of the past medical history, and a physical 
examination by a physician. The data were registered by a study nurse or physician. The medical 
interview collected standardized information on e.g., the diagnosis, karyotype, and comorbidities 
of the participants. The general physical exam was used to obtain a general impression of the 
patient with measurement of height, weight, dysmorphic features, and other parameters. Written 
informed consent was obtained from all participants. If the participant was under the age of 18 
years, both the participant and the parents signed the informed consent. Ethical approval was 
obtained as appropriate to each country. Twenty-eight patients of this dsd-LIFE study were also 
included in another study of our research group.8
In the total dsd-LIFE cohort, information on 346 patients classified as having TS (including patients 
with karyotype 45,X/46,XY) was available. We excluded patients without a classified karyotype 
(n=4) and patients with a male phenotype (n=14), so the total study population consisted of 328 
patients with Turner syndrome. We evaluated the information about karyotype (including type of 
tissue investigated), age at diagnosis, gestational age, birth weight, dysmorphic features (typical 
Turner stigmata), cardiac/renal involvement (bicuspid aortic valve (BAV), coarctation of the aorta 
(COA), aortic stenosis, and horseshoe kidney (HK)) and gonadal function (FSH, spontaneous 
puberty, puberty induction, and age at puberty induction). Analyses for final height and the use 
of growth hormone will be described in a separate paper. A variable was only analyzed if data 
was available for >20% of the patients.
Karyotype
Patients were divided into 8 subgroups based on their karyotype (Table 1): 1) monosomy 45,X 
(n=150); 2) mosaicism 45,X/46,XX (n=31); 3) isochromosome (45,X/46,X,i(Xq), 46,X,i(Xq) or 
45,X/46,X,i(Xq)/47,X,i(Xq),i(Xq), n=59); 4) deletion (45,X/46,X,del(X) or 46,X,del(X), n=19); 5) 
polyploidy (45,X/46,XX/47,XXX or 45,X/47,XXX, n=16); 6) ring X material (45,X/46,X,r(X), n=12); 
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7) Y-material (45,X/46,XY, 45,X/46,XX/46,XY or 45,X/48,XXYY, n=31); and unknown (n=10). We 
evaluated the tissue used for the determination of the karyotype, the karyotype in other tissues, 
and the percentage of 45,X or 46,XX cells if available. 
Age at diagnosis and clinical presentation
Age at diagnosis was recorded in years. When the diagnosis was made prenatally, age at 
diagnosis was considered to be 0 years. The severity of dysmorphic features was rated by the 
local physician into four groups of Turner stigmata: ‘no stigmata’, ‘minimal stigmata’ (only short 
stature <150 cm), ‘moderate stigmata’ (short stature, compact squat stature (appearance) and/
or nevi) and ‘typical stigmata’ (short stature, typical facies, short neck, webbing of the neck, 
broad chest, cubiti valgi and/or nevi). The associations between dysmorphic features and 
karyotype were analyzed by comparing the prevalence of patients with ‘typical stigmata’ in the 
different karyotype groups. Furthermore, information about gestational age, birth weight, and 
the presence or a history of BAV, COA, aortic stenosis and HK, retrieved from medical records, 
was analyzed.
Gonadal function
We analyzed information about spontaneous puberty, puberty induction, and age at puberty 
induction. To evaluate gonadal function at diagnosis and at the age of 16, information about 
serum FSH (U/L), LH (U/L), estradiol (pmol/L) and AMH (pmol/L) concentrations was present. 
Because of low numbers of patients with laboratory analyses, however, only FSH concentrations 
at diagnosis were analyzed. Serum concentrations of all parameters were measured and 
interpreted in the participating hospitals. 
Statistical analysis
Statistical analysis was performed using SPSS version 22 (SPSS Inc, Chicago, IL). Descriptive 
statistics were used to describe baseline characteristics of the study population. Normality 
of continuous variables was determined using visual and statistical methods (e.g., shape of 
histogram, skewness, and kurtosis). Because most variables were not normally distributed, 
median and range (min-max) were presented. Because of varying numbers of missing data, 
the numbers of participants included in each analysis were reported separately. We created 
two larger subgroups: one group with the monosomy 45,X karyotype and one group with all 
other karyotypes, as we hypothesized patients with monosomy 45,X to have the least favorable 
phenotype. Furthermore, we compared each single karyotype group with the mosaicism 
45,X/46,XX group, which was the group with the most favorable clinical phenotype in our 
population. 
To compare the continuous variables among the different karyotype groups, Mann-Whitney 
U-tests were used with P values <0.05 being considered as statistically significant. Odds ratios 
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(OR) with 95% confidence intervals (95%CI) were calculated to analyze the associations between 
karyotypes and dichotomous variables, when at least two patients with the feature were present 
in a subgroup. When zeros occurred in the referent group, 0.5 was added to each cell to enable 
estimation of the ORs.
RESULTS
Patient characteristics and karyotype
The patient characteristics are presented in Table 1. For most cases, the karyotype was reported 
from peripheral blood only. However, for three patients karyotype was reported from buccal 
mucosa and for one patient, information from amniotic fluid only was available. The most 
prevalent karyotype was monosomy 45,X (46%), followed by the karyotype with isochromosome 
(18%). Within the isochromosome group, 78% of the women had a mosaicism isochromosome 
karyotype (e.g., 45,X/46,X,i(Xq)) (n=46), while 22% had a structural abnormality of the 
X-chromosome (e.g., 46,X,i(Xq)) (n=13), without any differences in clinical features between 
these groups. In the mosaicism 45,X/46,XX group, information about percentage of 45,X cells 
was available for 20 patients. The median percentage of 45,X cells in mosaicism was 33%, with 
a minimum of 10% and a maximum of 97% in the only patient with a percentage of 45,X cells 
>90%. The age of the patients at assessment ranged from 15 to 73 years, with a median age of 
28 years. The two patients of 15 years old turned 16 during recruitment. For less than half of the 
patients, data on gestational age and/or birth weight were available. The median gestational age 
was within the normal range (39 weeks, range 30-42), while the median birth weight was 2805 
grams (range 650-4279 grams). 
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Table 1. Description of karyotype and baseline characteristics of patients with Turner syndrome.



























Median age at assessment (min-max) in years 28 (15-73) 328
Median age at diagnosis (min-max) in years 10 (0-61) 281
Median gestational age (min-max) in weeks 39 (30-42) 124
Median birth weight (min-max) in grams 2805 (650-4279) 156














Bicuspid aortic valve 45 316 14.2
Coarctation of the aorta 17 315 5.4
Aortic stenosis 7 311 2.3
Horseshoe kidney 34 311 10.9
Spontaneous puberty 83 309 26.9
Puberty induction 240 309 77.7
Median age at puberty induction (min-max) in years 14 (8-20) 224





















Percentages were calculated on the available data. †FSH levels were measured and interpreted in different 
study centers.
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Age at diagnosis 
The distribution of age at diagnosis is shown in Figure 1. The age at diagnosis ranged from 
prenatally to 61 years (median 10 years). In the total population, 4% of the patients were diagnosed 
prenatally and 9% of the patients were diagnosed in adulthood. Patients with monosomy 45,X 
were far more frequently diagnosed prenatally or in infancy compared to patients with other 
karyotypes. Furthermore, both karyotype groups had a peak age at diagnosis in the age range 
of 10-13 years. In the total population patients with typical Turner stigmata were diagnosed earlier 
than patients with no, mild or moderate stigmata (median 7 (0-61) versus median 11 (0-59) 
years, respectively; p<0.001). 
Table 2 shows the median age at diagnosis in the two subgroups (monosomy 45,X and other 
karyotypes), which differed by one year only: 10 (0-61) years in patients with monosomy 45,X 
versus 11 (0-39) years in all other karyotypes (p=0.025). No clear differences in age at diagnoses 
were seen among the other karyotypes (Table 3), when compared to mosaicism 45,X/46,XX or 
monosomy 45,X. 


























Figure 1. Age at diagnosis of Turner syndrome (TS) patients with monosomy 45,X (n = 125) 
versus other karyotypes related to TS (n = 150).
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Clinical presentation
More than 80% of our study population showed Turner stigmata, with 21% (n=59) classifi ed 
in the most severe category ‘typical stigmata’ (Table 1). Monosomy 45,X was associated with 
higher prevalence rates of typical Turner stigmata, BAV and COA compared to the group of other 
karyotypes with ORs varying between 2.4 (95%CI: 1.3-4.6) for BAV to 6.0 (95%CI: 1.7-21.3) for 
COA, whereas no clear associations were observed with aortic stenosis or HK (Table 2). 
Table 2. Clinical features of Turner syndrome patients with monosomy 45,X karyotype (n=150) versus other 














Typical Turner stigmata 40/126 (32%) 16/143 (11%) 3.7 (1.9-7.0)
BAV 29/143 (20%) 16/165 (10%) 2.4 (1.3-4.6)
COA 14/141 (10%) 3/166 (2%) 6.0 (1.7-21.3)
Aortic stenosis 5/140 (4%) 2/163 (1%) 3.0 (0.6-15.6)
HK 19/141 (14%) 15/162 (9%) 1.5 (0.7-3.1)
Spontaneous puberty 15/137 (11%) 65/164 (40%) 0.2 (0.1-0.3)
Puberty induction 124/137 (91%) 110/164 (67%) 4.7 (2.4-9.0)














Percentages were calculated on the available data. †P values from Mann-Whitney U-tests. ‡FSH levels were 
measured and interpreted in different study centers. Abbreviations:  BAV = bicuspid aortic valve, COA = 
coarctation of the aorta, HK = horseshoe kidney.
Table 3 shows the clinical features of patients in six main karyotype groups compared to patients 
with mosaicism 45,X/46,XX. Patients from the monosomy 45,X group showed more typical 
Turner stigmata (32%) compared to mosaicism 45,X/46,XX (OR 4.9, 95%CI: 1.1-21.8), while the 
numbers were in the same range for patients with ring X material (30%; OR 4.5, 95%CI: 0.6-32.7). 
No patients in the mosaicism 45,X/46,XX group had a BAV, COA, or aortic stenosis, but patients 
in several other karyotype groups did. Regarding BAV, the estimated ORs varied between 10.4 
(95%CI: 0.6-186.4) for patients with isochromosome (14% BAV) and 16.2 (95%CI: 1.0-273.1) for 
patients with monosomy 45,X (20% BAV), while these ORs were 15.0 and 14.1 for patients with 
ring X or Y material, respectively (17% BAV). Differences were less clear for COA and HK and 
irrelevant for aortic stenosis. Birth weight and gestational age were not associated with typical 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A history of spontaneous puberty was seen in 27% of the total population, ranging from 11% in 
women with monosomy 45,X to 67% in women with mosaicism 45,X/46,XX. Puberty induction 
was used in 78% of the patients (Tables 1-3), as some of these patients had spontaneous 
regressive puberty which required induction therapy. The patient groups with monosomy 45,X, 
isochromosome, and Y-material clearly showed less spontaneous puberty and more puberty 
induction than the group with mosaicism 45,X/46,XX. Compared to monosomy 45,X, however, 
the isochromosome group had a higher prevalence of spontaneous puberty (30% versus 
11%; p=0.001) and a lower prevalence of puberty induction (79% versus 91%; p=0.029). No 
differences were seen in median age at puberty induction between the karyotype groups. 
FSH concentration at diagnosis was analyzed for 74 TS girls with age at diagnosis <18 years. As 
shown in Figure 2, FSH levels measured at diagnosis (median 23 (0-289) U/L) were associated 
with age at diagnosis. Both Table 2 and Figure 2 show that FSH levels at diagnosis among TS 
girls were higher in patients with monosomy 45,X compared to all other karyotypes (median 60 
(1-289) versus 13 (0-166) U/L; p=0.010). 























Figure 2. Age at diagnosis and FSH at diagnosis in Turner syndrome girls with monosomy 45,X (n=25) 
compared to other karyotypes (n=49).
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Compared to girls with mosaicism 45,X/46,XX, the levels of FSH at diagnosis were higher 
among girls with monosomy 45,X (p<0.001), isochromosome (p=0.007), ring X (p=0.001), and 
Y-material (p<0.001, Table 3). In girls with spontaneous puberty, FSH at diagnosis was lower 
compared to girls without spontaneous puberty (median 8 (0-126) U/L versus 46 (0-289) U/L, 
p=0.002). 
In the group with a Y-material karyotype (n=31), information about gonadectomy surgery was 
available for 21 women, of whom 20 had a gonadectomy. Furthermore, three patients with 
Y-material had clitoral surgery and four patients had a vaginoplasty. One patient with karyotype 
45,X/46,XY did not have a gonadectomy and six patients with other karyotypes did have a 
gonadectomy (monosomy 45,X (n=3), isochromosome (n=2) and mosaicism 45,X/46,XX 
(n=1)), for unknown reasons.
Table 4. Summary of associations between karyotype and phenotype for the four largest karyotype groups 
in Turner syndrome based on the results of this study.
Karyotype N % Phenotype
Monosomy
45,X
150 46 Most severe phenotype
Typical Turner stigmata
High % of BAV and COA
Low % of spontaneous puberty, high % of puberty 
induction





31 10 Some typical Turner stigmata
Intermediate % of BAV and very low % of COA
Low % of spontaneous puberty, high % of puberty 
induction





59 18 Some typical Turner stigmata
Intermediate % of BAV and very low % of COA
Intermediate % of spontaneous puberty, high % of puberty 
induction
Intermediate levels of FSH at diagnosis
Mosaicism
45,X/46,XX
31 10 Least severe phenotype
Few typical Turner stigmata
Very low % of BAV and COA
High % of spontaneous puberty, low % of puberty induction
Low levels of FSH at diagnosis
FSH levels were measured and interpreted in different study centers. Abbreviations: BAV = bicuspid aortic 
valve, COA = coarctation of the aorta.
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Table 4 shows a summary of the karyotype – phenotype associations in our study population. 
Karyotype groups with low numbers were not included in this table, which clearly shows a range 
in severity of phenotype between the main karyotype groups with monosomy 45,X leading to 
the most severe and mosaicism to the least severe phenotype and patients with Y-material or 
isochromosome being intermediate.
DISCUSSION 
Turner syndrome used to be a clinically detected syndrome, with the diagnosis based on typical 
Turner stigmata such as short stature, delayed puberty, webbing of the neck, and cubitus valgus, 
discovered by Henri Turner and Otto Ullrich. With the implementation of karyotyping, however, 
diagnosis of TS changed. Nowadays, a large heterogeneity is known to exist in the karyotypes of 
TS, leading to a range of different phenotypes. Adequate understanding of the clinical phenotype 
is important for the personalized follow-up of patients.
Our study, examining a large group of 328 individuals with TS from 14 study centers in 6 European 
countries, showed that the clinical signs of TS are the most severe in patients with monosomy 
45,X. They showed more typical Turner stigmata and multiple Turner related pathology in contrast 
to the patients with mosaicism 45,X/46,XX. Isochromosome and Y-material showed a more 
‘intermediate’ phenotype. Gonadal dysfunction, an important complication in Turner syndrome, 
was the most favorable in patients with mosaicism in terms of spontaneous puberty. 
In the present study, median age at diagnosis was 10 (0-61) years, which is within the range 
indicated in the literature.3-5 This large age range shows that diagnostic tools should be improved, 
especially at an earlier age. One study showed an average delay of 7.7 years for girls diagnosed 
in childhood or adolescence, based on standardized measuring of the karyotype in the presence 
of dysmorphic features and/or height below the 5th percentile.3 Early age at diagnosis has several 
advantages. When girls with TS are diagnosed at a young age, growth hormone treatment 
can be started early, which leads to improved final height. A height gain of 5-10 cm has been 
reported with growth hormone treatment,17-19 but some studies starting with high doses of growth 
hormone at a young age suggest an increased final height of up to 17 cm.20, 21 Furthermore, early 
diagnosis allows age-appropriate start of estrogen therapy for puberty, which has been shown to 
have a positive impact on quality of life.22, 23 Early age at diagnosis also enables timely screening 
for associated problems such as ear disease, cardiac and renal malformations, psychological 
problems, and learning difficulties. Ear problems including hearing loss have a profound impact 
on the quality of life in TS patients and parents, so early proactive surveillance and treatment is 
necessary.24 Altogether, early diagnosis provides a context to understand the child’s problems 
and provide support to deal with those problems. A disadvantage of early diagnosis could be that 
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children with (mild) Turner syndrome are unnecessarily medicalized. Therefore, individualized 
follow up and adequate information for parents and individuals with Turner syndrome, preferably 
in specialized centers, is necessary to prevent overtreatment. 
We found a small difference in age at diagnosis between monosomy 45,X and other karyotypes, 
which is consistent with previous research reports.4-7, 25 In addition, Cameron-Pimblett et al. and 
Stochholm et al. showed that TS patients with isochromosome, mosaicism 45,X/46,XX and ring 
X were diagnosed later than patients with monosomy 45,X, but this was not an observation 
in the present study.6, 7 The favorable phenotype of patients with mosaicism 45,X/46,XX could 
explain the more pronounced difficulties in diagnosing patients in this group, especially when the 
percentage of 45,X cells is low.
Our results about karyotype - phenotype associations confirm the findings observed in earlier 
studies.4, 7 In the most recent study of our research group in which we focused on the association 
between karyotype, dysmorphic features and cardio-aortic malformations, the association of 
monosomy 45,X with typical Turner stigmata was confirmed, but not with cardiac symptoms.8 In 
a smaller research cohort, El-Mansoury et al. also found an association between typical Turner 
stigmata and monosomy 45,X.4 Furthermore, they observed more cardiovascular malformations 
in patients with monosomy 45,X compared to other karyotypes. 
Cameron-Pimblett et al. found in a cohort of 656 women with TS that the patients with a mosaicism 
45,X/46,XX karyotype had a lower frequency of comorbidities compared to monosomy 45,X, 
which is similar to our study.7 However, the isochromosome and Y-material group seemed to 
have similar outcomes to the monosomy 45,X group in their study, which was not the case in our 
population in which patients with isochromosome or Y-material formed intermediate phenotypes. 
Fewer of these patients had typical Turner stigmata compared to patients with monosomy 45,X. 
In addition, patients with isochromosome and Y-material seemed to have lower percentages of 
congenital heart defects compared to karyotype monosomy 45,X, which Cameron-Pimblett et 
al. also showed. Another previous study confirms that patients with isochromosome show less 
congenital heart defects, but they found higher prevalence rates in the Y-material group.26
As we did not find differences in clinical outcome between the two isochromosome subgroups 
(structural abnormal X-chromosome (46,X iso (X) and mosaicism (45,X/46,X iso (X)) and the 
group numbers were small, the subgroups were combined (n=59). This may explain, however, 
some of the contradictory findings with the other studies mentioned above. 
TS patients with a mild mosaicism 45,X/46,XX can be expected to have only a very mild 
phenotype or even no clinical signs of TS. Therefore, knowledge about the karyotype phenotype 
association will help to prevent unnecessary diagnostics as well. However, it is still unclear 
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which percentage of 45,X cells should be used as a cut-off value for clinical follow up and which 
follow up procedures are necessary for mild mosaicism 45,X/46,XX. Future studies on this topic 
are therefore recommended.
Gonadal dysfunction is part of the phenotype in TS and leads to absence of spontaneous 
puberty, estrogen deficiency, and infertility. Spontaneous puberty was present in 27% of our 
total population, which is in line with other studies, where approximately 30% of girls with TS are 
reported to show spontaneous pubertal changes.9-12 Spontaneous pregnancy occurs in 4.8-7.6% 
of patients with TS, mostly in women with a mosaicism 45,X/46,XX karyotype and spontaneous 
menarche.13-15 However, most girls (even those with spontaneous puberty) do not fully progress 
into puberty.9 Therefore, adequate follow up of pubertal development is important. An additional 
finding of our study was that patients with isochromosome show more spontaneous puberty 
than monosomy 45,X patients, but less spontaneous puberty than patients with mosaicism 
45,X/46,XX. This suggests that the patients with isochromosome have an ‘intermediate’ 
phenotype regarding gonadal function. 
El-Mansoury et al. found statistically significant increased FSH levels in monosomy 45,X versus 
mosaicism 45,X/46,XX.4 We confirm this finding, but also investigated FSH levels in other 
karyotype groups. We showed that levels of FSH at diagnosis were higher among girls with 
isochromosome (p=0.007), ring X (p=0.001), and Y-material (p<0.001) compared to girls with 
mosaicism 45,X/46,XX. However, FSH levels were measured and interpreted in different study 
centers, so these results should be interpreted with caution. 
A key strength of this study is the large study population comprising patients from six European 
countries. To our knowledge, this is the first study to assess karyotype-phenotype associations 
in a large European population. We used standard operating procedures and the study was 
performed in a standardized manner. Furthermore, many characteristics were included to 
provide a comprehensive overview of karyotype-phenotype associations. Table 4 provides a 
summary of these associations which may help clinicians to provide individualized care for their 
patients with TS.
Limitations of this observational study are the missing data and the possibility of selection bias. 
Furthermore, the design of the study did not allow longitudinal interpretation of the data. All 
biochemical parameters were measured and interpreted in the participating hospitals with the 
reference values and timing of measurements possibly being different between the centers. 
In part of our analyses, we chose to divide the study population into seven karyotype groups. 
Consequently, some groups were small when looking at specific characteristics. Therefore, 
these results need to be interpreted with caution.
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CONCLUSION
In this large study population with TS patients from six European countries, we show strong 
associations between karyotype and phenotype. Patients with mosaicism 45,X/46,XX have the 
most favorable phenotype and patients with monosomy 45,X the most severe phenotype, with 
more typical Turner stigmata, higher prevalence rates of BAV and COA and a low percentage 
of spontaneous puberty. Patients with isochromosome show a more ‘intermediate’ phenotype 
with spontaneous puberty in 30% and typical Turner stigmata in 15% of the patients. Patients 
with Y-material show intermediate levels of Turner stigmata as well, but show low percentage of 
spontaneous puberty and high levels of FSH at diagnosis. Despite the more severe features in 
patients with monosomy 45,X, the median age at diagnosis was only slightly lower compared 
to patients with other karyotypes, which suggests opportunities for improvement of knowledge 
and diagnostics.
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Turner syndrome (TS) is a chromosomal condition and reported to be associated with a 
prolonged rate-corrected QT (QTc) interval.
Objectives
To evaluate the prevalence of QTc prolongation in patients with TS, to compare their QTc 
intervals with healthy controls, and to investigate whether QTc prolongation is associated with a 
monosomy 45,X karyotype.
Method
Girls (n=101) and women (n=251) with TS visiting our expertise center from 2004-2018 were 
included in this cross-sectional study. QT intervals of 12-leaded electrocardiograms were 
measured manually, using Bazett’s and Hodges’ formulas to correct for heart rate. A QTc interval 
of >450 ms for girls and >460 ms for women was considered prolonged. Corrected QT (QTc) 
intervals of patients with TS were compared with the QTc intervals of healthy girls and women 
from the same age-groups derived from the literature.
Results
In total, 5% of the population with TS had a prolonged QTc interval using Bazett’s formula and 0% 
using Hodges’ formula. Mean QTc intervals of these patients were not prolonged compared with 
the QTc interval of healthy individuals from the literature. Girls showed shorter mean QTc intervals 
compared with women. We found no association between monosomy 45,X and prolongation of 
the QTc interval.
Conclusions
This study shows that the QTc interval in girls and women with TS is not prolonged compared with 
the general population derived from the literature, using both Bazett’s and Hodges’ formulas. 
Furthermore, girls show shorter QTc intervals compared with women, and a monosomy 45,X 
karyotype is not associated with QTc prolongation.
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INTRODUCTION
Turner syndrome (TS) is a chromosomal condition that affects phenotypic females who have 
one intact X-chromosome and complete or partial absence of the second sex chromosome.1 TS 
is associated with various cardiovascular abnormalities, such as a bicuspid aortic valve (BAV) 
and coarctation of the aorta (COA).2 A number of studies have reported a higher prevalence of 
abnormal electrocardiogram (ECG) findings in small patient groups, of which prolongation of 
the corrected QT (QTc) interval was the most frequently suggested abnormality.3-9 A resting ECG 
at the time of diagnosis is therefore recommended.1 The mechanism behind QTc prolongation 
in TS is unknown, although there are theories suggesting that it is due to the loss of a sex 
chromosome or associated with the administration of sex hormones.10, 11 
In the general population, a prolonged QTc interval is associated with cardiac arrhythmia, 
torsades de pointes, a form of ventricular tachycardia, and even death.12 Whether the reported 
QTc prolongation in patients with TS contributes to a higher mortality rate in this population is not 
clear. The QTc interval can be calculated with both Bazett’s and Hodges’ formulas.13, 14 Studies 
describing QTc prolongation in small cohorts of girls and women with TS have mostly used 
Bazett’s formula. However, as suggested by the latest European Clinical Practice Guidelines for 
the care of girls and women with TS, Hodges’ formula is preferred, because of the described 
elevated intrinsic heart rate in this patient group.1, 4, 7, 8, 15, 16
Evaluation of the QTc interval is challenging. The QT interval can be measured manually on 
printed or computerized ECGs, or automatically by a computer algorithm that measures the 
QT interval. The American Heart Association reported that it is essential to visually validate the 
QT interval reported by a computer algorithm, in view of the clinical importance of QTc interval 
prolongation.15 The definition of QTc prolongation is still under debate. Some studies suggesting 
QTc prolongation in TS, used a threshold of 440 ms in girls and women, whereas the American 
Heart Association and other studies suggest a QTc threshold of 460 ms for women in general.15, 
17, 18 For girls there is less evidence available, but two large studies suggested that a QTc interval 
>450 ms should be considered prolonged in children up to the age of 16.19, 20
Previous studies showed an association between karyotype and phenotype in patients with 
TS. Patients with a monosomy 45,X have a more severe phenotype compared with other 
patients, presenting with more dysmorphic features, cardiovascular abnormalities, and other 
comorbidities.21, 22 The association between karyotype and QTc prolongation was rarely studied, 
and the outcomes were contradicting.3, 5, 8 
Our objectives were: (1) to evaluate the prevalence of QTc prolongation with both Bazett’s and 
Hodges’ formulas, (2) to compare the mean QTc intervals of girls and women with TS to those 
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of healthy age-matched references derived from the literature, and (3) to evaluate whether QTc 
prolongation is associated with a monosomy 45,X karyotype in a large population of patients of 
all ages with TS.
METHODS
Patients
In this cross-sectional study, we included all patients with clinically and genetically diagnosed 
TS, who visited the Turner center of expertise of the Amalia Children’s Hospital and Radboud 
university medical center between 2004 and 2018. The printed ECGs of girls (1-16 years old), 
and the computerized ECGs of women (>16 years old) were evaluated. We chose these age 
categories, because most studies on normal QTc values in children included patients younger 
than 17 years old. Children <1 year were not included, because the cut off value in this patient 
group is under debate. This study was approved by the local ethical committee.
 
Data on age, karyotype, hypertension, growth hormone treatment, and cardiac malformations 
were obtained from the medical records. The use of possible QTc prolonging drugs was reviewed 
using the Credible Meds list.23 Hypertension was defined as the need for antihypertensive 
medication to normalize the blood pressure. The presence or absence of cardiac malformations 
was diagnosed by echocardiography in children, and by echocardiography and MRI in adults 
according to the (inter)national protocol.1 Information about mortality was obtained consulting 
the Municipal Personal Records Database (GBA).
All karyotypes, analyzed under supervision of a clinical geneticist [MK], were classified into 
seven subgroups: monosomy 45,X; mosaicism 45,X/46,XX; isochromosome (e.g., 46,X iso 
(X), 45,X/46,X iso (X)); deletion (e.g., 46,X del (X), 45,X/46,X del (X)), multiple cell lines (e.g., 
45,X/47,XXX, 45,X/46,XX/47,XXX); ring X (e.g., 46,X ring (X), 45,X/46,X ring (X)); and Y-material 
(e.g., 45,X/46,XY). If it was not possible to classify a karyotype into one of the karyotype groups 
(for example if karyotype information was available but not complete), it was categorized as 
‘non-classifiable’ and excluded from karyotype analysis (n=3). The karyotype was examined in 
lymphocytes (30 cells) and/or buccal cells (100 cells). Since monosomy of the X-chromosome 
(45,X) can be more reliably established in buccal cells than in a blood sample, the karyotype of 
the buccal cells was used for classification when available.24 To search for associations between 
monosomy 45,X and QTc prolongation, the monosomy 45,X group was compared with patients 
with other karyotypes. 
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Electrocardiogram
Twelve-leaded ECGs were recorded at 25 mm/s with an amplitude of 10 mm/mV. The QT-
interval was measured manually on the printed or computerized ECGs from the onset of the 
QRS complex to the end of the T-wave. The QT interval was preferably measured three times in 
lead II. The ‘teach-the-tangent’ method was used to exclude the U-wave.15 The correction of the 
QT interval was done with both Bazett’s (QTc = QT / √ RR (previous RR interval)) and Hodges’ 
formula (QTc = QT + 1.75 (heart rate – 60)).13, 14 Use of both formulas ensures that our study 
could be compared with prior studies and Hodges’ formula will eliminate the strong correlation 
with heart rate. Measurements were carried out by two researchers [MB, IN], under supervision 
of two pediatric cardiologists [ZF, LK]. Both researchers were blinded to the karyotype and the 
medical history of the patients.
A QTc interval >450 ms was considered prolonged for girls until the age of 16 years old.19, 20 For 
women, QTc prolongation was defined as a QTc interval >460 ms.15 Based on these definitions, 
the prevalence of QTc prolongation using both Bazett’s and Hodges’ formula was evaluated, 
and compared with other studies investigating prevalence of QTc prolongation in patients with 
TS. As some of these studies defined QTc prolongation as a QTc interval >440 ms, we also 
evaluated prevalence of QTc intervals using this specific time interval definition. A QTc interval of 
<340 ms was defined as a short QTc interval for both girls and women.25, 26 
To investigate the possible difference between the QTc interval of patients with TS and the 
general population, we performed a literature search. We selected studies with a large number 
of healthy girls and/or women (n>700) that were divided into age groups and that reported the 
mean/median QTc interval using both Bazett’s and Hodges’ formulas. We created the same age 
groups in our TS cohort and compared the QTc intervals of our patients with those derived from 
the age-matched healthy cohort, see Table 3.27-29 
Statistics
Statistical analyses were performed with SPSS version 25.0. Descriptive statistics were used 
to describe baseline characteristics of the study population. Normality of continuous variables 
was determined using visual and statistical methods (e.g., shape of histogram, skewness, and 
kurtosis). Values were given as mean ± SD or median (min-max), depending on the normality 
of the variables. The QTc interval of girls/women with TS was compared with the QTc interval of 
healthy individuals from the same age group (derived from literature), using one-sample T-tests. 
Unpaired t-tests or Mann-Whitney U tests and Chi-square tests were performed to compare 
the QTc interval between girls and women within our population with TS, and to compare the 
45,X group with the ‘other karyotype’ group. A p-value of <0.05 was considered statistically 
significant.
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Inter- and intra-observer reliability were expressed as intraclass correlation coefficients (ICCs). 
ICC estimates and their 95% confidence intervals were calculated based on absolute-agreement, 
single measurement, 2-way mixed-effects model. An ICC <0.20 was considered as poor 
agreement, 0.21-0.40 as fair agreement, 0.41-0.60 as moderate agreement, 0.61-0.80 as good 
agreement, and 0.81-1.00 as very good agreement.30 We decided to consider an agreement of 
>0.80 as acceptable for the inter- and intra-observer reliability in this study.
RESULTS
In total, 426 patients (120 girls and 306 women) were eligible for this study. We excluded 74 
patients because of age <1 year (n=4), no karyotype available or other genetic condition 
associated with cardiac malformations (n=19), no informed consent (n=11), no ECG available 
or poor quality (n=39), and the presence of a male phenotype (n=1). After exclusion, the total 
study population consisted of 352 patients with TS (101 girls and 251 women).
Demographic and clinical characteristics are presented in Table 1. The median age of the total 
population was 23 years (1-65 years), 11 years (1-16 years) for girls and 30 years (17-65 years) 
for women. The most common karyotype in our population was monosomy 45,X, followed by 
isochromosome and mosaicism 45,X/46,XX.
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Values are expressed as median (min-max) and n (%). In two cases, information on hypertension was 
missing. †Currently being treated with GH or treated with GH in the past. Abbreviations: BAV = bicuspid 
aortic valve, COA = coarctation of the aorta, GH = growth hormone. 
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The mean heart rate, QT-interval and QTc interval of the total cohort, girls and women with TS are 
shown in Table 2. The mean QTc interval of the total population using Bazett’s formula was longer 
compared with Hodges’ formula (420 and 400 ms (p<0.001), respectively). Girls with TS had a 
shorter QTc interval compared with women with TS, regardless of the correction formula. Of all 
patients, 5% (n=19) had a prolonged QTc interval according to Bazett’s and 0% (n=0) according 
to Hodges’ formula. When using a threshold of 440 ms, 18 girls (18%) and 55 women (22%) had 
a prolonged QTc interval using Bazett’s formula. With Hodges’ formula, no girls and 11 women 
(4%) had a QTc interval >440 ms. No patients, either girls or women, had a Bazett or Hodge QTc 
interval longer than 500 ms. Furthermore, no patients showed a short QTc interval of <340 ms. 













































Values are expressed as mean ± SD. Differences between girls and women were tested with t-tests and 
Chi-square tests. Abbreviations: bpm = beats per minute, QTc = corrected QT interval, bQTc = QTc interval 
with Bazett’s formula, hQTc = QTc interval with Hodges’ formula, ms = millisecond.
Table 3 shows the QTc intervals of girls and women with TS divided into age groups, compared 
with the QTc intervals of healthy girls and women from the same age groups, derived from 
literature. Girls and women with TS show comparable, or even shorter QTc intervals compared 
with the reference group. 
Cardiac malformations and hypertension
The presence of BAV (22% of the population, see Table 1) in girls and women with TS did not 
result in a statistically significant longer QTc interval using Bazett’s (420 ± 28 ms versus 420 ± 
25 ms, p=0.945) and Hodges’ (401 ± 21 ms versus 400 ± 19 ms, p=0.462) formulas. Also, the 
presence of COA (5% of the population, see Table 1) in girls and women with TS did not result in 
a statistically significant longer QTc interval using both formulas. Patients with hypertension (13% 
of the population, see Table 1) showed statistically significant longer QTc intervals with Bazett’s 
formula (430 ± 28 ms versus 418 ± 24 ms; p=0.002) and Hodges’ formula (410 ± 19 ms versus 
398 ± 19 ms; p<0.001), compared with patients without hypertension. However, most of the 
patients with hypertension were women (4 girls and 42 women).
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Table 3. QTc intervals in patients with TS versus QTc of healthy girls and women from the literature.
TS girls Qiu 2007
N bQTc hQTc N bQTc hQTc P-bQTc P-hQTc
1-5 y 11 410 ± 23 394 ± 21 292 415 395 0.480 0.841
6-10 y 39 416 ± 25 391 ± 18 288 418 399 0.698 0.008
11-15 y 39 413 ± 25 393 ± 19 341 419 405 0.149 <0.001
TS women Rijnbeek 2014
N bQTc hQTc N bQTc hQTc P-bQTc P-hQTc
16-19 y 50 418 ± 22 397 ± 18 385 429 414 <0.001 <0.001
20-29 y 87 419 ± 25 399 ± 17 868 418 409 0.808 <0.001
30-39 y 61 426 ± 25 408 ± 20 1435 419 412 0.024 0.152
40-49 y 45 424 ± 26 406 ± 19 597 421 412 0.465 0.029
50-59 y 17 423 ± 31 405 ± 20 1077 427 416 0.612 0.034
60-69 y 3 421 ± 18 398 ± 14 1124 429 416 0.513 0.161
TS girls Palhares 2017
N bQTc hQTc N bQTc hQTc P-bQTc P-hQTc
1-2 y 2 438 ± 6 430 ± 11 216 421 404 0.170 0.179
3-4 y 6 398 ± 18 383 ± 13 667 424 401 0.014 0.017
5-7 y 14 415 ± 21 388 ± 11 1947 425 403 0.109 <0.001
8-11 y 38 415 ± 26 392 ± 19 4601 427 407 0.006 <0.001
12-15 y 29 415 ± 26 394 ± 20 10709 426 409 0.025 0.001
TS women Palhares 2017
N bQTc hQTc N bQTc hQTc P-bQTc P-hQTc
16-19 y 50 418 ± 22 397 ± 18 14453 423 408 0.144 <0.001
20-29 y 87 419 ± 25 399 ± 17 43281 426 411 0.008 <0.001
30-39 y 61 426 ± 25 408 ± 20 55671 429 414 0.432 0.030
40-49 y 45 424 ± 26 406 ± 19 57942 432 418 0.045 <0.001
50-59 y 17 423 ± 31 405 ± 20 46563 435 421 0.132 0.004
60-69 y 3 421 ± 18 398 ± 14 28620 437 423 0.260 0.093
Values given are mean ± SD (in ms) for patients with TS, and mean or median in ms for the reference 
groups.27-29 The QTc interval of girls/women with TS was compared with the QTc interval of healthy individuals 
from the same age group, derived from the literature, with a 1-sample t-test (P-bQTc/P-hQTc). The study 
of Palhares et al.29 included both children and adults, so this study was used as a reference for both girls 
and women with TS. Methods may differ between the different studies. Abbreviations: QTc = corrected QT 
interval, bQTc = QTc interval with Bazett’s formula, hQTc = QTc interval with Hodges’ formula, P-bQTc = 
P-value calculated for the QTc interval with Bazett’s formula, P-hQTc = P-value calculated for the QTc interval 
with Hodges’ formula, TS = Turner syndrome, y = year.
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Karyotype: monosomy 45,X versus ‘other karyotype’
The karyotype and relevant demographic and clinical data are shown in Table 4. In addition 
to blood, 36% of the karyotypes of the total population were determined in a second cell line 
(buccal cells); of the 120 subjects with monosomy 45,X, 69% of the karyotypes were determined 
in both blood and buccal cells. In 25 patients of the total population (7%), the blood originally 
showed a 45,X karyotype, whereas the buccal cells displayed another karyotype.






Age (years) 23 (2-65) 24 (1-61) 0.570
Hypertension (n (%)) 16 (13%) 29 (13%) 0.883
BAV (n (%)) 34 (28%) 40 (17%) 0.018
COA (n (%)) 9 (8%) 9 (4%) 0.152
GH (n (%)) 88 (73%) 142 (62%) 0.034
Values are expressed as median (min-max). Differences between the 45,X and ‘other karyotype’ group were 
tested with Mann-Whitney U-tests and Chi-square tests. Three patients with ‘not to classify’ karyotype were 
excluded from karyotype analysis. Abbreviations: BAV = Bicuspid Aortic valve; COA = Coarctation of the 
Aorta; GH = Growth hormone.
Both karyotype groups were similar in terms of age and hypertension. The presence of a BAV 
was more common in the 45,X group compared with the ‘other karyotype’ group (28% versus 
17%, respectively), and more patients in the 45,X karyotype group were treated with growth 
hormone (73% versus 62%, respectively). Table 5 shows that patients with a monosomy 45,X 
karyotype had a higher basic heart rate compared with the patients with other karyotypes (89 ± 
18 ms versus 83 ± 17 ms; p=0.002). There was no statistically significant difference between 
QTc interval of patients with monosomy 45,X compared with patients with other karyotypes, 
when using both formulas. 
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Table 5. The mean heart rate, QT interval and QTc interval of the total cohort, monosomy 45,X group and the 








Heart rate bpm 85 ± 18 89 ± 18 83 ± 17 0.002
QT interval ms 356 ± 33 351 ± 35 358 ± 33 0.056
QTc Bazett ms 420 ± 25 423 ± 26 418 ± 24 0.060
Prolonged bQTc n (%) 18 (5%) 7 (6%) 11 (5%) 0.679
QTc Hodges ms 400 ± 19 402 ± 19 398 ± 19 0.084
Prolonged hQTc n (%) 0 (0%) 0 (0%) 0 (0%) -
Values are expressed as mean ± SD. Differences between the 45,X and ‘other karyotype’ group were 
tested with t-tests and Chi-square tests. †Three patients with ‘not to classify’ karyotype were excluded from 
karyotype analysis. Abbreviations: bpm = beats per minute; bQTc = QTc interval with Bazett’s formula; hQTc 
= QTc interval with Hodges’ formula. 
Growth hormone
The use of growth hormone was not associated with a longer QTc interval when using Bazett’s 
formula (419 ± 25 versus 422 ± 26 ms, p=0.336). It even showed a statistically significant 
shorter QTc interval when using Hodges’ formula (398 ± 18 ms versus 403 ± 20 ms, p=0.02). 
Furthermore, the heart rate in the growth hormone group was higher compared with patients who 
did not use growth hormone (87 ± 17 versus 82 ± 18 bpm, p=0.025).
QTc prolonging medication
In the total population, 4 patients (1%) used QTc prolonging medication at the time of the ECG, 
according to the Credible Meds list ((es)citalopram (n=3) and domperidone (n=1)). None of 
these patients had a prolonged QTc interval using both correction formulas (402, 416, 442, and 
454 ms using Bazett’s formula, and 395, 430, 440, and 445 ms using Hodges’ formula). 
Mortality
In the total Turner population, 5 patients died at age 44-67 years. Causes of death were aortic 
dissection (n=2), intestinal ischemia (n=1), Non-Hodgkin lymphoma (n=1), and unknown 
(n=1). None of these patients had a QTc interval of >460 ms at the time of the ECG (Bazett: 
401-434 ms, Hodge: 383-412 ms).
Inter- and intra-observer variability
Inter- and intra-observer variability in this study was very low. Agreement between the two 
researchers measuring QT intervals was good with an ICC of 0.90 (95% CI 0.76-0.96). Intra-
observer reliability was very good with an ICC of 0.97 (95% CI 0.92-0.99).
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DISCUSSION
This is a unique study investigating the QTc interval in a very large population of 352 girls and 
women with TS, using both Bazett’s and Hodges’ formula for the correction of the QT interval. We 
show no QTc prolongation using Hodges’ formula in girls and women with TS. Mean QTc intervals 
are not prolonged, when compared with the QTc intervals of healthy individuals of the same age 
group derived from the literature. Girls with TS show significantly shorter QTc intervals compared 
with women with TS, and there is no difference in QTc prolongation between monosomy 45,X 
karyotype and other karyotypes. This suggests that QTc prolongation is not a specific feature of 
girls and women with TS.
We found a clear difference in the prevalence of QTc prolongation using Bazett’s and Hodges’ 
formulas, since only Hodges’ formula (linear approach) adequately corrects for the high heart 
rate in patients with TS.1, 8, 15 This current study describes a much lower prevalence of QTc 
prolongation compared with other recent studies investigating the QTc interval in patients with 
TS (Bazett: 11-36%, Hodge 7-15%).3-5, 8 It is important to note the differences between our study 
and previous studies investigating the QTc interval in patients with TS, which could explain the 
differences in the results. At first, in our study different cut off values were used for the definition of 
QTc prolongation (450 ms for girls and 460 ms for women, compared with 440 ms in some other 
studies).15, 17-20 When we used 440 ms as a cut off value for girls and women with TS, we showed 
prolonged QTc intervals with Bazett’s formula of 18% and 22% in girls and women, respectively. 
With Hodges’ formula, we found 0% and 4% QTc prolongation using this cut off value. These 
results show that our findings when using Bazett’s formula are comparable to previous studies, 
but we have interpreted the results differently according to the American Heart Association and 
other studies advising for cut off values and the use of Hodges’ formula, as mentioned before.
We compared our QTc results to the general population, as derived from literature, and showed 
that the QTc interval in girls and women from different age groups was not prolonged. Mean QTc 
intervals using both formulas were even shorter compared with the general population in some 
age groups, although this difference seems to be of minor clinical relevance.
We found no statistically significant difference between the QTc interval of patients with 
karyotype 45,X and other karyotypes. Previous studies showed conflicting results in small study 
populations. Bondy et al. did not find an association between karyotype and QTc prolongation in 
girls with TS, although the number of individuals with a normal cell line in this study was small.3 
On the contrary, Dalla Pozza et al. and Trolle et al. did find a longer QTc interval (with Bazett’s and 
Hodges’ formula) in patients with karyotype 45,X compared with other karyotypes, with mean 
differences of 10 ms (p<0.05) and 10,6 ms (p=0.055) respectively.5, 8 However, it is questionable 
whether this difference is clinically relevant. The percentage of patients with karyotypes other 
than monosomy 45,X was high in our population. This is probably because we included buccal 
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cell analysis to determine karyotype, and not only lymphocytes, which changed the karyotype in 
7% of the total population. This suggests that, in case a monosomy 45,X karyotype is diagnosed 
in lymphocytes, a buccal sampling should be considered.
In this study, we showed that TS patients with hypertension have longer QTc intervals compared 
with patients without hypertension. Previous research has shown the same association between 
hypertension and prolonged QTc interval in the general population.31, 32 Thus, the prevalence 
of QTc prolongation in patients with TS and hypertension was still comparable to the general 
population (with hypertension). Also, the presence of BAV or COA was not associated with 
longer QTc intervals in our cohort. The use of growth hormone was associated with a shorter QTc 
interval using Hodges’ formula, although the difference was only 5 ms. This association might 
be explained by the fact that more girls used growth hormone compared with women, and girls 
show shorter QTc intervals compared with women.
As reported by Yap et al., the most common cause of acquired long QT syndrome is drug 
induced.12 None of the patients in our population using QT prolonging drugs, showed a prolonged 
QTc interval. Furthermore, none of our patients used anti-arrhythmics, which are described as 
the most common cause of acquired long QT syndrome. 
A prolonged QTc interval >500 ms was not observed in our study. This is important, because 
previous studies showed that a QTc interval of >500 ms is associated with sudden cardiac 
death and torsades de pointes, which means these patients are possibly more at risk.33 Patel et 
al. reported in a large study in patients with sinus tachycardia (baseline sinus rate of 100 bpm) 
that a prolonged Bazett’s QTc but normal Hodges’ QTc did not have a significantly increased 
risk of cardiovascular events when compared with the normal Bazett and Hodge QTc.34 Studies 
investigating QTc prolongation in patients with TS showed no association with sudden cardiac 
death.
Our study has some limitations. We measured the QT interval manually, which means it may be 
difficult to compare our results to studies measuring the QT interval with a computer algorithm. 
It is suggested that the automatically measured QT interval is often longer than the QT interval 
as measured in any individual lead.15 Furthermore, we did not study a healthy population as a 
control group, but we chose to compare our results to international, well accepted references 
(data derived from the literature). According to clinical practice, the previous RR interval of the 
QT interval was used for Bazett’s formula. For Hodges’ formula, heart rate was used, which 
might result in different values.
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CONCLUSION AND RECOMMENDATIONS
This large study, including 352 girls and women with TS, shows that QTc prolongation is not a 
special feature of girls and women with TS. Even in patients with BAV, COA, and monosomy 
45,X, we found no statistically significant longer QTc interval compared with other patients with 
TS. Only patients with hypertension showed a prolonged QTc interval, as is described in the 
general population. 
In the international TS guideline, the presence of QTc prolongation in TS was the main reason 
for the recommendation of performing an ECG at diagnosis.1 Since we show no QTc interval 
prolongation using Hodges’ formula and mean QTc intervals comparable to healthy individuals 
derived from the literature, we question whether ECG should be a routine examination for this 
indication in patients with TS without other clinical indication for it. Furthermore, ECG follow up 
of TS patients with and without prolonged QTc intervals should not differ from the guidelines of 
the general population. 
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ABSTRACT
Turner syndrome (TS) is a chromosomal condition which is associated with an increased 
prevalence of cardiac morbidity and mortality. In this cross-sectional study, Minnesota based 
electrocardiographic (ECG) abnormalities, aortic dimensions, routine- and myocardial strain 
echocardiographic parameters, and karyotype-cardiac phenotype associations were assessed 
in girls with TS. In total, 101 girls with TS (0-18 years) were included. The prevalence of major 
ECG abnormalities was 2% (T-wave abnormalities) and 39% had minor ECG abnormalities. 
Dilatation of the ascending aorta (z-score >2) was present in 16%, but the prevalence was 
much lower when using TS specific z-scores. No left ventricular hypertrophy was detected and 
the age-matched global longitudinal strain was reduced in only 6% of the patients. Cardiac 
abnormalities seemed more common in patients with a non-mosaic 45,X karyotype compared 
with other karyotypes, although no statistically significant association was found. Lowering the 
frequency of echocardiography and ECG screening might be considered in girls with TS without 
cardiovascular malformations and/or risk factors for aortic dissection. Nevertheless, a large 
prospective study is needed to confirm our results. The appropriate z-score for the assessment 
of aortic dilatation remains an important knowledge gap. The karyotype was not significantly 
associated with the presence of cardiac abnormalities, therefore cardiac screening should not 
depend on karyotype alone. 
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INTRODUCTION
Turner syndrome (TS) is a chromosomal condition that affects females who have one intact 
X-chromosome and complete or partial absence of the second sex chromosome.1 Short stature 
and premature ovarian failure are the cardinal features of TS, with a variety of associated problems 
including cardiac involvement.2 The latter can be divided into congenital malformations, such 
as a bicuspid aortic valve (BAV), aortic coarctation (COA), and partial anomalous pulmonary 
venous return (PAPVR), and acquired problems such as ascending aortic dilatation and aortic 
dissection.3-7 Hypertension is another common comorbidity in patients with TS, which could 
lead to left ventricular hypertrophy, and eventually left ventricular dysfunction.8-10 However, little is 
known on the prevalence of these abnormalities in girls with TS.
Besides cardiovascular malformations, electrocardiogram (ECG) abnormalities, mainly QTc 
prolongation, have been reported.11-17 We recently found no increased prevalence of QTc 
prolongation using Hodges formula in a large cohort of girls (n=101) and women (n=251) with 
TS, as was confirmed by Harrahill et al. in 112 women with TS.18, 19 ECG is mostly performed at 
every clinical visit of patients with TS. Reports on ECG abnormalities other than QTc prolongation 
are limited,11, 12 and the clinical consequences of ECG abnormalities remain unclear.
Routine echocardiography enables the assessment of cardiac malformations, dimensions, and 
function in patients with TS. For children, it is common to calculate z-scores of left ventricular- 
and aortic dimensions  taking the body surface area (BSA) into account.20 Z-scores of aortic 
dimensions can be calculated using different methods, but no uniform method has been 
established. Myocardial strain analysis, mainly global longitudinal strain (GLS), can be used 
to detect subtle changes in left ventricular systolic function, that are not detectable with the left 
ventricular ejection fraction (EF).21, 22 However, this sensitive technique has only been investigated 
in very small cohorts of patients with TS, with contradicting results.23-25
Previous studies have explored the relationship between karyotype and phenotype, including 
cardiovascular malformations, and have reported different results.26-31 Most studies have 
suggested that the prevalence of cardiovascular malformations is higher in patients with a 
monosomy 45,X karyotype, compared with other karyotypes. However, associations between 
karyotype and specific cardiac function tests such as ECG or GLS, have hardly been described.12
We aim to assess the prevalence of specific cardiac abnormalities in childhood, including ECG 
abnormalities, aortic dimensions, routine- and myocardial strain parameters, and to look for 




Girls with TS, aged 0-18 years, visiting the TS outpatient clinic from April 2010 till June 2017 at 
the department of pediatrics, Amalia Children’s Hospital, Radboudumc, Nijmegen were eligible 
for this retrospective study. Diagnosis of TS was based on clinical features and cytogenetic 
analysis. Patients were excluded if the cardiac follow up was performed outside our institution, 
if the quality of the echocardiography was insufficient to perform strain analysis, if cytogenetic 
analysis showed <5% cells with karyotype 45,X or if the patient had other genetic abnormalities 
that could lead to cardiac problems. This study was approved by the local ethics committee 
(CMO Arnhem-Nijmegen). The current study population is partially overlapping with the study 
population of two previous publications.18, 31 
Karyotypes were classified and divided into seven subgroups: monosomy 45,X, mosaicism 
45,X/46,XX, isochromosome (e.g., 45,X/46,i(Xq) or 46,X,i(Xq)), deletion (e.g., (45,X/)46,X,del(Xp) 
or (45,X/)46,X,del(Xq)), polyploidy (e.g., 45,X/47,XXX), ring X (e.g., 45,X/46,X,r(X)), and Y-material 
(e.g., 45,X/46,XY). The karyotype was examined in lymphocytes (30 cells) and/or buccal 
cells (100 cells).  If available, the karyotype of the buccal cells was used for classification.32 
Patients with a monosomy 45,X karyotype were compared with patients with other karyotypes. 
To describe characteristics of the population, data on age, height and weight were collected. 
For the assessment of cardiac abnormalities, the most recent ECG and echocardiogram at the 
time of inclusion were studied. Definition of COA was based on history of surgical or catheter 
intervention. Presence of hypertension was defined as the need for anti-hypertensive treatment, 
and associations between hypertension and other cardiac abnormalities were investigated. 
Electrocardiography
Resting 12-lead ECGs were scored for type of heart rhythm, heart rate, PR, QRS and QT intervals, 
QRS axis and morphology of the P wave, QRS complex and ST segment. The QT interval was 
measured manually and the corrected QT interval (QTc) was calculated using Hodges’ formula.1 
Abnormal ECG findings were coded according to the Minnesota Code.33 The ECG abnormalities 
in this study were classified into ‘major’ and ‘minor’ ECG abnormalities as binary, not mutually 
exclusive, variables and are shown in Appendix 1a and 1b.34 ECG intervals were adjusted for age 
at time of the ECG, according to Sharieff et al.35 A prolonged QRS interval was defined as >100 
ms and a prolonged QTc interval as >450 ms.36-38 The heart rate of girls with TS was compared 




Assessment of cardiac morphology and cardiac function was carried out using a routine 
echocardiography scanner (GE, Vingmed Ultrasound, Horten, Norway) with a 3.0 MHz and a 5.0 
MHz transducer. The aortic root was measured at three levels (aortic annulus in systole, sinus of 
Valsalva and ascending aorta both in diastole) and z-scores were calculated according to the 
method of Gautier et al. (providing normative data of 353 healthy children).40 Second, specific 
z-scores for patients with TS were calculated according to Quezada et al., providing standard 
values for the aortic size of healthy girls and women with TS.41 Dilatation for all measurement 
levels was defined as a z-score >2. Additionally, the aortic size index (ASI; ascending aortic 
diameter / BSA; cm/m2) was calculated for girls ≥15 years.20 Associations between aortic 
dilatation (according to Gautier et al.) and other cardiac abnormalities were investigated.
Routine- and myocardial strain parameters
Z-scores of left ventricular dimensions were based on normal values of M-mode measurements 
of a healthy population as given by Kampmann et al., using an online z-score calculator.42, 43 
The left ventricular systolic function was indicated using fractional shortening (FS) and ejection 
fraction (EF). LV mass (LVM) was calculated using the formula first described by Devereux,44 and 
LV mass for height z-scores were calculated according to Foster et al.45 
Global longitudinal strain (GLS) of the left ventricle was assessed offline using 2D speckle-
tracking echocardiography as described earlier by our group.46 Analysis was performed using 
echocardiographic quantification software (EchoPAC version 113; GE Medical Systems, Horten, 
Norway). Strain results were compared with age- and vendor specific normative values,47, 48 and 
compared with results reported in other TS populations.23, 24 
Statistical analysis
Statistical analysis was carried out using SPSS 25 (SPSS inc, Chicago, IL). Baseline characteristics 
were expressed as frequency and percentage for categorical variables and as mean or median 
for continuous variables. Associations between cardiac abnormalities, ECG abnormalities and 
karyotype were analyzed with an independent T-test, or a Mann-Whitney U test for non-normally 
distributed variables. In addition, odds ratios (ORs) and 95% confidence intervals (95%CI) were 
calculated. A one sample T-test was used to compare the heart rate and strain parameters of the 
study cohort with values of a reference population derived from the literature.39, 47 Analyses were 
performed if a subgroup consisted of at least three cases. A P-value <0.05 and OR with a 95%CI 




Data from 139 patients with a confirmed diagnosis of TS were available for this study. A total of 38 
patients were excluded from this study, of whom 23 patients without an available echocardiogram 
in our study center, 13 patients whose quality of the echocardiogram was not sufficient for offline 
strain analysis, one patient with <5% 45,X cells in buccal cell analysis, and one patient with 
another genetic abnormality that could lead to cardiac problems. After exclusion, the final study 
cohort consisted of 101 girls with TS. Data of patient characteristics, karyotype, and cardiac 
malformations are shown in Table 1. Age, height, weight, karyotype, and prevalence of cardiac 
malformations of the excluded patients were not significantly different from those of our study 
cohort (data not shown). Eleven girls had a history of cardiac surgery, including repair of aortic 
valve (n=2) and aortic coarctation (n=8). One girl had surgery for both indications, including 
repair of ascending aortic aneurysm. None of the girls with PAPVR (n=2) underwent surgery. 
Hypertension was present in seven girls (7% of the population).
The most common karyotype was monosomy 45,X (31%). Buccal cell analysis was available in 
86% of the patients with a 45,X monosomy in lymphocytes. In five of these girls (16%), buccal 
cell analysis showed a second cell line with a mean percentage of 26 (5-70)% 46,XX cells. These 
patients were eventually classified as mosaicism 45,X/46,XX.
Electrocardiography
ECG intervals and abnormalities according to the Minnesota criteria in girls with TS are described 
in Table 2. The heart rate of girls with TS was higher compared with the heart rate of healthy age-
matched girls, derived from the literature (data not shown). None of the patients had (a history 
of) severe arrhythmia or QTc prolongation. Only two girls (aged 8 and 15 years) had major ECG 
abnormalities (isolated T-wave abnormalities). No patients with a short PR interval met the criteria 
of Wolf-Parkinson White syndrome. Girls with hypertension did not have an increased prevalence 
of ECG abnormalities (OR 95%CI: 1.5 (0.3-7.6)). Details about the QTc interval and associated 
factors can be found in our previous study.18
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Table 1. Description of patient characteristics, karyotype, and cardiac malformations in girls with Turner 
syndrome undergoing detailed cardiac evaluation
N=101
Age in years median (min-max) 11 (0 - 18)
Height SDS median (min-max) -2.0 (-3.3 - 0.7)
Weight for height SDS median (min-max) 1.0 (-1.6 - 3.7)
Karyotype
Karyotype†
•  Monosomy 45,X

















(History of) COA 9 (9%)
Aortic stenosis 5 (5%)
Aortic regurgitation 7 (7%)
PAPVR 2 (2%)
Persistent left vena cava superior 1 (1%)
Patent ductus arteriosus 1 (1%)
Previous cardiac surgery 11 (11%)
Previous aortic dissection 0 (0%)
†Determined in lymphocytes and/or buccal cells. If the buccal cell analysis showed a second cell line, this 
karyotype was used for classification. #Mean percentage of 26 (5-70)% 46,XX cells. Abbreviations: SDS = 
standard deviation score, BAV = Bicuspid aortic valve, COA = Coarctation of the aorta, PAPVR = Partial 
anomalous pulmonary venous return.
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Major ECG abnormalities (Minnesota Code) N %
T wave Items
•   T amplitude negative or biphasic with negative phase >1.0 mm, but not as deep  
as 5.0 mm in aVF (5.2) 
2 2.1
Other
•  QTc prolongation (>450 ms, Hodges)





Total number of ECGs with at least one major ECG abnormality 2 2.1
Minor ECG abnormalities (Minnesota Code) N %
QRS Axis Deviation
•  Right-axis deviation (2.2) 5 5.3
High Amplitude R waves
•  R amplitude in V5 or V6 plus S amplitude in V1 > 35.0 mm (3.3) 3 3.2
T wave Items
•  T amplitude zero with less than 1.0 mm negative phase (5.3) 1 1.1
AV conduction defect
•  Long PR interval (6.3) 






•  Incomplete right bundle branch block (7.3) 22 23.4
Arrhythmias
•  Ventricular premature beats (8.1.2)
•  Regular supraventricular rhythm (8.4.1)
•  Sinus tachycardia (8.7)









Any other 0 0
Total number of ECGs with at least one minor ECG abnormality 37 39.4
Abnormal ECG findings were coded according to the Minnesota Code.33 The ECG abnormalities were 
corrected for age according to Sharieff et al.35 The ECG abnormalities were not mutually exclusive; patients 




The aortic root dimensions of girls with TS and z-scores using different methods are shown in 
Table 3. Eight patients (9%, aged 3-18 years) had a z-score >3 of the ascending aorta according 
to Gautier et al., while no patients had a current z-score >3 according to Quezada et al. All girls 
with a z-score >3 according to Gautier et al. had at least one cardiac abnormality. The mean 
ASI in girls ≥15 years was 1.5 cm/m2; only one girl had an ASI >2 cm/m2 (2.1 cm/m2), which 
corresponded with a z-score of 3.2 according to Gautier et al. Ascending aortic dilatation was 
associated with the presence of a BAV (OR 95%CI: 12.4 (3.5-43.1)), COA (OR 95%CI: 5.4 (1.3-
23.2)) and a history of cardiac surgery (OR 95%CI: 6.0 (1.5-23.3)). Ascending aortic z-scores were 
not significantly higher in girls with hypertension (0.9 vs. 0.7; p=0.683) and presence of aortic 
dilatation was not associated with age (p=0.616), even when girls with cardiac malformations or 
a history of cardiac surgery were excluded from the analyses.
Routine- and myocardial strain parameters 
Table 3 shows the routine- and myocardial strain parameters. None of the patients had a FS 
<28% or an EF <55%. The mean z-score of the LVM was low. The mean GLS in girls with TS 
was -21.3 ± 3.0% and did not significantly differ from the values of age-matched healthy children 
derived from the literature.47 According to those values, 6% of the girls had an abnormally low 
GLS for their age, without association with cardiac malformations or heartrate. Presence of 
hypertension was not associated with the LVM z-score (-1.2 vs. -1.4; p=0.662) or GLS (-19.8 vs. 
-21.5%; p=0.145)
Karyotype versus cardiac phenotype
No statistically significant association was found between karyotype (non-mosaic 45,X vs. 
other) and any of the cardiac abnormalities (Table 4), although the prevalence of cardiac 
malformations in patients with a non-mosaic 45,X karyotype seemed higher compared with 
the other karyotypes. A more detailed subgroup analysis could not be executed due to small 
numbers in each subgroup. 
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Table 3. Aortic dimensions, routine- and myocardial strain parameters in girls with Turner syndrome.
Aortic dimensions n (%) Mean Z-score ± SD 
Aortic dilatation (z-score)


















Routine parameters Mean ± SD Mean Z-score ± SD
LIVDd (mm) 41.8 ± 6.2 0.6 ± 0.9
LIVDs (mm) 26.3 ± 4.3 0.4 ± 1.0
IVSd (mm) 5.7 ± 1.1 -0.5 ± 0.9
IVSs (mm) 8.6 ± 1.8 0.0 ± 0.8
LVPWDd (mm) 5.6 ± 1.1 -0.7 ± 0.7
LVPWDs (mm) 10.7 ± 1.9 0.2 ± 0.8
LVM (g)† 69.6 ± 26.4 -1.4 ± 1.1
FS (%) 37.2 ± 4.6 
EF (%) 67.3 ± 5.6 
Strain parameters Mean ± SD P-value‡
GLS (%) total group -21.3 ± 3.0
•  <1 year -20.3 -
•  1-4 years -23.9 ± 2.3 0.193
•  5-9 years -22.3 ± 2.5 0.467
•  10-14 years -20.9 ± 2.9 0.431
•  15-18 years -20.0 ± 3.0 0.369
Abnormal GLS§, n (%) 6 (6%)
Aortic root Z-scores were calculated based on reference populations of Gautier et al. and Quezada 
et al.40, 41 Measurements of the aortic root were based on available data (annulus n=100, sinus n=101, 
ascending aorta n=94). †Left ventricular mass-for-height z-scores were calculated according to Foster et 
al.45 ‡Difference between mean GLS of girls with TS and healthy girls from the cohort of Klitsie et al.47 using 
the same age groups, calculated with a one-sample T-test. §Abnormal GLS for age, according to Klitsie et 
al.47 Abbreviations:  FS = Fractional shortening, EF = Ejection fraction, LVIDd = Left ventricular internal 
dimension at end-diastole, LVIDs = Left ventricular internal dimension at end-systole, IVSd = Interventricular 
septum thickness at end-diastole, IVSs = Interventricular septum thickness at end-systole, LVPWDd = Left 
ventricular posterior wall thickness at end-diastole, LVPWDs = Left ventricular posterior wall thickness at 
end-systole, LVM = Left ventricular mass, GLS = Global longitudinal strain.
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BAV 10 (32%) 12 (17%) 2.3 (0.9-6.1)
COA 5 (16%) 4 (6%) 3.2 (0.8-12.8)
BAV | COA 3 (10%) 2 (3%) 3.6 (0.6-23.0)
Aortic regurgitation 4 (13%) 3 (4%) 3.3 (0.7-15.5)
Aortic stenosis 2 (7%) 3 (4%) -
PAPVR 2 (7%) 0 (0%) -
Cardiac surgery 6 (20%) 5 (7%) 3.3 (0.9-11.6)
Aortic dilatation† (ascendens) 4/30 (13%) 11/64 (17%) 0.7 (0.2-2.6)
ECG abnormalities 15/29 (52%) 23/65 (35%) 2.0 (0.8-4.8)
LVMz -1.4 ± 1.2 -1.4 ± 1.1 0.912
GLS (%) -21.1 ± 3.0 -21.4 ± 3.0 0.653
% abnormal GLS 3 (10%) 3 (4%) 2.4 (0.5-12.6)
Values given are n (%) or mean ± SD. †According to Gautier et al.40 ORs were only calculated if there were 
≥3 cases in the 45,X subgroup. Abbreviations: BAV = Bicuspid aortic valve, COA = Coarctation of the aorta, 
PAPVR = Partial anomalous pulmonary venous return, ECG = Electrocardiogram, LVMz = z-score of the left 
ventricular mass, GLS = Global longitudinal strain.
DISCUSSION
This study investigated cardiac abnormalities, including ECG abnormalities, aortic dimensions, 
routine- and myocardial strain parameters, and karyotype - cardiac phenotype associations in 
a large cohort of girls with TS. We showed a low prevalence of major and a high prevalence of 
minor ECG abnormalities. Ascending aortic dilatation was seen in 16% of our patients. However, 
the prevalence was much lower when using specific z-scores assessed in patients with TS. Our 
girls with TS showed no left ventricular hypertrophy and the age matched GLS was reduced in 
only 6% of the patients. In general, girls with a non-mosaic 45,X karyotype seemed to have a 
higher prevalence of an abnormal cardiac phenotype compared with other karyotypes, although 
this association was not statistically significant. 
Electrocardiography
The value of a routine ECG in patients with TS is under debate. The clinical TS guideline advises to 
perform at least one ECG at diagnosis, and in clinical practice it is often performed during every 
cardiac evaluation. The evidence for (recurrent) ECG examination is weak, and reports on ECG 
abnormalities (other than QTc prolongation) in patients with TS are rare.1 To our best knowledge, 
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two studies of Bondy et al. are the only studies that have investigated ECG abnormalities in 78 
girls and 100 women with TS.11, 12 
In general, we found similar ECG abnormalities to Bondy et al, although in a lower prevalence. 
Most importantly, we showed a low prevalence of major ECG abnormalities according to the 
Minnesota Criteria in the current study. This is not surprising since major ECG abnormalities in 
general, for example signs of myocardial infarction or T-wave abnormalities, are less common in 
children compared with adults. Although ECG data of healthy children are scarce and definition 
of an abnormal ECG differs, the prevalence of ECG abnormalities in our study is similar to two 
earlier, large studies.49, 50 These studies included healthy (non-athlete) subjects aged 14-35 years 
and found an abnormal ECG in 2.5-49%.
Clinical relevance of the ECG findings may be as follows: First, presence of right axis deviation 
(RAD) may indicate the presence of a PAPVR.51 In the current study, we found a relatively high 
prevalence of RAD compared with the general population (reported prevalence 0.13-0.8% in 
children and young adults).49, 50 Two out of the five patients with RAD had a PAPVR, but this 
association could not be analyzed due to the small amount of numbers. The low prevalence of 
PAPVR in our study might be explained by the use of echocardiography solely without cardiac 
magnetic resonance imaging (CMR).52 The undetected PAPVR are probably hemodynamic 
unimportant and did not lead to right atrial or right ventricular dilatation. Second, QTc prolongation 
in the general population is known to be associated with arrhythmias or even sudden cardiac 
death.53 However, there is no evidence for a higher mortality rate in patients with TS due to 
QTc prolongation, and we found no patients with QTc prolongation using Hodges- formula in a 
previous study.18, 20 Third, an excessive sympathetic drive has been described in patients with 
TS.15, 20 This might be confirmed by the increased heart rate and the relatively high prevalence 
of a short PR interval found in our cohort. The PR interval in children varies with heartrate and is 
therefore usually shorter in children with a higher heartrate (e.g. young children).35, 39 The clinical 
consequences of a short PR interval in girls with TS are unclear; none of the patients met the 
criteria of Wolff-Parkinson-White syndrome. 
Regarding minor ECG abnormalities, an incomplete right bundle branch block (IRBBB) was 
the most common abnormality (23%) in our population, a higher prevalence than in the 
normal pediatric population (3%).54 However, an IRBBB is considered as a benign conduction 
disturbance of unknown etiology that usually disappears in adulthood. We support the general 




The prevalence of ascending aortic dilatation (z-score>2) in girls with TS is known to be 
significantly increased, and the results in this study (using z-scores according to Gautier et al.) 
match those in the literature.55 With the use of the advised TS specific z-score, prevalence of 
aortic dilatation was relatively low,1, 20, 41 although the differences in methods of measuring the 
aortic root should be taken into account (Quezada et al: inner-edge to inner-edge; Gautier et al: 
leading-edge to leading-edge). 
A disadvantage of both of these z-scores is that they are based on body surface area (BSA), 
which could lead to over- or underestimation of aortic dilatation in patients with a relatively 
high or low weight for their height.56 Correcting the aortic diameter using height instead of BSA 
could partly solve this problem.57 Recently, a new screening tool was reported, but only for 
relatively tall patients with connective tissue disease (e.g., Marfan).58 A tool for patients with 
TS and short stature has not yet been reported. The authors believe that seeking international 
agreements which z-score should be used in TS and building a TS specific curve of progression 
of aortic dilatation with time is mandatory. In other words, more research is needed in larger TS 
populations, as well as prospective studies of the same patients from childhood into adulthood, 
in order to be able to follow the patients with abnormal ascending aortic z-scores.
Routine- and myocardial strain parameters 
The LVM z-score in this study was relatively low, and not in line with previous studies reporting 
on normal left ventricular parameters or even left ventricular hypertrophy in girls and women 
with TS.8, 10, 23, 24 This might be partly due to the differences in methods used to calculate the 
LVM (e.g., LVM/BSA, LV mass-for-height, LVM index). Although this cannot completely explain 
why our results contradicted those in the literature, it is clear that no signs of left ventricular 
hypertrophy in our pediatric patients with TS were found.
Abnormal (decreased) GLS is regarded as a sensitive marker for discrete abnormalities of left 
ventricular systolic function, even before decreased FS or EF is detected.21 Studies reporting on 
strain parameters in patients with TS showed contradictory results. Oberhoffer et al. reported 
comparable mean strain values in 38 young adults with TS,23 whereas Abdelmassih showed 
lower mean GLS values (-13.2 ± 1.1%) in 36 girls with TS compared with controls (-18.3 ± 
2.4%).24 In our large cohort, the mean GLS in girls with TS was comparable with the normal 
values in healthy children reported in the meta-analysis of Levy et al.48, even as the mean GLS of 
healthy children from matched age-groups derived from the literature.47 However, we found that 
6% had an abnormal low GLS for their age, which was not associated with cardiac malformations 
or heartrate.47 Whether the abnormal GLS in these girls is a marker for (discrete) myocardial 
damage or increased afterload, remains to be assessed in a prospective longitudinal study. 
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Risk factors for acquired heart disease
The risk factors for aortic dilatation in girls with TS found in this study partially correspond to 
the risk factors described in girls and women with TS.57, 59 We found that BAV and COA were 
associated with ascending aortic dilatation. Hypertension is another important risk factor known 
to be associated with aortic dilatation, although this association was not found in our cohort.60 
This might be due to our definition of hypertension, resulting in lower prevalence of hypertension 
in this cohort (7%) compared with the literature (25-40%).61 
In general, hypertension and other cardiac malformations such as COA or aortic valve stenosis 
could lead to left ventricular hypertrophy and eventually to left ventricular dysfunction.62, 63 
We could not find any of these associations in our cohort. It is possible that left ventricular 
hypertrophy and subsequently ventricular dysfunction will develop later in life and are not yet 
present in our young population. Another possible explanation could be that early correction of 
cardiac abnormalities, e.g., COA or aortic stenosis, prevented the development of left ventricular 
hypertrophy and/or dysfunction. 
Karyotype-phenotype associations
Cardiac abnormalities are often found in patients with monosomy 45,X, but are also present in 
patients with other karyotypes.27-31, 64 In our cohort, patients with a non-mosaic 45,X karyotype 
seemed to have a higher prevalence of cardiac malformations, for example BAV or COA, and 
ECG abnormalities compared with other patients. However, no statistical significance was 
measured, possibly due to insufficient power in this study to demonstrate an effect. Another 
explanation might be the relatively lower prevalence of monosomy 45,X in our cohort (31%). 
This is partly due to our search for undetected cell lines in buccal smears of 45,X monosomy 
patients, which revealed a mosaic pattern in five girls. In addition, all girls with short stature are 
being screened for TS in the Netherlands, which might lead to a more frequent diagnosis of (low 
grade) mosaicism. These factors may explain the differences between our study and others. 
Limitations
Our study is a retrospective study which comes with its limitations. We analyzed ECGs and 
echocardiograms performed during routine clinical care, yet only in a large cohort of girls and not 
in a mixed population as often reported in other studies. The small numbers in some subgroups 
might have hampered the finding of significant associations. No data on healthy controls were 
available and differences in height between patients with TS and healthy subjects make it difficult 
to compare these two groups. To reduce this bias, we decided to use different z-scores. 
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CONCLUSION AND RECOMMENDATIONS
This study investigated cardiac abnormalities in a large cohort of girls with TS, including ECG 
abnormalities, aortic dimensions, myocardial strain analysis, and karyotype ‒ cardiac phenotype 
associations. We found a low prevalence of major ECG abnormalities, no QTc prolongation and no 
severe arrhythmias. Although the prevalence of minor ECG abnormalities was high (39%), these 
were mainly nonspecific and of no clinical relevance. In contrast to other studies, no evidence for 
left ventricular hypertrophy was found. Mean GLS was comparable with age-matched controls 
derived from literature while an abnormal low GLS was rare. Although the prevalence of most 
cardiac abnormalities was higher in patients with a non-mosaic 45,X karyotype compared with 
other karyotypes, no statistically significant association could be detected. 
Our results suggest that cardiac screening of patients with TS should not depend on the 
karyotype alone. Furthermore, lowering the frequency of cardiac echocardiography and ECG 
screening might be considered in girls with TS without cardiovascular malformations and/or risk 
factors for aortic dissection. Nevertheless, a large prospective study, for example using a registry 
database, is needed to confirm these statements. Last, the appropriate z-score to be used for 
the assessment of aortic dilatation remains an important knowledge gap. 
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APPENDIX 1A. 
Major ECG Abnormalities from Minnesota Code
Abnormality Minnesota codes (MC)
Major Q wave abnormalities
(Old prevalent MI)
MC 1-1, 1-2
Minor Q wave abnormalities plus ST-T abnormalities (Possible old MI) MC 1-3 plus MC 4-1 or 4-2, or 5-1 or 5-2
Major Isolated ST-T abnormalities MC 4-1 or 4-2 or 5-1 or 5-2
Left ventricular hypertrophy plus ST-T abnormalities MC 3-1 plus MC 4-1 or 4-2 or 5-1 or 5-2
Major AV conduction defects
Third-degree AV block (AVB3) MC 6-1
Second-degree AV block (AVB2) MC 6-2
Ventricular preexcitation pattern (WPW) MC 6-4
Artificial pacemaker MC 6-8
Ventricular Conduction defect
Complete or Intermittent LBBB MC 7-1
Complete or Intermittent RBBB MC 7-2
Nonspecific intraventricular block MC 7-4
RBBB with left anterior hemiblock MC 7-8
Brugada pattern MC 7-9
Arrhythmias
    Ventricular fibrillation or Ventricular asystole MC 8-2
    Atrial Fibrillation or Flutter (Continuous or intermittent) MC 8-3
    Supraventricular tachycardia MC 8-4-2 or MC 8-4-1 with tachycardia
Major QT prolongation  QTc Hodge >450 ms
Adapted from Healy et al.34 Abbreviations: AVB = atrioventricular block, LBBB = left bundle branch block, MI 
= myocardial infarction, RBBB = right bundle branch block, WPW = Wolff-Parkinson-White pattern. 
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APPENDIX 1B.
Minor ECG abnormalities from Minnesota Code
Abnormality Minnesota codes (MC)
Minor Isolated Q/QS waves MC 1-3
Left axis deviation MC 2-1
Right axis deviation MC 2-2
High Amplitude R waves (left ventricular) MC 3-1, 3-3, 3-4
High Amplitude R waves (right ventricular) MC 3-2
Minor ST/T abnormalities MC 4-3, 4-4, 5-3, 5-4
Long PR interval MC 6-3
Short PR interval MC 6-5
Incomplete RBBB MC 7-3
Incomplete LBBB MC 7-6, 7-7
Premature beats (supraventricular) MC 8-1-1
Premature beats (ventricular) MC 8-1-2
Premature beats (combined) MC 8-1-3, 8-1-5
Wandering atrial pacemaker MC 8-1-4
Sinus tachycardia MC 8-7
Sinus bradycardia MC 8-8
Supraventricular rhythm persistent MC 8-4-1
Low voltage QRS MC 9-1
ST segment elevation MC 9-2
High amplitude P wave MC 9-3
Left atrial enlargement MC 9-6
Early Repolarization MC 9-7
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Turner syndrome (TS) is a chromosomal condition with a broad phenotypic spectrum. In contrast 
to the medical conditions, socioeconomic factors are not well understood. Our goal was to 
evaluate the socioeconomic status (SES) among women with TS in a European-wide cohort, and 
to look for possible associated factors. 
Methods
This study was part of the multicenter dsd-LIFE study, including 328 women with TS. We evaluated 
SES (education, occupation and income) using patient-reported outcomes. Furthermore, 
information was collected on karyotype, age at diagnosis, comorbidity, marital status, social 
integration and discrimination. Reference data on SES were retrieved from the European Social 
Survey. Linear and logistic regression analyses were performed to compare SES of the study 
population with the reference population, and to analyze possible associated factors. 
Results
Women with TS showed a high level of education, employment status and satisfaction with 
income. In contrast, fewer women were living together and fewer social activities were reported 
compared with the reference population. The latter factors were more strongly associated with 
SES than medical factors. The unemployment rate was the highest in TS women aged 26-30 
years, while a low education was associated with a later age at diagnosis. No major differences 
in SES were found among the different karyotype groups.
Conclusions
The SES in women with TS was generally comparable with the reference population, although 
they were less frequently living with a partner or having social activities. More attention is needed 




Turner syndrome (TS) is a chromosomal condition that affects phenotypic females who have one 
intact X-chromosome and complete or partial absence of the second sex chromosome.1 The main 
well-described features are a short stature, ovarian dysfunction and comorbidities such as cardiac 
malformations, thyroid and renal disorders. TS is also associated with a specific neurocognitive 
phenotype, which includes intact intellectual function and verbal abilities, but relative weaknesses 
in visual-spatial, executive and/or social cognitive tasks.2 The above-mentioned features may lead 
to impaired quality of life in some domains, reported by several studies.3, 4 However, not much is 
known about socioeconomic status (SES) among patients with TS.
SES is the descriptive term for the position of persons within society, based on three main 
components: (1) level of education, (2) occupation, and (3) income.5 It is well known that SES 
can influence the health of individuals and vice versa.6 SES among patients with TS has been 
described by a number of study groups.7-11 They have mostly reported higher levels of education 
compared with the general population and a comparable employment status. Gould et al. have 
investigated SES in 261 American women with TS, and found a baccalaureate degree or higher 
in 70% of these women and an employment rate of 80.4%, both higher compared with controls.11 
A large birth cohort registry study from Denmark, describing SES in 831 patients with TS, has 
shown that patients were more likely to retire early and had a lower income before the age of 
30.10 Naess et al., however, have found a high degree of satisfaction with their financial and 
leisure situation among patients with TS.9 
Since these studies have only evaluated SES in selected cohorts with patients from one country 
and studies describing karyotype-phenotype associations with SES are scarce, the aim of this 
study was to evaluate SES in a large population of European women with TS, compared with 
the general European population. Furthermore, we investigated whether there is an association 
between SES and factors such as karyotype, age at diagnosis, comorbidity, marital status, social 
integration and discrimination among women with TS.
METHODS
Study population
This study was part of the European dsd-LIFE study (https://www.dsd-life.eu/), a cross-sectional 
clinical outcome study, which aims to improve treatment and care of patients included under 
the umbrella term ‘disorder/differences of sex development’ (DSD). More detailed information 
about dsd-LIFE has been published earlier.12, 13 Participants aged 16 years and older with TS 
and other forms of DSD were recruited from February 2014 through September 2015 in fourteen 
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study centers in six European countries: Germany, France, The Netherlands, Poland, Sweden, 
and The United Kingdom. From the total dsd-LIFE cohort, information of 346 patients diagnosed 
with TS was available. Patients with a non-classifiable karyotype (n=4) and patients with a male 
phenotype (n=14; 45,X/46,XY males) were excluded. The final study population consisted of 328 
females with TS. 
Information about the study population (women with TS) was collected in two ways. The 
first (medical part) consisted of a medical interview, retrospective chart review and medical 
examinations. The second part of the study (patient-related outcomes (PROs)) included 
standardized instruments and self-constructed questionnaires. In the current study, the results 
of the PROs were analyzed, mainly focusing on the results of the self-reported questionnaires 
regarding sociodemographic data. Information about comorbidities was obtained from the first 
part (medical part) of the study. Written informed consent was obtained from all participants. If 
the participant was under the age of 18 years, both the participant and the parents signed the 
informed consent. Ethical approval was obtained as appropriate to each country. 
Reference population
Reference data on sociodemographic and economic factors were retrieved from the European 
Social Survey (ESS, http://www.europeansocialsurvey.org), Batch 7 (2014). Using frequency 
matching in 5-years age groups, age-matched female participants from Germany, France, The 
Netherlands, Poland, Sweden, and The United Kingdom were included, in order to achieve 
similar age distributions between the study- and the reference population. In total, 6577 women 
from the same countries as the study population were eligible for inclusion. After frequency 
matching for age, the reference population consisted of 1911 European women.
Study design
This study consisted of two parts:
 (1)    The SES in the study population was evaluated and compared with the reference population. 
The SES consisted of three main components: level of education, occupational status 
and satisfaction with income. These factors were studied in the study- and reference 
population and in defined age groups (15-25, 26-50 years, and >50 years). In addition, 
marital status and social integration in both of the populations were evaluated, as these 
factors also seem to be important in the evaluation of SES.4, 10 Since the distribution of 
country of residence was different in the study- and reference population, all analyses 
were corrected for country of residence.
 (2)    Within the study population, the effects of possible associated factors (karyotype, age at 
diagnosis, comorbidity, marital status, social integration and discrimination) on the three 
main components of SES in women with TS were analyzed. Analyses were adjusted for 
age, because age strongly influences the SES.
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Description of outcome variables
To evaluate the SES in the study population, standardized questions and classifications according 
to the ESS were used, which are summarized in Table 1. In addition, self-constructed questions 
were added to evaluate specific elements in the TS population only. Dichotomous variables were 
created to analyze the outcome variables. To create these dichotomous variables, one category/
question was used as a ‘reference category’. First, this reference category was compared with 
all other answering options. Second, the other answering options were separately compared 
with the reference category. For the three main components of SES, this was done as follows 
(see Table 1):
 -    Level of education: Medium level of education was used as a reference category and 
compared with all other answering options (medium versus other). Thereafter, patients 
with a high level or a low level of education were compared with patients with a medium 
educational level (high versus medium and low versus medium) 
 -    Occupational status: The prevalence of ‘paid work’ was used as a reference category 
and compared with all other answering options (paid work versus other), followed by the 
other answering options being separately compared with the ‘reference category’ paid 
work (e.g., unemployed versus paid work).
 -    Satisfaction with household income: ‘Living very comfortably on present income’ was used 
as a reference category and compared with all other answering options (living comfortably 
versus other). Thereafter, the other categories were compared with the ‘reference category’. 
The answering options ‘finding it difficult on present income’ and ‘finding it very difficult on 
present income’ were combined, resulting in a variable ‘finding it (very) difficult on present 
income’ versus the reference category. 
Possible associated factors
Karyotype - The study population was divided into eight subgroups based on their karyotype: 1. 
monosomy 45,X; 2. mosaicism 45,X/46,XX; 3. isochromosome; 4. deletion; 5. polyploidy; 6. ring 
X material; 7. Y-material; and 8. unknown. A monosomy 45,X karyotype was used as a reference 
category; all the other karyotypes were separately compared with monosomy 45,X. 
Comorbidity - Comorbidity was divided into five subgroups: cardiac comorbidity (hypertension, 
coarctation of the aorta, bicuspid aortic valve (BAV) and aortic stenosis), renal comorbidity 
(horseshoe kidney, renal insufficiency and urinary tract infections), endocrinopathy (obesity, 
diabetes mellitus type 1, diabetes mellitus type 2, insulin resistance and Hashimoto thyroiditis), 
visual/auditory problems, and other comorbidities (crohn/colitis, celiac disease, fatty liver, 
hepatitis, hyperlipidemia, osteoporosis and fractures). Patients’ perspective on their own health 
was assessed with an ESS question (see Table 1). Patients reporting to have a (very) good health 
and a (very) bad health were compared with patients who reported to have a fair health. 
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Marital status and social integration - Questions regarding marital and social status are 
summarized in Table 1. For the analysis of marital status, one subgroup ‘Living with partner’ was 
created (regardless of patients being married or in a civil union or not), to be able to compare 
the study population with the reference population. This group was also used as a reference 
category for all other answering options. Patients with ‘(much) more’ and ‘(much) less’ social 
activities, were compared with patients who answered ‘the same as other people of my age’ 
(reference category). 
Statistical analysis
Statistical analysis was performed using SPSS version 25. Descriptive statistics were used to 
describe baseline characteristics of the study- and the reference population. Visual inspection 
of e.g. skewness, kurtosis and shape of the histogram was used to determine normality of the 
continuous variables. The following statistical analyses were executed: 
 (1)    To compare the SES of the study population with the reference population, binary logistic 
regression was used to calculate Odds Ratios (OR) with 95% confidence intervals 
(95%CI). Thereafter, the OR was adjusted for country of residence (ORadj), to correct for 
the differences in country of residence between the study- and the reference population. 
For continuous variables, linear regression was used to correct for country of residence 
leading to p-values from the adjusted analyses (Padj).
 (2)    To investigate associations between SES and possible associated factors within the 
study population, ORs and 95%CIs were calculated and corrected for age (ORadj). 
Linear regression was used to look for associations and to correct for age in continuous 
variables (Padj).
ORs were only calculated if there were at least three cases in one subgroup. P-values <0.05 and 
ORs with 95%CIs excluding 1 were considered statistically significant and relevant, respectively. 
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Table 1. Questions and classification used to assess socioeconomic status and possible associated factors 
in women with TS and a European reference population.




‘What is the highest level of education 
you have successfully completed’?  
Categorized according to the ES-ISCED†: 
standardized scale that measures 
education in seven levels.
ESS Answering options: ES-ISCED I – V2
Classification:
•   Low: ES-ISCED I and II
•   Medium: ES-ISCED IIIb, IIIa and IV.
•   High: ES-ISCED V1 or V2
‘About how many years of education 
have you completed, whether full-time or 
part-time?’
ESS Number of years
Occupational 
status
‘Which of these descriptions best 
describes your situation in the last seven 
days?’
ESS Answering options
•   In paid work‡ (or away temporarily; 
employee, self-employed, working for 
your family business)
•   In education (not paid for by 
employer), even if on vacation
•   Unemployed and actively looking 
for a job
•   Unemployed, wanting a job but not 
actively looking for a job
•   Permanently sick or disabled
•   Retired
•   In community or military service
•   Doing housework, looking after 
children or other persons
•   Other
‘How many hours do you/did you usually 
work a week?’
ESS Number of hours
Satisfaction with 
income
‘Which of the descriptions comes closest 
to how you feel about your household’s 
income nowadays?’
ESS Answering options
•   Living very comfortably on present 
income‡
•   Coping on present income
•   Finding it difficult on present income






‘How is your health in general?’ ESS Answering options
•   Very good
•   Good
•   Fair‡
•   Bad
•   Very bad
Marital status ‘How are you living’? SC Answering options
•   Single or separated, living alone
•   Married or in a legally registered civil 
union, living with partner‡
•   Living with partner without being 
married or in a civil union‡
•   Having a partner, but not living with 
him/her in the same household
•   Living with parents
‘How many children live regularly in your 
household?’§




‘Compared to other people of your age, 
how often would you say to take part in 
social activities?’
ESS Answering options
•   Much more than most
•   More than most
•   About the same‡
•   Less than most
•   Much less than most
‘How many people, if any, are there with 
whom you can discuss intimate and 
personal matters?’
ESS Number of people
‘Have you been discriminated against 
because of your condition?’
SC Answering options
•   Yes
•   No
‘Over the past 12 months, have you had 
contact with any support groups for your 
condition?’
SC Answering options
•   Yes
•   No
†ES-ISCED Classification: I = less than lower secondary; II = lower secondary; IIIb = lower tier upper 
secondary, IIIa = upper tier upper secondary, IV = advanced vocational, sub-degree; V1 = lower tertiary 
education, BA level; V2 = higher tertiary education, ≥ MA level. ‡This category was used as a reference 
category to compare the other variables with. §Including biological children, children by egg/sperm donation, 





Baseline characteristics of the study population
The baseline characteristics of our study population are summarized in Table 2. Monosomy 45,X 
was the most common karyotype (46%), followed by the presence of an isochromosome (18%), 
mosaicism 45,X/46,XX (10%), and Y-material (10%). The most frequently reported comorbidity 
was a visual and/or auditory problem.
Table 2. Baseline characteristics of 328 women with Turner syndrome.
Age in years 
Median (range) 28 (15-73)
Age at diagnosis in years 
Median (range) 10 (0-61)
Karyotype 
•  Monosomy 45,X 
•  Mosaicism 45,X/46,XX 
•  Isochromosome 
•  Deletion 
•  Polyploidy 
•  Ring material 





















Socioeconomic status: study population versus reference population
Table 3 shows the SES of the study population compared with the reference population. Most 
women with TS lived in France (39%) and the Netherlands (25%), whereas the reference 
population was more uniformly distributed over the different countries of residence included in 
this study.
Level of education
Information on level of education was available for 293 of the 328 patients with TS. On average, 
patients with TS achieved a higher level of education compared with the reference population 
(Figure 1, Table 3). This difference was observed in all age-groups. 
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Occupational status
Information on occupational status was available for 303 of the 328 patients with TS. Women 
with TS more frequently reported to be sick or disabled, and less often reported to be doing 
housework or looking after children compared with the reference population (See Figure 1, 
Table 3). The unemployment rate between the study- and the reference population did not differ 
significantly. However, unemployment status in women with TS aged 26-50 years was higher 
compared with the same age group in the reference population (ORadj 95%CI: 2.4 (1.4-4.1)). Rate 




















































































Figure 1. Educational level, occupational status and satisfaction with income in women with Turner syndrome 
compared with an age-matched European reference population
*ORadj (95%CI) excludes 1. Abbreviations: TS = women with Turner syndrome, Ref = European reference 
population.
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Age in years 
(Median (range))
28 (15-73) 29 (15-75) P=0.906
Country of residence P<0.001
•  Germany 49 (15%) 425 (22%)
•  France 129 (39%) 272 (14%)
•  The Netherlands 83 (25%) 253 (13%)
•  Poland 6 (2%) 328 (17%)
•  Sweden 50 (15%) 286 (15%)
•  United Kingdom 11 (3%) 347 (18%)
Level of education
•  High 100 (34%) 433 (23%) P=0.013 1.7 (1.3-2.3)
•  Medium 144 (49%) 889 (47%) P=0.496 0.9 (0.7-1.2)
•  Low 49 (17%) 569 (30%) P<0.001 0.6 (0.4-0.9)
Educational years 
(median (range)) 14 (1-26) 13 (1-31) P<0.001 P=0.009
Occupational status
•  Paid work 152 (50%) 918 (48%) P=0.528 1.1 (0.8-1.4)
•  Education 82 (27%) 480 (25%) P=0.833 1.0 (0.8-1.4)
•  Unemployed 33 (11%) 144 (8%) P=0.124 1.5 (0.9-2.3)
•  Sick/disabled 17 (6%) 40 (2%) P=0.001 2.2 (1.2-4.2)
•  Retired 10 (3%) 58 (3%) P=0.909 1.0 (0.5-2.1)
•  Housework 3 (1%) 233 (12%) P<0.001 0.1 (0.0-0.3)
•  Other 6 (2%) 31 (2%) P=0.731 1.0 (0.4-2.4)
Hours worked
Median (range) 35 (0-60) 37 (0-113) P<0.001 P=0.008
Satisfaction with income
•  Living comfortably 110 (40%) 635 (34%) P=0.045 1.1 (0.8-1.4)
•  Coping 125 (46%) 878 (47%) P=0.163 1.0 (0.8-1.3)
•  Difficult 30 (11%) 278 (15%) P=0.029 0.8 (0.5-1.2)
•  Very difficult 9 (3%) 79 (4%) P=0.250 0.8 (0.4-1.8)
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Marital status
•  Married/living together 100 (33%) 894 (47%) P<0.001 0.5 (0.4-0.7)
•  Living with parents 100 (33%) N/A
•  Single/separated 95 (31%) N/A
•   Having a partner, not living in the 
same household
9 (3%) N/A
Living with children 61 (20%) 753 (39%) P<0.001 0.4 (0.3-0.5)
Social activities
•   (much) more than others 26 (9%) 299 (16%) P=0.002 0.5 (0.3-0.8)
•   The same as others 158 (52%) 929 (49%) P=0.380 1.0 (0.8-1.3)
•   (much) less than others 123 (40%) 677 (36%) P=0.613 1.3 (1.0-1.7)
Discrimination based on condition 64 (21%) N/A
Contact with support groups 67 (22%) N/A
The prevalence was calculated based on available data. Abbreviations: Padj = the corrected p-value for 
country of residence using linear regression, ORadj = the Odds Ratio adjusted for country of residence 
using binary logistic regression.
Satisfaction with income
Information on satisfaction with household income was available for 274 of the 328 patients with 
TS. Most women with TS were satisfied with their present household income (‘living comfortably’ 
or ‘coping’, see Figure 1, Table 3). Only nine women (3%) reported living to be very difficult on the 
present income. There were no differences in income satisfaction between the study population 
and the reference population or among different age groups within the study population itself. 
Marital status and social integration
Women with TS from all age groups were less frequently married or living together with a partner 
compared with the reference population. They mostly had 4-6 persons to discuss personal 
matters with (38% versus 40% in the reference population). Women with TS reported to have 
fewer social activities compared with others of their age. 
Socioeconomic status: associated factors within the study population
Table 4 shows the multivariate analyses of the association between SES and possible associated 




Patients with high educational levels were more often separated or single, less often lived with 
their parents and experienced less discrimination because of their condition compared with 
patients with a lower level of education. In addition, the age at diagnosis was higher in patients 
with a low level of education compared with patients with medium level of education, even when 
corrected for age. 
Occupational status
In general, subjective general health and marital status were the most important factors associated 
with occupational status in women with TS. In regard to the comorbidities analyzed, only cardiac 
comorbidity was associated with a lower chance of having a paid job. No clear associations were 
found in the other occupational groups and were therefore not shown in Table 4.
Satisfaction with income
Women who were satisfied with their present household income reported a better general health 
status. The group of women who lived with children in their household were more often satisfied 
with their income compared with others. Low satisfaction with income was associated with worse 
general health and cardiac comorbidity. Additionally, this group of women was more often in 
contact with a support group.
Possible associated factors
Karyotype - The SES of 7 different karyotype groups is shown in supplement A (Table 5). 
Karyotype monosomy 45,X was not associated with level of education, occupational status or 
satisfaction with income (see Table 4). Based on small numbers in some karyotype groups, not 
all comparisons could be made. Patients with an isochromosome were more likely to be living 
comfortably on their present income (ORadj 95%CI: 2.5 (1.2-4.9)) compared with patients with 
monosomy 45,X. No other associations between karyotype and SES were found. Patients with 
a ring X karyotype seemed to have comparable levels of education with the other TS women 
and the reference population, although the rate of unemployment was relatively high (40%), 
and satisfaction with income relatively low. The hours worked per week and the number of 
educational years were similar.
Marital status - Being separated or single was associated with cardiac comorbidity (ORadj 95%CI: 
2.1 (1.1-3.9)). Furthermore, women living with children in the same household were more often 
married or living with a partner (ORadj 95%CI: 3.2 (1.7-6.2)) compared with others. 
Social integration - Having fewer social activities than others was associated with worse 
subjective health (ORadj 95%CI: 0.3 (0.2-0.5)). These women experienced more discrimination 
(ORadj 95%CI: 2.2 (1.2-3.9)) and were more often sick or disabled (ORadj 95%CI: 6.7 (1.7-25.7)). 
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Women who had contact with a support group less often had a mosaicism karyotype (ORadj 
95%CI: 0.2 (0.0-0.9)), reported worse subjective health (ORadj 95%CI: 0.5 (0.3-0.8)) and had 
more ‘other comorbidities’ (ORadj 95%CI: 2.1 (1.1-4.0)).
DISCUSSION
This study, investigating a large group of 328 individuals with TS from fourteen study centers in 
six European countries, shows that the socioeconomic status of European women with TS is 
generally not impaired compared with a reference population. Women in our study population 
had a high level of education, employment status and satisfaction with income. However, 
patients were less likely to be married or living together with a partner in all age groups and 
reported to have fewer social activities compared with other people of their age. Furthermore, 
the unemployment rate in women aged 26-30 years was relatively high.
Level of Education
In our study population, women with TS were in general highly educated. This finding is supported 
by other studies.8-11, 14 However, the definition of ‘high educational level’ differs among studies 
and countries. In this study, the ESS criteria were used, which made it possible to compare the 
educational levels of the study population with the European population. The high employment 
status could possibly be explained by academic accommodations which have expanded over 
the last years. A recent study has investigated cognitive deficits, such as visuospatial deficits, 
and provision of academic accommodations, such as extra time or remedial classes, in females 
with TS.15 Their results showed progress in the obtainment of academic accommodations 
needed within recent decades for females with TS. Furthermore, coping skills of this patient 
group, including perseverance in the face of adversity and equability of temperament,11 could be 
an explanation for the achievement of a high educational attainment.
A low educational status was associated with later age at diagnosis in our study. Reimann et al. 
have reported that patients with a late diagnosis (≥13 years) were more likely to develop depressive 
symptoms and decreased deception of competence.16 These observations suggest that an early 
diagnosis may contribute to a higher educational status, besides the well-known advantages like 
an early start of growth hormone treatment, puberty induction and timely screening for associated 
comorbidities.17 Earlier detection of problems, such as hearing difficulties, neurocognitive problems 
and social difficulties, could lead to personalized counseling and treatment, creating the optimal 
environment for the child to develop in school and at home. With improvement of knowledge and 
diagnostics, such as screening for TS in girls with short stature, patients could be diagnosed earlier. 
More studies are needed to evaluate the exact mechanisms behind the associations between level 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In the literature, a wide range of employment rate has been described (29%-90%), probably 
explained by the different age-ranges of the study populations.7-9, 11, 14, 18, 19 As expected, fewer 
patients had a paid job in the younger populations, and more patients were in education. Gould 
et al. have found a higher prevalence of patients with paid work compared to controls (80% 
versus 70%), whereas most other studies have shown comparable rates in patients with TS 
versus controls. Some even described that patients with TS have a lower occupational status 
than would be expected from the level of education, and that they have fewer positive/challenging 
working experiences.20, 21 This specific topic was not investigated in the current study.
Patients with TS more often reported to be sick or disabled compared with controls, especially 
in the patient group aged 50 or higher, most likely due to a higher morbidity rate in patients with 
TS.22 Although one study has described retirement at an earlier age compared with controls,10 
this was not observed in our (relatively young) study population.22
The prevalence of unemployment in the total TS population was comparable with the prevalence 
in the reference population. However, a higher unemployment rate in women with TS aged 26-50 
years was found, with the highest prevalence among women aged 26-30 years. We hypothesize 
that girls with TS do well in the protected environment of education, but face more difficulties 
when looking for or starting a new job. 
Satisfaction with income
European women with TS were similarly satisfied with their income as the reference population. 
Income in women with TS has only been described by two studies in the past. In a cohort of 80 
women with TS, Naess et al. have found that these women were more satisfied with their income 
compared with controls.9 In contrast, a Danish registry study has reported that the proportion 
of women with TS with an income below the median was increased before the age of 30 years, 
and was similar with controls thereafter.10 In our study, no difference in satisfaction with income 
among age groups was found, although the difference in marital status between the study 
population and reference population has to be taken into account. 
The association between income and subjective general health in patients with TS was also 
found in the reference population and has been described by others.23 An explanation for 
the association between satisfaction with income and children in the household may be the 
high costs of assisted reproductive technology (e.g., egg donation or in vitro fertilization) and 
adoption procedures in many countries.24
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SES and associated factors
In general, comorbidities were not associated with SES, except for cardiac comorbidities. Even 
visual- and auditory problems were not associated with SES in our study. This might indicate that 
comorbidities are adequately treated and have a low impact on SES in patients with TS. Marital 
status and social factors, however, were more clearly associated with SES in patients with TS in 
our study.
Recent studies have described that patients with TS are less ready for (medical) transition than 
age-matched patients with other chronic conditions, and that they lack some of the transition 
readiness skills.25, 26 Besides these medical transition difficulties, it seems that (young) women 
with TS also struggle with other transitions in life, including difficulties in the transition from school 
to a working life, but also moving out from their parents’ house or starting a romantic relationship. 
This hypothesis is supported by the relatively high unemployment rate in the age group 26-30 
years in our study, the high prevalence of women living with their parents and the low prevalence 
of women being married or living with a partner in all different age groups. The decreased self-
esteem, which has been frequently described in patients with TS, might play a role in these 
transitional problems.4, 19, 20 Early screening for psychosocial problems, as suggested in the 
clinical TS guideline, may lead to better psychosocial support, better self-esteem and in the end 
less (negative) impact on SES.1 
The TS guideline also advises to encourage early involvement of patients in TS support groups. 
Our data suggest that patients who contacted a support group in the past 12 months, had more 
medical and social problems. This probably explains the association between karyotype and 
contact with a support group, as patients with monosomy 45,X/46,XX are known to have a less 
severe phenotype compared with other karyotypes.13 The value of a support group has never 
been investigated in patients with TS, but studies investigating other diseases have shown that 
a support group may be of additional value for patients.27, 28 Patients should be encouraged to 
join TS support groups, which are now contacted by a minority, but could play an important role 
in the psychosocial support for girls and women with TS. 
SES and karyotype
No major differences in SES were found between the different karyotype groups. Patients with 
an isochromosome karyotype seemed to be more satisfied with their income compared to 
patients with monosomy 45,X. We have no clear explanation for this association, although we 
have shown in a previous study that patients with an isochromosome karyotype have a less 
severe phenotype compared with monosomy 45,X.13 In our study population, patients with a 
ring X karyotype seemed to show comparable educational levels to the other karyotypes and 
the reference population. This is an interesting finding, as other studies have reported a higher 
prevalence of mental retardation and cognitive impairment in the ring X group. Kuntsi et al. have 
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described a group of 47 patients with a ring X-chromosome, and have found an increased risk 
of learning difficulties and associated behavioral maladjustment.29 In the latter study, 63% of the 
patients with a ring X-chromosome had special educational needs and only 69% had been to a 
mainstream school, whereas the patients in our study showed educational levels comparable 
with the other karyotypes and the reference population. However, our study population included 
only 12 patients with this karyotype. SES in patients with a ring X karyotype has been described 
by only one study before, which also showed that SES in this group was similar to the other 
karyotype groups.11 
Limitations
Despite the large study population and the well described reference group, several limitations 
apply to this study. Most women with TS were recruited from patient support groups and 
outpatient clinics with the risk of selection bias. It might be that women with TS with a higher 
educational level were more willing to participate in this study, more integrated in follow up in 
specialized centers, and more willing to complete the rather long questionnaire. Some of the 
questions from the questionnaire were self-constructed and not validated, although most of 
the questions used in this study were ESS questions. This allowed us to compare our study 
population with a European reference population. As for the variable satisfaction with income, 
it is important to note that this is a subjective measure, not necessarily reflecting the actual 
income. Last, there were some missing data, which are reported in the tables. Small numbers, 
especially in the karyotype groups, require the results to be interpreted with caution.
CONCLUSION AND RECOMMENDATIONS
SES in patients with TS is generally not impaired. Patients with TS had higher levels of education 
and comparable employment status and satisfaction with income compared with the general 
European population. In contrast, patients with TS were less likely to be living together with a 
partner and reported fewer social activities. The unemployment rate in women aged 26-30 years 
was relatively high. 
The most important factors associated with SES were the subjective general health, social 
difficulties and marital status. Comorbidities appeared to have less impact on SES. A low level of 
education was associated with a later age at diagnosis, so strategies to allow for early diagnosis 
of TS are necessary. 
In general, transitions seem to be difficult for women with TS, including the transition from school 
to working life, but also moving out from their parents’ house or starting a romantic relationship. 
Apart from early diagnosis and medical intervention, early psychosociological intervention should 
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be developed to reinforce and support the individual’s self-esteem. In addition, contact with a 
support group might help to prevent difficulties with transitions and should be encouraged.
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‘How can personalized healthcare for females with Turner syndrome be optimized?’
 
This thesis focuses on three main knowledge gaps in the care for females with TS: (1) 
karyotype-phenotype associations to predict clinical course, (2) cardiac involvement, and (3) the 
socioeconomic status in females with TS. With increasing knowledge in these three domains, we 
aim to be of value to the healthcare for these girls and women. This chapter further elaborates 
on the primary findings presented in this thesis, placing them in a broader perspective and 
discussing their clinical relevance.
PART I: PRIMARY FINDINGS AND CLINICAL IMPLICATIONS
Karyotype and phenotype
Importance of careful description of dysmorphic features
A careful description of dysmorphic features in females with TS is important for two reasons. First, 
specific knowledge of these features is needed to be able to clinically diagnose girls with TS at 
a young age. In Chapter 2, we showed that dysmorphic features in TS are more diverse than 
expected from the literature, which in some cases could explain delayed diagnosis. Also, some 
dysmorphic features seem to change in severity and/or visibility over the years, as the prevalence 
of features such as pigmented nevi or dysplastic nails is different in younger girls compared with 
adult women with TS. This is important information, as some dysmorphic features are very subtle 
and can only be recognized by experienced health care providers with knowledge of dysmorphic 
features. A recent Turkish study showed that knowledge about TS among physicians is scarce.1 
In this study, 140 physicians (pediatricians, gynecologists and family physicians) answered a 
questionnaire with 18 multiple-choice questions. More than 50% of the family physicians and 
30% of the pediatricians were not aware that a short stature is the most common finding in TS, 
and even more physicians did not answer the questions regarding physical examination findings 
properly. So, knowledge about TS in general, and especially about dysmorphic features, needs 
to be improved significantly. This can also prevent unnecessary additional diagnostics in girls 
with TS presenting with short stature. Educational training on the clinical features of TS should be 
incorporated into the regular training program for medical students and physicians. 
Second, the presence of specific dysmorphic features may be related to other clinical 
characteristics. For instance, the presence of neck webbing was associated with the presence 
of coarctation of the aorta (Chapter 2), which confirms the findings of previous studies.2, 
3 These results can contribute to further understanding of the underlying mechanisms of the 
development of cardiac malformations, due to lymphatic malformations. In case of webbing of 
the neck, physicians should be aware of the increased risk of aortic coarctation.
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Early diagnosis of TS
An early age at diagnosis of TS may be important for several reasons. It enables: (1) psychosocial 
support for girls and their parents; (2) early initiation of growth hormone therapy, to increase the 
final height; (3) puberty induction at an appropriate age, which optimizes self-esteem, social 
adjustment and initiation of sexual activity; (4) early recognition of comorbidities, such as cardiac 
or renal abnormalities and hearing impairment; and (5) timely removal of the gonads in girls 
with Y-chromosomal material, who are at risk for gonadoblastoma.4-7 Lastly, we described an 
association between age at diagnosis and educational level in Chapter 6, in which females 
who were diagnosed later in life seemed to have a lower educational status. This finding needs 
to be confirmed by other studies. In summary, early diagnosis provides a context to understand 
the child’s medical and social challenges and provide support to deal with those challenges. In 
contrast, a disadvantage of early diagnosis could be that girls with (mild) TS are unnecessarily 
medicalized. Personalized follow up and adequate information for parents and individuals with 
TS, preferably in specialized centers, is necessary to prevent over treatment.
Given the benefits of early diagnosis and the fact that diagnosis is often delayed, new diagnostic- 
and screening tools should be developed. With a diagnostic test, the presence of a suspected 
disease can be confirmed. The primary purpose of a screening test is to detect a disease in 
large numbers of apparently healthy individuals. For example, all young girls with short stature 
should be screened for TS, as is already the common practice in the Netherlands. Previous 
studies have shown that there are large differences in referral patterns of children with short 
stature between countries.8 The original Dutch guidelines for short stature were sensitive for 
the detection of TS, but led to an increased number of referrals. Other guidelines, for example 
the United Kingdom consensus guideline, led to far fewer referrals but were less sensitive for 
TS.8 Based on these results, a new Dutch guideline for short stature was developed with high 
sensitivity and an acceptable false-positive rate, in which distance to target height is the most 
important criterium.9 This guideline also recommends performing chromosomal analysis in case 
of an unexplained short stature in girls, which is not yet performed in all countries.10 Besides 
screening of girls with a short stature, it is important to screen girls presenting with coarctation 
of the aorta for TS. One study found that at least 12% of the girls born with coarctation of the 
aorta had karyotype-confirmed TS.11 Last, it would also be interesting to consider a screening 
program for all newborns, or even prenatal screening (see Future perspectives). Currently, no 
such screening program for TS exists.
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Karyotype-phenotype associations
The karyotype-phenotype association in TS is weak. Although it might provide some general 
information on the severity of clinical features, the karyotype cannot predict the exact phenotype 
of an individual with TS (Chapter 2-5). The literature, and even the different studies described 
in this thesis, give contradictory results on the karyotype-phenotype association. This can be 
explained by pitfalls that complicate the investigation of karyotype-phenotype associations. For 
example, the karyotype can be determined in different tissues. We showed that the karyotype in 
cultured lymphocytes often differs from the karyotype in buccal cells. In approximately one-fifth 
of the females with an original 45,X cell line in lymphocytes, FISH examination of buccal cells 
revealed a second cell line (Chapter 2, 4, 5). This might support the theory that all females with 
a 45,X TS have a hidden second cell line somewhere in the body (cryptic mosaicism), and that 
the ‘true’ monosomy 45,X karyotype does not exist.12




(5-10%), few clinical signs
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clinical signs of TS
More certainty on the 
diagnosis
Figure 1. Reasons for the genetic investigation of a second tissue in females with TS.
In order to get a more complete overview of the karyotype, we suggest that at least two tissues 
should be investigated in females with TS in the following cases (see Figure 1):
•  Investigating a second tissue can provide more information about the genetic profile of 
females with a monosomy 45,X karyotype in lymphocytes for several reasons. First, it may 
detect the presence of (hidden) Y-chromosomal material.13 This is clinically relevant, as 
these females are probably more at risk for gonadoblastoma, and therefore a gonadectomy 
should be considered.7, 14 Second, the finding of a 46,XX cell line in girls with TS may be 
helpful for the patient and health care professionals, as these females generally show a less 
severe phenotype and better gonadal function (Chapter 2).6, 15 A recent study found that 
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females with ≤70% 45,X cells showed a significantly lower frequency of cardiac and renal 
anomalies compared with those with >70% 45,X cells, although this should be confirmed in 
a larger cohort.16 The authors also emphasized the value of investigation of a second tissue, 
in order to provide a more personalized follow up in the future.   
•  Investigating a second tissue may confirm the diagnosis of TS in females with low-grade 
mosaicism in lymphocytes, or in females with a 46,XX karyotype but strong clinical suspicion 
for TS. 
Still, results should be interpreted with caution, as even investigation of two tissues might not 
provide sufficient clarity on the karyotype. A striking example is a recent case report, describing a 
girl with monosomy 45,X in three different cell types (lymphocytes, buccal cells, and urine cells), 
but a cryptic mosaicism in the ovaries.17 The karyotype can differ between tissues within one 
female with TS, and two females with the exact same karyotype can exhibit very different clinical 
features. Apart from the karyotype, probably other underlying genetic mechanisms also play a 
role in the phenotypic variability in women with TS.
Knowledge gaps in cardiac care
Electrocardiography
The clinical TS guideline suggests performing at least one electrocardiogram (ECG) at diagnosis. 
In clinical practice, performance of an ECG is relatively cheap and non-invasive, and ECG is 
assessed during almost every cardiac evaluation. However, the evidence for (recurrent) ECG 
examination is weak, and studies on ECG abnormalities are rare. In small study populations, 
QTc prolongation was the most commonly reported abnormality, which can be involved in life-
threatening situations. Identification may have consequences in the form of further diagnostic 
tests as well as recommendations of lifestyle, such as avoiding QT-prolonging medication and 
high-potassium foods, and obviously may be of concern to the patient.18 Other relevant ECG 
abnormalities may be arrhythmias or conduction abnormalities, although it is not clear whether 
these are more common in females with TS. Therefore, the assessment of the exact prevalence 
of ECG abnormalities is essential.
ECG abnormalities in general
In this thesis, we describe very few major ECG abnormalities (only two girls with isolated T-wave 
abnormalities) and no arrhythmias in a population of girls with TS (Chapter 5). Girls with TS 
did show a higher heart rate compared to healthy controls, probably due to the autonomic 
dysfunction and the excessive sympathetic drive that has been described earlier in females with 
TS.19, 20 The pathophysiologic mechanisms behind this autonomic dysfunction are not yet clear. 
However, this might explain the relatively short PQ interval that we found in these girls. 
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QTc prolongation
Regarding the diagnosis of QTc prolongation in females with TS, there were some uncertainties:
•  The threshold at which to define QTc prolongation was unclear. Many studies used a 
threshold of 440 ms in both girls and women, which according to contemporary guidelines 
might be too low.21, 22
•  Different correction formulas can be used to correct the QT interval for heart rate. Most 
studies used Bazett’s formula (QTc=QT/√RR).23 However, the clinical TS guideline states 
that Hodges’ formula (QTc=QT + 1.75 (heart rate - 60) may be preferred over Bazett’s 
formula, because it takes the higher heart rate in females with TS into account.24
Until now, QTc prolongation in females with TS was only investigated in relatively small populations 
of girls, or women with TS. More importantly, there is no published evidence for sudden cardiac 
death related to QTc prolongation in females with TS, except for one case report.25
We were the first to show an absence of QTc prolongation in a very large population of girls and 
women with TS using an appropriate definition of QTc prolongation and the advised formula 
to correct for heart rate (Hodges formula, Chapter 4) In addition, mean QTc intervals were 
comparable with age-matched healthy females, derived from the literature. Subsequently, a 
recent prospective study found comparable results.26 Although they reported longer mean QTc 
intervals in women with TS compared with controls, the prevalence of QTc prolongation using 
Hodges’ formula did not differ from that of a matched control group. Although many women used 
QT prolonging medications, none had presented with ventricular arrhythmia. Another reassuring 
finding is the normalization of a prolonged QTc interval during exercise testing.27
The main reason for the recommendation of an ECG described in the clinical TS guideline was 
the previously reported QTc prolongation.28 As we found no QTc prolongation or arrhythmias 
in our cohort, we question the value of screening ECGs in all females at every clinical visit. We 
suggest that in females without cardiac morbidity or other clinical indication for an ECG, routine 
follow up with ECG is not needed. Furthermore, the warning for the use of QT prolonging drugs 
in asymptomatic females with TS is not evidence based considering our results and those of 
Harrahill et al. (Chapter 4).26
Echocardiography
In general, there are three reasons for cardiac imaging using echocardiography in girls with TS 
(see Figure 2). 
•  First, it can be used to detect cardiovascular malformations. We found a high prevalence 
of cardiac malformations in our population of girls with TS, such as a bicuspid aortic valve 
(BAV) and coarctation of the aorta (COA, Chapter 5). Females with BAV can develop 
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aortic stenosis and/or regurgitation, although the prevalence of these complications in our 
population of girls with TS was low. 
•  Second, echocardiography can be used to measure aortic dimensions, mainly for the risk 
assessment of aortic dissection. Aortic dilatation, which is a known risk factor for dissection, 
was a common fi nding in our pediatric population, but greatly depended on the method of 
z-score calculation and the defi nition of aortic dilatation. Girls with a ‘TS-specifi c z-score’ 
>3 are thought to be more at risk for aortic dissection, but in our population, there were no 
girls with a TS-specifi c z-score >3. Nine percent of the girls had a z-score >3 based on 
z-scores of Gautier et al (healthy population). However, all these girls also had other cardiac 
abnormalities (mostly BAV), which is shown to be an important risk factor for aortic dilatation 
in this thesis (Chapter 5). The appropriate z-score to be used for the assessment of aortic 
dilatation remains an important knowledge gap.
•  Third, left ventricular hypertrophy or left ventricular systolic dysfunction can be detected 
with echocardiography, and perhaps more accurately with the myocardial strain technique. 
We expected that the described cardiovascular malformations (e.g., BAV, COA) and also 
hypertension in females with TS would lead to an increased left ventricular mass and 
subsequently an impaired left ventricular systolic function. This can be measured with a 
sensitive technique, myocardial strain analysis, which is currently not (yet) applied in the 
routine care. However, in our girls with TS, left ventricular hypertrophy and an abnormal 
(decreased) global longitudinal strain were uncommon fi ndings. Whether an abnormal 
strain value in TS is a marker for myocardial damage or increased afterload remains to be 
assessed in a prospective longitudinal study, which should include also women with TS. 
For now, strain analysis is not recommended as a routine diagnostic tool in girls with TS.
Frequency of cardiac imaging in girls with TS
Because of lack of evidence, guideline recommendations are generally defensive and based 
on expert consensus. Yet, we believe that cardiac care for females with TS should be more 
personalized. There is no doubt that girls with TS should be screened for cardiac abnormalities 
at diagnosis. Furthermore, girls with TS and cardiac malformations or other risk factors for aortic 
dissection, such as hypertension, should be adequately monitored. However, it is questionable 
whether the current cardiac monitoring recommendations are also appropriate for asymptomatic 
girls without any cardiac malformations and risk factors. The results described in this thesis 
suggest that girls with TS, without congenital cardiovascular malformations, are at low risk 
for the development of cardiac abnormalities such as left ventricular hypertrophy or systolic 
dysfunction. In addition, girls in our cohort did not show a ‘TS specifi c z-score’ >3, and only a 
few had z-scores >3 using z-scores according to Gautier et al, based on a healthy population. 
All girls with a z-score >3 (according to Gautier et al.) also had other cardiac abnormalities 
such as BAV, which is known to be an important risk factor for aortic dilatation. Although aortic 
dissection has been described in young girls without cardiac abnormalities or aortic dilatation, 
GENERAL DISCUSSION 157
these cases are extremely rare. In our opinion, cardiac screening in girls with a low risk profi le 
(no cardiovascular malformations or risk factors for aortic dissection, and an aortic z-score <2) 
should not be intensifi ed and might even be reduced. Nevertheless, a larger prospective study, 
for example using a registry database, is needed to confi rm these statements. 
Echocardiography in girls 
with TS
To detect congenital 
malformations




To search for LVH or left 
ventricular dysfunction
Our findings














Figure 2. Reasons to perform electrocardiography and echocardiography in girls (and women) with TS, in 
comparison with our fi ndings.
*9% had a z-score >3 based on a healthy population (Gautier et al.). No girls had a ‘TS specifi c z-score’ 
>3. Abbreviations: BAV = bicuspid aortic valve, COA = coarctation of the aorta, LVH = left ventricular 
hypertrophy.
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Karyotype versus cardiac abnormalities
Previous studies and the chapters within this thesis show contradictory results on association 
between karyotype and cardiac malformations. Chapter 3 showed associations between 
monosomy 45,X and cardiovascular malformations such as BAV and COA. Chapter 5 showed 
a higher prevalence of an abnormal cardiac phenotype in girls with monosomy 45,X compared 
with other karyotypes, although this difference was not statistically significant. These differences 
may be explained by the number of included participants, or due to the differences in karyotype 
analyses (only lymphocytes versus lymphocytes and buccal cells). The contradictory results 
imply that all females with TS should be screened for cardiovascular malformations following 
the same protocol, regardless of karyotype. Whether this is also the case for females with a very 
small percentage of 45,X cells (<10%) was not studied in this thesis. It could be expected that 
these females will show less cardiac malformations, and therefore might need less surveillance.29 
This should be further investigated. Until then, the recommended screening protocol should be 
applied to all females with TS. 
Socioeconomic status in women with TS
In this thesis, the socioeconomic status (SES) in European women with TS was described 
(Chapter 6). In general, the SES was not impaired in our study population. We found a higher 
educational status compared with a European reference population, equal occupational 
attainment, and equal satisfaction with income. These findings were reasonably comparable 
with previous reports and have broadened our knowledge on SES of women from single country 
studies to a more heterogenous cohort of European women. 
Yet, specific areas within SES, such as social integration, should be improved. Women with TS 
in our cohort reported fewer social activities than controls and experienced more discrimination. 
Furthermore, young women seemed to struggle with life events. These included difficulties in 
the transition from school to a working life, but also moving out from the parental home and 
starting a romantic relationship. This hypothesis is supported by our reports on the relatively 
high unemployment rate in the age group of 26-30 years, the high prevalence of women living 
with their parents and the low prevalence of women of all ages living with a partner (Chapter 
6). Early recognition of psychosocial problems is important to prevent problems in the social 
and professional lives of women with TS. A qualitative study described that many young women 
with TS do not acknowledge the extent of their difficulties in social relationships, consciously or 
not, but they are often willing to take part in social skills programs.30 So, interventions should 
be developed to improve social skills and self-esteem (see Future perspectives). Monitoring 
programs in specialized centers might play an important role in this process, for example in the 
form of a multidisciplinary TS outpatient clinic, in collaboration with support groups. We found 
that these support groups are now mostly visited by women experiencing problems (Chapter 6). 
However, regular contact with peers and/or peer supporters may be helpful for any girl or woman 
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with TS. In our experience, females with TS have a great need for recognition and understanding 
from peers, and therefore regular contact with support groups should be encouraged.
PART II: FUTURE PERSPECTIVES
The results of our thesis are an important starting point for future innovations and research in 
the fields of genetics, early screening for TS, cardiac follow up and personalized psychosocial 
support. 
Epigenetics and genomics
We showed that karyotype-phenotype associations should be interpreted with caution, as a 
specific karyotype can exhibit very different features. This suggests that other underlying 
mechanisms play an important role in the phenotypic expression of TS. There are several 
pathophysiological hypotheses, including X-chromosome inactivation, parental imprinting, 
and altered epigenetic and RNA expression to explain the broad variability of the phenotype in 
females with TS.
X-chromosome inactivation
Specific X-linked genes have been proposed to be candidates for the etiology of TS. These are 
mostly so-called ‘escape genes’, normally escaping X-inactivation, of which two active copies are 
apparently needed for an adequate gene function. Most of these escape genes are located in the 
pseudo autosomal region (PAR) of the X-chromosome. PAR is a homologous region on the tips 
of the X- and Y-chromosome, that behaves like an autosome and recombines during meiosis.31 
The SHOX gene is the most important example of a gene within this region, of which decreased 
expression has been convincingly linked with a skeletal phenotype, including short stature, in 
females with TS.32 Other escape genes have been proposed to be involved in the phenotypic 
expression in TS, among which are KDM6A, KDM5C, CSF2RA, RPS4X, TIMP1 and IL3RA (see 
Figure 3).33-35 The KDM6A gene (also called UTX) belongs to the homeobox genes, which are 
known for their ability to regulate embryogenesis and guide tissue differentiation.36 KDM6A is 
thought to be involved in germ cell development, which makes it a potential candidate gene in 
ovarian failure in TS.33, 36 Furthermore, KDM6A is needed for proper cardiac cell differentiation,37 
and might explain cardiac involvement in TS. The KDM5C gene is important for the transcriptional 
repression of neuronal genes and might play a role in the neurocognitive profile of TS.33 Other 
genes may be involved as well, but thus far have not yet been thoroughly investigated. 
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Figure 3. Schematic representation of the X-chromosome.
Red indicates escape genes. Abbreviations: PAR = Pseudo-autosomal region, Cen = centromere, XIST = 
X-inactive specific transcript. Genes mentioned have been proposed to be candidates for the etiology of TS.
Adapted from Berletch et al.48
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Parental imprinting
Parental imprinting is another research topic in TS. Imprinting is defined as a process by 
which some genes are preferentially activated or inactivated depending on their parental origin 
(either paternally or maternally).38 In females with TS, the remaining X-chromosome is mostly of 
maternal origin and it has been suggested that imprinting may be a potential explanation for 
the phenotypic variability.39, 40 Some studies described an association between the origin of the 
X-chromosome and specific features, such as cognitive function (particularly social function), 
growth, and visceral adiposity and lipid metabolism.41-44 However, other studies did not find any 
associations between the parental origin of the X-chromosome and phenotypic features.38, 45-47 
The most recent study, using both karyotyping and FISH analysis, also showed no correlation 
between parental imprinting and phenotypic features such as cardiac/renal anomalies, 
lymphedema and spontaneous puberty.39 In conclusion, results are contradictory and all the 
limitations of karyotype-phenotype analyses apply, as mentioned before in this thesis. The exact 
influence of parental imprinting in TS, if present at all, remains to be elucidated, but for now the 
parental origin of the X-chromosome appears to have rather few clinical implications.
Epigenetics and RNA expression
Recent research has suggested that epigenetic mechanisms are altered in females with TS, 
by which the haploinsufficiency might affect other autosomal genes and subsequently alter the 
regulation of gene expression across the genome.33, 34 Trolle et al. found that the DNA in females 
with TS is globally hypomethylated, as compared to females with a normal 46,XX karyotype. They 
found that the TIMP1 gene (encoding tissue inhibitor of matrix metalloproteinase 1) was affected. 
This gene escapes X-inactivation and has been implicated in the formation of aortic dilatation.49 
Furthermore, one study described that haploinsufficiency together with the presence of specific 
risk alleles of a paralogue gene (TIMP3, situated on chromosome 22) increases the risk for BAV 
and aortopathy significantly.50 This suggests that a two-hit event is needed to increase the risk 
for aortic dysfunction: a single copy of TIMP1 (due to haploinsufficiency of the X-chromosome) 
and the presence of TIMP3 risk alleles. This could possibly explain why two females with the 
same X-chromosome deletion might have different cardiac features. Future studies should focus 
on studying such genetic mechanisms that might influence the phenotypic variability in females 
with TS.
Early diagnosis of TS – possibilities and pitfalls of prenatal or neonatal screening
Given the advantages of an early age at diagnosis, as mentioned before, new screening options 
such as prenatal- and newborn screening might be considered. However, these developments 
are accompanied by many ethical dilemmas and strict criteria must be met. Wilson and Jungner 
have described ten criteria for inclusion of a condition in a population-based screening program 
(see Table 1).51 In 2008, the world health organization (WHO) has added additional criteria (see 
Table 2).52 
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Table 1. Wilson and Jungner’s classic screening criteria
•  The condition sought should be an important health problem.
•  There should be an accepted treatment for patients with recognized disease.
•  Facilities for diagnosis and treatment should be available.
•  There should be a recognizable latent or early symptomatic state.
•  There should be a suitable test or examination.
•  The test should be acceptable to the population
•   The natural history of the condition, including development from latent to declared disease, should be adequately 
understood.
•  There should be an agreed policy on whom to treat as patients
•   The cost of case-finding (including diagnosis and treatment of patients diagnosed) should be economically balanced 
in relation to possible expenditure on medical care as a whole.
•  Case-finding should be a continuing process and not a ‘once and for all’ project. 
Table 2. WHO 2008: Additional screening criteria
•  The screening program should respond to a recognized need.
•  The objectives of screening should be defined at the outset.
•  There should be a defined target population.
•  There should be scientific evidence of screening program effectiveness.
•  The program should integrate education, testing, clinical services and program management.
•  There should be quality assurance, with mechanisms to minimize potential risks of screening.
•  The program should ensure informed choice, confidentiality and respect for autonomy.
•  The program should promote equity and access to screening for the entire target population.
•  Program evaluation should be planned from the outset.
•  The overall benefits of screening should outweigh the harm.
There are several considerations before screening for TS could be applied. First, an infrastructure 
for follow-up, treatment and support of the newborns diagnosed with TS must be developed, 
to optimally support these girls and their parents.28 For example, follow up in specialized TS 
outpatient clinics with a multidisciplinary approach, in close cooperation with patient support 
groups, is optimal. Second, consensus is needed about follow up for individuals with a positive 
screening test. Females with a mild phenotype, no or only a few clinical manifestations and a 
small percentage of 45,X cells should be prevented from over diagnosis and treatment, which 
can lead to unnecessary concerns in these females. An (early) diagnosis in these cases may 
not always be beneficial. Interdisciplinary collaboration, including the involvement of medical 
ethicists and the patient support organizations, could contribute to the assessment of complex 
cases. Third, it is questionable whether TS should be considered a treatable disease. Although 
many prevention and treatment options are available, such as growth hormone therapy, puberty 
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induction, fertility preservation, diagnosis of associated conditions and psychosocial support, TS 
cannot be cured. The Dutch Health Council has recently decided that non-treatable conditions 
should not be included in the newborn screening program and that the overall benefits of 
screening do not outweigh the harm. Possible drawbacks to screening for TS include the 
possibility of stigmatization, over diagnosis and treatment, false positive diagnosis and extra 
costs. 
Screening techniques
There are several techniques for early screening of TS, of which the most optimal one is yet to 
be determined: 
•  Prenatal screening - Non-invasive prenatal testing (NIPT) is increasingly used in prenatal 
screening. This technique, which started as a screening tool in pregnancy for trisomy 13, 
18 and 21, also has the capability to screen for aneuploidies of the sex chromosomes. 
However, recent studies have shown that the positive predictive value for the determination 
of sex chromosomal disorders such as TS is low (9-25%).53-55 This may be due to placental 
mosaicism, maternal mosaicism of the X-chromosome or early embryonic demise of a co-
twin affected by monosomy 45,X.55 Therefore, the diagnosis needs to be confirmed with 
more invasive techniques such as amniocentesis, which is associated with a procedure-
related risk for complications or fetal loss.56 As a consequence of prenatal screening, some 
parents choose for termination of pregnancy (TOP).54, 57 It could be expected that this 
prevalence will increase when the NIPT test is offered to all pregnant women.58 Adequate 
counseling by experienced health care professionals is crucial to enable parents to make a 
well-informed choice. For now, the NIPT test is not offered in The Netherlands for detection 
of sex chromosomal abnormalities, mainly because of the low positive predictive value, but 
is currently being used in other countries.
•  Newborn screening - Karyotyping, the gold-standard technique for the diagnosis of TS, 
is not suitable for newborn screening as it is too time-invasive and costly.28 The most 
promising is the use of whole exome sequencing (WES) or whole genome sequencing 
(WGS), relatively new techniques which are increasingly used to diagnose various kinds 
of genetic conditions. One study showed that WES is sufficiently sensitive as well as 
specific for diagnosis of TS.59 Yet, much more research is needed to investigate whether 
such techniques are suitable tools for a population-based screening of TS (and many other 
genetic conditions).
In conclusion, with the development of new techniques, prenatal or newborn screening for TS 
should be considered in the future, provided that there is a reliable screening technique, an 
adequate follow up protocol, and that the benefits of screening outweigh the harms.
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International TS registries 
As TS is a rare condition (affecting less than 1 in 2000 people), research with larger patient 
cohorts is difficult to establish, but not impossible. The development of an international TS 
registry and biobank enables health care providers and researchers to gain insight into a much 
larger population of females with TS and could help us answer unsolved questions. Currently, the 
I-TS registry is being developed, which is an interprofessional registry to increase collaboration 
between different disciplines, study centers and countries (https://i-turnersyndrome.org/). The 
I-Turner registry is part of the I-DSD registry (https://home.i-dsd.org), in which data is currently 
being collected in more than 70 centers from 27 countries in Africa, Asia, Europe, North America 
and South America.
One important and unsolved question is which criteria should be used for the definition of TS, 
and how we should monitor females with low-grade mosaicism. This is particularly important as 
genetic techniques continue to evolve. Additionally, it would be interesting to further identify the 
role of tissue-specific mosaicism in relation to a specific phenotype in specific organs, such as 
the heart or the ovaries. For example, the karyotype in cardiac tissue could be assessed during 
cardiac operation. Last, the I-TS registry enables comparison of the care provided for females 
with TS within different countries.  
Knowledge gaps in cardiac care
Using TS registries, the remaining knowledge gaps in cardiac care could be addressed. Although 
no severe arrhythmias were found in our cross-sectional study, this should be confirmed in 
larger (registry) studies as well as prospective studies of the same patients from childhood into 
adulthood. The same applies to the risk estimation for aortic dissection in females with TS. In the 
context of personalized follow up, models should be developed to accurately predict future aortic 
dissection risk, especially in females with TS, with and without other risk factors such as systemic 
hypertension. This starts with the investigation of the most accurate approach to measure the 
aortic diameter (leading edge to leading edge / inner edge to inner edge), but also the most 
accurate parameter to define aortic dilatation and aneurysm (different z-scores / absolute 
measurement / aortic size index).22 In addition, the influence of growth hormone treatment on 
aortic dimension should be elucidated, as current studies report conflicting results.60 
Little is known about the criteria for elective aortic surgery and new medical treatments to 
prevent cardiac complications in females with TS. It is recommended to accurately diagnose 
and rigorously treat hypertension, both in girls and women with TS.61 However, the long-term 
effects of anti-hypertensive drugs in females with TS are not yet known. Recently, a retrospective 
study has evaluated the effect of medication, such as Losartan or Atenolol, on aortic growth.62 
There was no significant difference in aortic growth over time between those women treated 
and untreated for baseline dilatation, although there are several important limitations to this 
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finding. Longitudinal studies, e.g. using the Turner registry, are needed to answer these research 
questions. 
Personalized psychosocial support
Optimal personalized healthcare requires a complete overview of the clinical and genetic 
characteristics of a girl or woman with TS, but also of psychosocial characteristics. Besides 
regular medical screening, psychosocial screening should be offered to recognize developmental 
or emotional/behavioral challenges at an early age. This may be in the form of a simple (yearly) 
validated checklist included in routine clinical care, which can be executed by general health 
professionals (e.g., nurse practitioners or medical doctors). This specific screening method 
has not yet been investigated but could potentially be a good alternative to screening by a 
psychologist. This checklist could include questions in the domain of quality of life, social 
integration and learning difficulties. If there are any problems detected, referral for academic 
accommodations such as extra guidance at school, or psychosocial interventions can be 
provided by professionals in the specific area. 
The effects of psychosocial intervention programs have hardly been investigated. One study 
has evaluated the effects of a 1-day psychology workshop targeting problems of self-esteem in 
women diagnosed with TS, using cognitive-behavioral and narrative therapy techniques.63 They 
showed that this intervention has the potential to reduce psychological distress and improve 
self-esteem in women with TS. Other ongoing studies are the SOAR study and PEERS program, 
investigating new approaches to improve social skills.64, 65 These results will be of particular 
importance, as we have shown that females with TS experience difficulties in the areas of social 
and romantic relationships, and that these difficulties influence socioeconomic status.
Another important issue to address is the transition, which is defined as the transfer from 
pediatric to adult care. There are five goals within transition: (1) to increase knowledge of the 
young woman, (2) to stimulate self-management of the young woman, (3) to prepare caregivers 
as adolescents take over responsibility of their own care, (4) to encourage social participation 
of the young woman, and (5) to provide the young woman with appropriate care.66, 67 Without a 
seamless transition from pediatric to adult care, loss of follow up leading to suboptimal health 
outcomes may occur.68 Furthermore, the age of 16-25 years is a vulnerable period with important 
changes such as leaving high school, further education, independence and new relationships. 
That is why well-organized transition care is of crucial importance. Pediatricians and adult 
endocrinologists should work together in a transition program, for example as shown in Figure 
4. Studies have described a lack of skills for medical transition in women with TS, assessed 
with the TRAQ.67, 69 The TRAQ examines knowledge and health-related skills in areas such as 
disease characteristics, medical history, medication, treatment history, health service resources, 
and navigation of the healthcare system. Sheanon et al. described that young women with TS 
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indicated strong familiarity with personal medical history, but showed less knowledge about 
future screening recommendations and prevention guidelines for individuals with TS.67 This 
again shows an opportunity to improve education about the importance of continuity in medical 
care. The use of transition readiness questionnaires in routine transition care might help health 
care professionals to identify underdeveloped skills and knowledge gaps in young women with 
TS.67, 69 Transition readiness questionnaires specifically for TS have already been developed, and 
should be validated for clinical use.
It is important to start transition in early adolescence to identify knowledge gaps. Good transition 
care offers space and flexibility to adjust the individual transition timing, regardless of age. 
Unless a multidisciplinary young adult clinic is established, an older age than 18 years at transfer 
to adult endocrine care might be beneficial for some females.69 Future studies should focus on 
the development of personalized transition strategies.
 










Figure 4. Desired situation of medical transition.
Besides health care professionals, patient support organizations play an important role in 
the psychosocial support for girls and women with TS. The value of peer support in chronic 
conditions has been shown in several studies, but has not been studied specifically in females 
with TS.70, 71 Therefore, studies focusing especially on the value of patient support groups in 
TS are needed. In our opinion, the collaboration between expert centers and support groups 
may contribute to expertise and support outside the clinic. This can be in the form of a buddy 
project, experience coaches, social activities with peers, education, or interventional programs. 
An example of an interventional program could be specific training for job interviews, as we 
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have shown that young women with TS are relatively often unemployed. Scientific evidence for 
these interventions and the value of support groups might help to improve the position of these 
groups within the care network for females with TS, as they might contribute to the development 
of future care pathways or research proposals. In conclusion, cooperation between health care 
professionals, researchers and support groups is crucial to provide optimal personalized care 
for girls and women with TS. 
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Turner syndrome (TS) is a chromosomal condition that affects phenotypic females who have 
one intact X-chromosome and complete or partial (e.g., mosaic) absence of the second sex 
chromosome, in association with one or more clinical manifestations. It affects 25-50 per 
100.000 females. The most common clinical features are growth retardation, premature 
ovarian insufficiency and cardiac malformations such as a bicuspid aortic valve (BAV) and 
coarctation of the aorta (COA). Girls and women with TS show a large variety of clinical features 
and comorbidities, so individualized care is of utmost importance. Although much has been 
published on the clinical characteristics of females with TS, significant knowledge gaps still exist. 
This thesis focuses on three main knowledge gaps in the care for females with TS: karyotype-
phenotype associations to predict clinical course, cardiac involvement and the socioeconomic 
status. 
In chapter 2 we describe associations between karyotype and phenotype, including dysmorphic 
features and cardiovascular malformations. In this prospective study, we used a checklist to 
search for dysmorphic features in females with TS. We found differences in the prevalence of 
these features between girls and women, suggesting that dysmorphic features might change in 
severity and/or visibility over the years. Three phenotypic patterns were distinguished: a severe 
phenotype, a lymphatic phenotype and a skeletal phenotype, which were more prevalent in girls 
and women with a monosomy 45,X karyotype. Cardiac abnormalities (such as BAV or COA) were 
not associated with karyotype. Dysmorphic features of females with a mosaicism karyotype can 
be very mild, which implies that identification of TS might be difficult. Health care professionals 
should be extra alert when webbing of the neck is seen in a female with TS, because of a 
significant association between neck webbing and COA.
Chapter 3 reports on karyotype – phenotype associations in a large European cohort. We 
describe several karyotype groups, in association with age at diagnosis, clinical features and 
gonadal function. Women with monosomy 45,X showed the most severe phenotype, with typical 
turner stigmata, a high prevalence of cardiac malformations and low prevalence of spontaneous 
puberty. In contrast, women with a mosaic karyotype showed the mildest phenotype with 
few turner stigmata, a low prevalence of cardiovascular malformations and a relatively high 
prevalence of spontaneous puberty. The phenotype of women with an isochromosome or 
Y-material karyotype was intermediate. Despite the more severe phenotype in women with a 
monosomy 45,X karyotype, age at diagnosis was only slightly lower compared with the other 
karyotypes (median 10 versus 11 years), which suggests opportunities for improvement of 
knowledge and diagnosis.
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Chapter 4 describes a study investigating the most reported ECG abnormality in TS: QTc 
prolongation. The prevalence of QTc prolongation was only investigated in relatively small 
cohorts, mostly using a definition for QTc prolongation of >440 ms, instead of the advised 450 
ms in children and 460 ms in adults. Additionally, most studies used Bazett’s formula to correct 
for heart rate instead of the recommended formula for females with TS (Hodges’ formula). In 
chapter 4, we investigated the QTc interval in a large cohort of girls and women with TS, using 
the advised formula and definition of QTc prolongation. We showed no QTc prolongation in our 
cohort using Hodges’ formula. Furthermore, the mean QTc interval was not prolonged compared 
with the mean QTc interval of healthy girls and women from the same age-categories, derived 
from the literature. We found no association between QTc prolongation and a monosomy 45,X 
karyotype. These results suggest that QTc prolongation is not an intrinsic feature of TS.
Little is known about ECG abnormalities other than QTc prolongation, but also about 
echocardiography findings such as left ventricular hypertrophy and cardiac strain parameter 
abnormalities. Chapter 5 describes a retrospective study which investigated specific cardiac 
abnormalities in girls with TS, including ECG abnormalities, routine- and myocardial strain 
parameters, and karyotype – phenotype associations. ECG abnormalities were coded according 
to the Minnesota Criteria, adapted to the normal values of healthy children. Cardiac morphology 
and function in children with TS were assessed by echocardiography, obtaining information on 
cardiovascular malformations, aortic diameters, routine left ventricular parameters and global 
longitudinal strain (GLS). We found no severe arrythmias and very few major ECG abnormalities. 
The minor ECG abnormalities we found were of no clinical relevance and mostly non-specific. 
The prevalence of ascending aortic dilatation was 16%, yet this percentage was much lower 
when using TS-specific z-scores. Left ventricular hypertrophy and an abnormal low GLS were 
uncommon in girls with TS. The karyotype was not significantly associated with the presence 
of cardiac abnormalities, therefore cardiac screening should not depend on karyotype alone. 
Lowering the frequency of cardiac echocardiography and ECG screening might be considered 
in girls with TS without cardiovascular malformations and/or risk factors for aortic dissection. 
Nevertheless, a large prospective study, for example using a registry database, is needed to 
confirm these statements.
Chapter 6 puts the above-mentioned findings in perspective and describes the socio-economic 
status (SES; level of education, occupation and income) of women with TS. Women from six 
European countries were included and SES was assessed using patient-reported outcome. 
These data were compared with data from a matched European reference population. Despite 
the frequent medical problems described in women with TS, it appeared that the socioeconomic 
status in these women was generally not impaired compared with the reference population. 
Women with TS had a higher educational level, similar occupational status, and similar 
satisfaction with income compared with the reference population. In contrast, the unemployment 
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rate in women aged 26-30 years was relatively high, women with TS reported to have fewer 
social activities compared with other women, and women with TS were less frequently living 
together with a partner. In general, these latter factors were more strongly associated with SES 
than comorbidities. Apart from early diagnosis and medical intervention, early psychological 
intervention should be developed to reinforce and support the individual’s self-esteem.
Chapter 7 provides a general discussion of the main findings in this thesis, the clinical implications 
of these findings and future perspectives. In part I, the importance of a careful description of 
dysmorphic features, and the pitfalls of karyotype-phenotype analyses are highlighted. The 
investigation of two tissues might be considered in specific cases, in order to get a more complete 
overview of the karyotype. Furthermore, we discuss the importance of personalized cardiac care 
for females with TS, including the frequency of ECG and echocardiography screening. Although 
the SES in women with TS is generally not impaired, specific areas such as social integration 
should be improved. 
In part II, future perspectives in the fields of genetics, early screening for TS, cardiac follow up 
and personalized psychosocial support are described. Finally, we emphasize the importance 
of cooperation between health care professionals, researchers and support groups to provide 




Turner syndroom (TS) is een chromosomale aandoening die alleen bij meisjes en vrouwen 
voorkomt. Normaliter is er bij vrouwen sprake van twee X-chromosomen in alle cellen, waarbij er 
bij TS maar één X-chromosoom aanwezig is in alle cellen (monosomie 45,X karyotype) of een 
gedeelte van de cellen (mozaïek 45,X/46,XX karyotype). Ook kan er sprake zijn van een structureel 
veranderd X-chromosoom (bijvoorbeeld een isochromosoom) of kan er een Y-chromosoom 
aanwezig zijn in een deel van de cellen. TS komt voor bij 25-50 op de 100.000 vrouwen. De 
meest voorkomende symptomen zijn een kleine lengte en niet goed functionerende eierstokken. 
Daarnaast kan er onder andere sprake zijn van specifieke uiterlijke kenmerken (dysmorfieën), 
nierafwijkingen en hartafwijkingen, bijvoorbeeld een tweeslippige (bicuspide) aortaklep, een 
vernauwing (coarctatie) van de lichaamsslagader of juist een verwijding van de lichaamsslagader 
(aortadilatatie). Er is een grote diversiteit in de mate waarop de verschillende symptomen 
voorkomen bij meisjes en vrouwen met TS, dus zorg op maat is heel belangrijk. Hoewel er al veel 
onderzoek is gedaan naar TS, zijn er ook nog belangrijke kennishiaten. Het doel van dit proefschrift 
is om meer kennis te vergaren over verbanden tussen het chromosomenpatroon en de ernst van 
symptomen (karyotype-fenotype associaties), hartafwijkingen en de sociaaleconomische status 
(opleidingsniveau, beroep en inkomen) van meisjes en vrouwen met TS. 
In hoofdstuk 2 onderzoeken we verbanden tussen het chromosomenpatroon (karyotype) en 
het fenotype (symptomen), bestaande uit Turner-specifieke uiterlijke kenmerken (dysmorfieën) 
en hartafwijkingen. In dit onderzoek hebben we met behulp van een checklist gekeken naar 
dysmorfieën bij meisjes en vrouwen met TS. Het bleek dat er verschillen waren in uiterlijke 
kenmerken tussen meisjes en vrouwen, wat suggereert dat deze over de jaren kunnen 
veranderen in ernst en/of zichtbaarheid. De uiterlijke kenmerken bij meisjes en vrouwen met 
een mozaïek karyotype waren soms zeer mild, waardoor TS moeilijker herkend kan worden. 
In totaal werden drie patronen onderscheiden: een ernstig patroon (meisjes en vrouwen met 
veel uiterlijke kenmerken), lymfatisch fenotype (kenmerken geassocieerd met afwijkingen aan 
het lymfesysteem) en een skeletaal fenotype (kenmerken geassocieerd met afwijkingen aan de 
botten en/of kleine lengte), alle drie vaker voorkomend bij meisjes en vrouwen met een monosomie 
45,X karyotype. We vonden geen verband tussen hartafwijkingen en het chromosomentype. 
Wel kwam overtollige huid in de nek (webbing) vaker voor bij meisjes en vrouwen met een 
vernauwing (coarctatie) van de lichaamsslagader. Voor behandelaren is het dus van belang om 
extra alert te zijn op deze hartafwijking indien er sprake is van overtollige huid in de nek. 
Hoofdstuk 3 gaat verder in op verbanden tussen het chromosomenpatroon en symptomen 
(karyotype-fenotype associaties) in een Europese groep vrouwen met TS. In dit hoofdstuk worden 
verschillende karyotype groepen beschreven en wordt onderzocht in hoeverre het karyotype 
samenhangt met de leeftijd van diagnose, de aanwezigheid van aangeboren afwijkingen en met 
CHAPTER 8182
de functie van de eierstokken. Wij vonden dat vrouwen met een monosomie 45,X karyotype over 
het algemeen de meest ernstige kenmerken hadden, waarbij er vaker sprake was van uiterlijke 
bijzonderheden, hartafwijkingen en minder vaak van spontane puberteit. Vrouwen met een 
mozaïek karyotype hadden vaak minder symptomen, met weinig uiterlijke kenmerken, weinig 
hartafwijkingen en juist vaker spontane puberteit. De ernst van de symptomen bij vrouwen met 
een isochromosoom of Y-materiaal karyotype lag daar tussenin. De diagnose TS werd maar iets 
eerder gesteld bij vrouwen met karyotype 45,X dan bij vrouwen met andere karyotypes (10 jaar 
versus 11 jaar), ondanks de ernstigere symptomen bij de eerstgenoemde groep. 
Hoofdstuk 4 beschrijft een onderzoek naar verlenging van het QT interval gecorrigeerd voor de 
hartslag (QTc interval). Dit is een afwijking die kan worden gezien op een hartfilmpje (ECG) en 
kan leiden tot hartritmestoornissen en zelfs tot plotselinge hartdood. Deze afwijking werd in het 
verleden door verschillende studies gerapporteerd in kleine groepen meisjes en vrouwen met 
TS. Daarbij is echter vaak een afkapwaarde van 440 milliseconden (ms) gebruikt (in plaats van de 
aanbevolen 450 ms bij kinderen en 460 ms bij volwassenen). Tevens is veelal de Bazett formule 
gebruikt om te corrigeren voor de hartslag in plaats van de (voor vrouwen met TS) aangeraden 
Hodges formule. In onze studie beschrijven wij het QTc interval van een grote groep meisjes 
(101) en vrouwen (251) met TS, met de aanbevolen afkapwaardes en correctieformule. We 
vonden géén QTc verlenging bij gebruik van de Hodges formule. Verder was het gemiddelde QTc 
interval van meisjes en vrouwen met TS niet langer dan dat van gezonde meisjes en vrouwen uit 
dezelfde leeftijdscategorie, zoals beschreven in de literatuur. Ook leek het chromosomenpatroon 
niet significant van invloed op het QTc interval. Deze resultaten suggereren dat QTc verlenging 
geen symptoom is van TS en dat daarmee het risico op hartritmestoornissen door QTc verlenging 
niet hoger is dan bij andere meisjes en vrouwen.
Hoofdstuk 5 beschrijft een studie waarin specifieke hartafwijkingen bij meisjes met TS zijn 
onderzocht, zoals afwijkingen op het hartfilmpje (ECG) en afwijkingen op een hartecho. Tevens is 
er gekeken naar het verband tussen het chromosomenpatroon en deze verschillende afwijkingen. 
ECG afwijkingen werden gerapporteerd en aangepast aan de normaalwaarden van gezonde 
kinderen. Met behulp van echo werden de afmetingen en de massa van de linker hartkamer 
bepaald, werd de diameter van de lichaamsslagader gemeten en werd er gekeken naar de 
functie van de linker hartkamer door middel van ‘global longitudinal strain (GLS)’. Wij vonden in 
deze groep meisjes geen ernstige hartritmestoornissen en weinig relevante ECG afwijkingen. Bij 
16% van de meisjes was er sprake van verwijding van de lichaamsslagader, maar dit percentage 
was veel lager bij gebruik van een andere (Turner-specifieke) methode. Geen van de meisjes 
had een verdikking van de linker hartkamer (linkerventrikelhypertrofie) en maar een paar meisjes 
hadden een abnormaal verlaagde GLS. Hoewel meisjes met een monosomie 45,X karyotype 
meer hartafwijkingen leken te hebben dan meisjes met een ander chromosomenpatroon, was 
dit verband niet statistisch significant. Dit suggereert dat de frequentie van controles voor het 
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hart niet moet afhangen van het karyotype. Verder zou kunnen worden overwogen om de 
frequentie van echo- en ECG-controles te verlagen bij meisjes met TS zonder hartafwijkingen 
en/of risicofactoren voor het scheuren van de aorta (aortadissectie). Verder onderzoek is nodig 
om dit te bevestigen.
Hoofdstuk 6 zet bovenstaande bevindingen in perspectief en beschrijft de sociaaleconomische 
status (SES; opleidingsniveau, beroep en inkomen) van vrouwen met TS. Hiervoor werden 
gegevens verzameld van vrouwen met TS uit zes Europese landen en vergeleken met de 
gegevens van andere Europese vrouwen. Ondanks de beschreven medische problemen, bleek 
dat de sociaaleconomische status van vrouwen met TS ongeveer vergelijkbaar was met andere 
Europese vrouwen. Vrouwen met TS hadden een beter opleidingsniveau, net zo vaak een 
betaalde baan en een vergelijkbare tevredenheid met het inkomen. Wel was de werkloosheid 
in de groep vrouwen in de leeftijd van 26-30 jaar relatief hoog, rapporteerden vrouwen met 
TS minder sociale activiteiten dan leeftijdsgenoten en waren zij minder vaak getrouwd of 
samenwonend. Over het algemeen leken deze laatstgenoemde psychosociale factoren meer 
van invloed op de sociaaleconomische status dan medische aandoeningen. De resultaten van 
deze studie laten zien het belangrijk is om tijdig aandacht te hebben voor het psychosociale 
welzijn van vrouwen met TS, zodat vrouwen met TS meer zelfvertrouwen krijgen en beter kunnen 
integreren op sociaal gebied. Lotgenotencontact, bijvoorbeeld via een patiëntenvereniging, kan 
daaraan bijdragen. 
Hoofdstuk 7 bediscussieert de belangrijkste bevindingen in dit proefschrift, de klinische relevantie 
daarvan en de mogelijkheden voor toekomstig onderzoek. In deel I beschrijven we het belang 
van een gedetailleerde beschrijving van uiterlijke kenmerken en de valkuilen van onderzoek naar 
verbanden tussen het chromosomenpatroon en symptomen. In specifieke gevallen kan het 
onderzoeken van ten minste twee weefsels (bijvoorbeeld bloed en wangslijmvlies) bijdragen om 
een completer overzicht te krijgen van het chromosomenpatroon. Het kan namelijk voorkomen 
dat in het ene type weefsel een monosomie 45,X chromosomenpatroon wordt gevonden en in 
het andere weefsel een mozaïek chromosomenpatroon. Verder bespreken we het belang van 
cardiale zorg op maat voor meisjes en vrouwen met TS. Hoewel de sociaaleconomische status 
van vrouwen met TS over het algemeen vergelijkbaar is met andere Europese vrouwen, is er ook 
ruimte voor verbetering, bijvoorbeeld op het gebied van sociale integratie.
In deel II wordt mogelijk toekomstig onderzoek op het gebied van genetica, vroege herkenning 
van TS, cardiale controles en gepersonaliseerde psychosociale ondersteuning besproken. Het 
opzetten van internationale databases kan helpen om onopgeloste vragen te beantwoorden. 
Tenslotte benadrukken we het belang van samenwerking tussen zorgpersoneel, onderzoekers 
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LIST OF ABBREVIATIONS
0-9
2D-STE  2-dimensional speckle tracking echocardiography
A
ADHD  Attention-deficit/hyperactivity disorder (ADHD)
AMH  Anti-müllerian hormone
ASD  Atrial septal defect
ASI  Aortic size index
AVB  Atrioventricular block
B
BAV  Bicuspid aortic valve
BSA  Body surface area
BMI  Body mass index
BPM  Beats per minute
bQTc  Corrected QT interval according to Bazett s formula
C
CI   Confidence interval
CMR  Cardiac magnetic resonance imaging
COA  Coarctation of the aorta
CT  Computed tomography
D
DSD  Disorder/differences of sex development
E
ECG  Electrocardiogram
EF  Ejection fraction
ESS  European social survey
F
FS  Fractional shortening
FSH  Follicle-stimulating hormone
G
GLS  Global longitudinal strain
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H
HK  Horseshoe kidney
hQTc  Corrected QT interval according to Hodges  formula
HR  Hazard ratio
HRT  Hormone replacement therapy
HRQoL  Health-related quality of life
HTN  Hypertension
I
(I)LBBB  (Incomplete) left bundle branch block
(I)RBBB  (Incomplete) right bundle branch block
IQ   Intelligence quotient
IVSd  Interventricular septum thickness at end-diastole
IVSs  Interventricular septum thickness at end-systole 
L
LVH  Left ventricular hypertrophy
LVIDd  Left ventricular internal dimension at end-diastole
LVIDs  Left ventricular internal dimension at end-systole
LVM  Left ventricular mass
LVPWd  Left ventricular posterior wall thickness at end-diastole
LVPWs  Left ventricular posterior wall thickness at end-systole
M
MC/MT IV Metacarpal/Metatarsal IV bones
MC  Minnesota code
MI   Myocardial infarction
MS  Millisecond
MRI  Magnetic resonance imaging
N
NIPT  Non-invasive prenatal testing
O
OR  Odds ratio
P
PAPVR  Partial anomalous pulmonary venous return
PAR  Pseudo-autosomal region
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PDA  Patent ductus arteriosus
PRO  Patient-related outcome
Q
QoL  Quality of Life
QTC  Corrected QT interval
R
RAD  Right Axis Deviation
RVH  Right ventricular hypertrophy
S
SES  Socioeconomic status
SHOX  Short stature homeobox-containing gene
T
TSZ  Turner-specific z-score
TS   Turner syndrome
TTE  Trans-thoracic echocardiography
V
VSD  Ventricular septal defect
W
WES  Whole-exome sequencing
WPW  Wolff-Parkinson-White pattern
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RESEARCH DATA MANAGEMENT
This thesis is based on the results of human studies, which were conducted in accordance with the 
principles of the Declaration of Helsinki. The medical and ethical review board CMO Radboudumc 
has given approval to conduct the studies in chapter 3, 4 and 5 (2015-2165; 2019-5322). For the 
European dsd-LIFE study (Chapter 2 and 6), ethical approval was obtained as appropriate to each 
country (first ethical approval: Ethics Commission of the Charité Universitätsmedizin, reference 
number EA2/069/13; The Netherlands: Medical Ethical Committee VU Medical Center reference 
number 2013.336).
Chapter 2 and 6 were part of the dsd-LIFE study. In this European study, data were collected 
from fourteen study centers from six European countries. Informed consent was given by all 
participants. If participants were underage, their parents gave their respective informed consent. 
A dsd-LIFE database was designed and the personal data of every patient was pseudonymized. 
A pseudonym was automatically created by a Remote Data Entry (RDE) system. Study data 
required for analysis were acquired and transferred electronically to a central database using 
an Electronic Data Capture system. At the end of the study, the data was exported from the 
database and prepared for statistical analysis. After acceptance of the study protocol, the 
pseudonymized data were received by our study group. 
For chapter 3, data were collected during patient’s regular visits to our outpatient clinics. Patients 
did not have to undergo any interventions and did not have to pay extra visits to the hospital. For 
chapter 4 and 5, we retrospectively investigated electro- and echocardiograms assessed during 
regular care to determine whether cardiac abnormalities or ECG abnormalities were present. The 
final databases were pseudonymized using unique individual subject codes. These codes were 
stored separately from the study data. Only the research team has access to the research data 
and corresponding code files.
The data and metadata for the analyses of the studies presented in all the chapters are stored at 
the secured research department server of the Amalia Children’s Hospital, Radboudumc in SPSS 
format (O:\Turneronderzoek). The myocardial strain data (chapter 5) is stored at the department 
of radiology (\\umcsanfsclp01\radng_music2\MUSIC_PROJECTS\2021_TURNER_2DS_Iris-
Noordman). Paper ECGs (chapter 4) were stored in the department archive (Radboudumc 
M325.03.016). All research data will be saved for 15 years after termination of the study (January 
31, 2021). Using these patient data in future research is only possible after a new approval by 
the medical ethical review board. The datasets analyzed during these studies are available from 
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Dit wat ongewone PhD-traject had ik niet succesvol af kunnen ronden zonder de hulp en steun 
van velen. Het is oorspronkelijk nooit mijn plan geweest om promotieonderzoek te gaan doen, 
totdat ik via het ‘Excellent Student Programma’ in aanraking kwam met de patiëntengroep die 
mijn hart heeft veroverd. De mogelijkheid om iets bij te kunnen dragen aan de zorg voor deze 
meisjes en vrouwen, ook al is het maar klein, motiveerde mij om de uitdaging aan te gaan en 
m ijn onzekerheid aan de kant te zetten. Het is niet gebruikelijk om als bachelorstudent aan een 
promotietraject te beginnen, maar het team om mij heen heeft altijd in mij geloofd. Zij hebben 
mij de steun gegeven die ik nodig had om dit project op te starten en te volbrengen, samen met 
vele anderen in mijn persoonlijke kring. Graag wil ik iedereen bedanken die op wat voor manier 
dan ook betrokken is geweest bij het tot stand komen van dit proefschrift.
Ik wil allereerst alle meisjes en vrouwen met het syndroom van Turner en hun families
bedanken voor de deelname aan de onderzoeken in dit proefschrift en voor de meest hartelijke 
ontvangst op familiedagen die je maar kan bedenken. Het was een verrijking om jullie te leren 
kennen en te horen over wat jullie bezighoudt. Turner Contact Nederland, ik heb ontzettend 
veel respect voor jullie inzet voor alle meisjes en vrouwen met het syndroom van Turner. Dank 
voor jullie betrokkenheid en jullie bijdrage aan dit proefschrift. Also a special thanks to the 
participants of the dsd-LIFE study and the dsd-LIFE group, who contributed to the dsd-
LIFE chapters of this paper. 
Ik ben veel dank verschuldigd aan mijn begeleidingsteam: dr. Janiëlle van der Velden, prof. dr. 
Livia Kapusta en prof. dr. Hedi Claahsen-van der Grinten.
Janiëlle, jij hebt mij vanaf het begin onder je hoede genomen en niet meer losgelaten. Wat ben 
ik je dankbaar voor je liefdevolle zetjes in de rug, positiviteit en je perfect invoelend vermogen. 
Door jou heb ik een enorme groei kunnen doormaken als onderzoeker, als dokter, maar vooral 
ook als persoon. Je wist precies wat ik wanneer nodig had en je hebt altijd in mij geloofd, ook 
als ik dat zelf soms niet deed. Naast de samenwerking binnen het onderzoek, hebben we ook 
daarbuiten leuke momenten gedeeld en veel gelachen. Vooral de ESPE meeting in Wenen staat 
me nog helder voor de geest en hier heb ik erg van genoten. Het is moeilijk in woorden uit te 
drukken hoe veel je voor mij hebt betekend. Dank voor alles wat je in de afgelopen jaren voor 
mij hebt gedaan.
Livia, wat heb ik veel van jou geleerd. We hebben intensief samengewerkt en ondanks je drukke 
baan was je altijd de snelste met het terugsturen van feedback. Een meeting op de vroege 
zaterdagochtend (het midden van jouw dag ) of afspreken in de vakantie: niets was je te gek 
en je maakte altijd tijd voor me. Vele uren hebben we achter de echopac pc gezeten om samen 
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te kijken naar echo’s. Ik ben je ontzettend dankbaar voor alles wat je me hebt geleerd over de 
(kinder)cardiologie en andere aspecten binnen en buiten de onderzoekswereld.
Hedi, ook jij was een belangrijk onderdeel van het team. Samen hebben we ons gebogen over 
de DSD-stukken in dit proefschrift en ik heb met veel plezier onder je supervisie gewerkt tijdens 
mijn keuzecoschap DSD. Jij hebt mij geleerd hoe je als clinicus onderzoeksdata goed kan 
interpreteren en hoe je hier voor je patiënten zo veel mogelijk uit kan halen. De manier waarop 
jij patiëntengroepen betrekt bij zowel zorg als onderzoek inspireert mij. Wat een eer dat ik jouw 
eerste promovendus mag zijn als kersverse hoogleraar. Bedankt voor alles!
Toon, als mentor van het eerste uur en later als lid van het onderzoeksteam, heb jij veel 
bijgedragen aan dit proefschrift. Sterker nog, zonder jouw idee was ik nooit bij dit onderzoek 
terechtgekomen! Bedankt voor je begeleiding, voor je lessen over de cardiologie en voor je 
klinische blik.
Zina, met veel plezier heb ik met jou samengewerkt. Wat fijn dat ik regelmatig met je mee mocht 
lopen op de afdeling en dat je me wegwijs hebt gemaakt in de wereld van de kindercardiologie. 
Bedankt voor je enthousiasme, ondersteunende woorden en je hulp bij dit proefschrift.
De afdelingen interne geneeskunde, klinische genetica en Health Evidence waren vaak betrokken 
in ons onderzoek. Ik wil met name Henri Timmers, Marlies Kempers en Nel Roeleveld 
hartelijk danken voor hun expertise. Nel, bedankt voor al je uitleg en het meedenken over de 
statistiek. Ik heb ontzettend veel van je geleerd. Ook Dominique Smeets wil ik bedanken voor 
alle hulp en uitleg in Jip en Janneketaal. Telefoontjes met jou maakten mijn dag altijd goed!
Gert, samenwerken met jou was altijd een feestje. Zonder jouw technische hulp en handigheidjes 
had hoofdstuk 5 niet in dit proefschrift gestaan. Ook Remy wil ik bedanken voor de hulp, lessen 
over strain en uiteraard de huizentips tussendoor! Ik voelde me altijd erg welkom bij jullie op de 
afdeling.
Misty en Melanie, bedankt voor jullie bijdrage aan de cardiale stukken in dit proefschrift. Samen 
hebben we er iets moois van gemaakt! Ik wens jullie veel succes met jullie verdere carrière.
Graag wil ik de manuscriptcommissie: prof. dr. Brunner, prof. dr. De Groote en dr. Sas van 
harte bedanken voor het lezen en beoordelen van mijn manuscript.
Dr. Fabienne Marchau, bedankt voor uw kritische blik op de discussie van dit proefschrift.
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De Stichting Kindercardiologie Nijmegen, afdeling kinderendocrinologie en prof. 
De Korte (afdeling Radiologie) wil ik bedanken voor de financiële ondersteuning bij het tot 
stand komen van dit promotietraject en proefschrift. Daarnaast bedank ik graag de Stichting 
Kindergeneeskunde Nijmegen voor hun financiële bijdrage middels het Sengers Stipendium.
Behalve Janiëlle en Hedi, wil ik ook de andere leden van het (voormalig) endo-team bedanken: 
Sandra, Petra, Yvonne, Karijn, Annelieke, Kees, Manon, Jacqueline en Teun. Jullie 
zijn een fantastisch team waar ik me echt onderdeel van voelde. Bedankt voor de wekelijkse 
endocrinologiebespreking waar ik altijd met veel plezier aansloot, voor de gezelligheid en voor 
het meeleven met mijn promotietraject. Ik hoop in de toekomst nog veel met jullie te mogen 
samenwerken.
Marianne en Emma, waar zou ik zijn geweest zonder jullie. Bedankt voor de fantastische 
ondersteuning en samenwerking.
Prof. dr. Willemsen, beste Michèl, ook zonder jou was dit boekje er niet gekomen. Als mijn ESP 
mentor en later enthousiaste volger vanaf de zijlijn heb je mij het vertrouwen gegeven dat ik dit 
kon. Ik heb je eerlijkheid, interesse en ondersteuning altijd erg gewaardeerd. Bedankt daarvoor! 
Mijn RIHS mentor, dr. Romana Netea-Maier, wil ik bedanken voor de waardevolle adviezen. 
Ook al hebben we elkaar niet vaak gezien, ik heb altijd het gevoel gehad dat de deur openstond. 
Michiel Schokking, bedankt voor alle begeleiding in de eerste fase van mijn onderzoekstraject. 
Het Excellent Student Programma en alle mensen die daarbij betrokken zijn, wil ik bedanken 
voor alle kansen die ik heb gekregen. Met heel veel plezier ben ik de afgelopen jaren onderdeel 
geweest van dit programma en ook het laatste jaar als commissielid heeft mij veel gebracht. 
Graag bedank ik mijn mede-commissieleden voor de fantastische samenwerking en inspirerende 
meetings. Ga zo door!
Ook wil ik de gehele vakgroep kindergeneeskunde en specifiek de arts-assistenten 
bedanken. Velen van jullie ben ik tegengekomen tijdens de bachelor, wetenschappelijke stage, 
coschappen of daarna. Ik voelde me altijd welkom in het team en heb met veel plezier meegedaan 
aan de overdrachten en onderwijsmomenten, die er met name in het laatste jaar voor zorgden 
dat ik binding kon houden met de kliniek. Ilja, Carolien, Floor en Hilde, een speciaal bedankje 
voor jullie enthousiasme en het meedenken over mijn traject.
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Graag wil ik alle mede-onderzoekers bedanken voor de samenwerking, ondersteuning en ook 
vooral voor de gezelligheid. Ik heb aan het eind van mijn PhD kort mogen ervaren hoe het is om 
dagelijks mensen om je heen te hebben die ook met onderzoek bezig zijn en ik vond het een 
enorme verrijking. Samen nadenken over ingewikkelde problemen, klagen over tegenslagen, 
of gewoon met z’n allen rustig aan het werk zijn. Helaas gooide COVID-19 een groot deel van 
het laatste jaar roet in het eten, maar gelukkig konden we toch met elkaar in contact blijven 
door online pubquizzen, wandelingetjes door het Kronenburger park, samenwerkdagen of 
intervisielunch op Plein ‘44. Wouter, bedankt voor het openstellen van jouw huis als ik helemaal 
klaar was met het mijne. Wat fi jn dat ik regelmatig langs mocht komen voor een cappuccino, 
chocomel en stroopwafels. Ik kon altijd op je rekenen als er naar mijn tekst gekeken moest 
worden en met veel plezier heb ik me bemoeid met jouw liefdesleven.  Bedankt voor de leuke 
tijd en succes met het afronden van je proefschrift! Lara, ook jij verdient een speciaal bedankje. 
Onze samenwerkdagen in coronatijd waren altijd een welkome afwisseling. We hebben elkaar 
op deze manier goed leren kennen, ik heb veel van je geleerd en we hebben echt een leuke tijd 
gehad. Onze nieuwe huizen waren een favoriet gespreksonderwerp; ook voor jou alvast veel 
woonplezier gewenst! Romy, ook jou wil ik bedanken voor de gezelligheid vanaf het eerste 
moment dat ik je leerde kennen. Geniet van je verlof en straks van je kleine man! Marjolein, 
bedankt voor al je tips en tricks, je authenticiteit en onze geslaagde etentjes. Dat er nog maar 
vele mogen volgen! Sapthami, wat een toffe dagen heb ik met jou in Wenen gehad! Zo fi jn om 
daar een maatje te hebben, dankjewel daarvoor.
Kindergeneeskundig team Maasziekenhuis Pantein, bedankt dat ik zo’n fantastisch 
seniorcoschap bij jullie heb mogen doen. Jullie werkwijze heeft mij geïnspireerd en ik kijk met 
veel plezier op deze tijd terug. Dank voor jullie coaching en jullie fl exibiliteit wat betreft mijn 
onderzoek.
Lieve Elleke, wat fi jn dat jij tijdens de eerste lockdown ook onderzoek deed. Samen werken in 
mijn huis maakte het allemaal een stukje leuker, al helemaal met taartjes van de Holy Sweets, 
koffi e van Gesha en wandelingetjes tussendoor. Ik heb deze periode als heel waardevol ervaren, 
maar ook tijdens de coschappen hebben we lief, leed en kamers (hello Winterswijk!) gedeeld. 
Bedankt voor alles!
Cogroep 210, en met name Inez, Gaia, Nelleke (en Bauke natuurlijk), Joep en Niels wil 
ik bedanken voor de gezelligheid tijdens de coschappen en daarna. Met name het coschap 
oogheelkunde staat nog in mijn geheugen gegrift. Op naar nog vele borrels en waalstranddates!
Gekkaaah Boiis, als ik jullie zie, voelt het altijd direct weer als vanouds. Bedankt voor de 
fantastische tijd!
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Anne en Maarten, Ellen en Ramon (en uiteraard Luca) en Kelly, bedankt voor de gezelligheid 
als ik weer eens in Haaksbergen was. Meiden, ik ken jullie al heel lang en ik vind het bijzonder 
dat we elkaar elke keer nog weer weten te vinden. Bedankt voor jullie vriendschap!
Iris, ook jij bent al heel lang onderdeel van mijn leven. Het voelt altijd heel vertrouwd als ik je 
weer spreek en ik wil je bedanken voor je oprechte belangstelling en interesse. 
Ook wil ik Nicole en Roderik bedanken voor al het meedenken en voor onze fi jne vriendschap! 
Nicole, je bent altijd een grote inspiratiebron voor me geweest en daar ben ik je heel dankbaar 
voor (en knuffelen met Floris en Victijn is altijd weer heerlijk ).
Lieve conservatoriumvrienden, ook al zie ik jullie helaas niet meer zo vaak, jullie hebben kleur 
in mijn leven gebracht. Ik ga graag naar jullie voorstellingen en optredens die mij terugbrengen 
naar de conservatoriumtijd, waar ik nog altijd met veel plezier en soms een beetje heimwee aan 
terugdenk. Ook al ben ik overtuigd van de keuzes die ik heb gemaakt, gelukkig vergeet ik door 
jullie nooit de liefde voor de muziek en het belang van creativiteit in het leven. En die kinderliedjes 
van Beatrijs komen hopelijk ooit nog van pas! 
Lieve Isabel, jou wil ik bedanken voor de bijzondere band die we hebben. Onze ontmoeting in 
Indonesië voelt nog als de dag van gisteren. Het is altijd een feestje als ik jou (en Tal!) weer zie 
en ik hoop op nog vele ontmoetingen ‘halverwege’ (in Nederland of daarbuiten). 
Lieve Loes en Aline, mijn paranimfen en beste vriendinnen, wat fi jn dat jullie mij op deze belangrijke 
dag willen bijstaan, net zoals jullie mij altijd hebben bijgestaan. Als mede-onderzoekers weten 
jullie als geen ander wat dit traject precies inhoudt en wat erbij komt kijken. Jullie weten alles 
altijd weer in perspectief te plaatsen en dat vind ik heel waardevol. Ik geniet van onze etentjes, 
sauna-bezoeken, weekendjes weg en alle andere dingen die we samen doen, maar het laatste 
jaar is mij wel duidelijk geworden dat wij niet veel nodig hebben om het samen leuk te hebben! 
Jullie zijn me heel dierbaar en ik hoop op nog vele mooie momenten samen in de toekomst. 
Lieve Karel en Irma, Nicole, Leon en Aiden, bedankt voor de interesse in mijn onderzoek, 
voor de gezelligheid en voor de jaarlijkse week Italië, waar ik heerlijk kon ontspannen als ik weer 
eens een artikel had ingeleverd. Ook de families van beide kanten waren altijd betrokken; met 
een speciale herinnering aan oma Bloem. Wat fi jn dat ik in zo’n warm bad terecht ben gekomen.
Als laatste wil ik mijn lieve familie bedanken, zij zijn voor mij ontzettend belangrijk. Graag 
bedank ik mijn opa en oma’s, die zo van harte met mij hebben meegeleefd. Wat fi jn dat jullie 
deze mijlpaal met mij kunnen meemaken. Ik weet zeker dat mijn overleden opa Van Dijk ook 
supertrots op mij zou zijn geweest. Bernard en Joke (peetoom en -tante, die altijd wel te porren 
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zijn voor een feestje in Nijmegen), familie Noordman en familie Van Dijk, ook jullie wil ik 
bedanken voor de interesse in mij, jullie enthousiasme en de gezelligheid. Ik ben er trots op 
onderdeel te zijn van deze families.
Rogier en Deveny, ook jullie zijn heel belangrijk voor mij. Roger, jouw wiskundige inzicht heeft 
dit proefschrift naar een hoger niveau getild en onder jouw invloed zijn er vele nieuwe hashtags 
ontstaan in de pizzeria in Pfunds. Dank voor je hulp; ik kan me geen leukere broer wensen! Dev, 
bedankt voor jouw creatieve hulp en voor de extra gezelligheid die je met je mee brengt binnen 
ons gezin.  
Lieve papa en mama, jullie hebben mij altijd onvoorwaardelijk gesteund in de dingen die ik 
doe en hebben met veel interesse dit hele traject van dichtbij gevolgd. Of het nu ging over het 
meedenken over de juiste stappen in mijn carrière, het oefenen van presentaties, het lezen van 
teksten of het luisteren naar problemen waar ik tegenaan liep, jullie stonden en staan altijd voor 
mij klaar. Ik kan in geen woorden beschrijven hoeveel jullie voor mij betekenen en ik wil jullie 
ontzettend bedanken voor de stabiele basis en de liefde die jullie mij hebben gegeven. 
Dan, last but definitely not least, lieve Tim, al zo veel jaren mijn steun en toeverlaat. ‘Bedankt voor 
alles’ zou jou absoluut tekort doen. Ik voel me gezegend dat ik elke avond bij jou mag thuiskomen. 
Jij hebt me altijd volledig gesteund gedurende dit promotietraject en hebt regelmatig geholpen 
met allerlei zaken rondom dit proefschrift. Ik geniet van onze momenten samen. Etentjes, reizen, 
wandelen, naar pretparken gaan waar ik met een blij hoofd rondren, of gewoon thuis op de bank; 
met jou is alles leuker. Ik ben met heel veel plezier met jou verhuisd naar ons prachtige huis in 
Lent en kijk uit naar onze toekomst samen. Ik hou ontzettend veel van jou.
203DANKWOORD
Iris D. Noordman
CLINICAL STUDIES ON KARYOTYPE-PHENOTYPE 
ASSOCIATIONS, CARDIAC ABNORMALITIES AND 
SOCIOECONOMIC STATUS
















































Iris D. N rdman
CLINICAL STUDIES ON KARYOTYPE-PHENOTYPE 
ASSOCIATIONS, CARDIAC ABNORMALITIES AND 
SOCIOECONOMIC STATUS
UITNODIGING
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Op 24 september 2021
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Radboud Universiteit
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